BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 355777 CCOc1ccc(CC(=O)CNN([C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)C(=O)CC)cc1 InChI=1S/C31H38N4O4/c1-3-30(37)35(34-22-27(36)18-24-14-16-28(17-15-24)39-4-2)29(19-23-8-6-5-7-9-23)31(38)33-21-26-12-10-25(20-32)11-13-26/h5-17,29,34H,3-4,18-22,32H2,1-2H3,(H,33,38)/t29-/m0/s1 HIZICQRQZNAZQO-LJAQVGFWSA-N 200010 US9234000, 1 Plasma kallikrein Human 89 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200010 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200010&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71186049 318589840 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355778 CCOc1ccc(C[C@@H](NS(C)(=O)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C29H36N4O5S/c1-3-38-25-15-13-22(14-16-25)18-27(33-39(2,36)37)29(35)32-26(17-21-7-5-4-6-8-21)28(34)31-20-24-11-9-23(19-30)10-12-24/h4-16,26-27,33H,3,17-20,30H2,1-2H3,(H,31,34)(H,32,35)/t26-,27+/m0/s1 FRZFKIXOXWONFI-RRPNLBNLSA-N 200011 US9234000, 2 Plasma kallikrein Human 820 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200011 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200011&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185488 318589841 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355779 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H38N4O4/c1-2-43-30-19-17-26(18-20-30)22-32(38-33(40)29-11-7-4-8-12-29)35(42)39-31(21-25-9-5-3-6-10-25)34(41)37-24-28-15-13-27(23-36)14-16-28/h3-20,31-32H,2,21-24,36H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t31-,32+/m0/s1 UCIXIQRCAGGOJY-AJQTZOPKSA-N 200012 US9234000, 3::US9512065, N-[(R)-1-[(S)-1-(4-aminomethyl-benzylcarbamoyl)-2-phenyl-ethylcarbamoyl]-2-(4-ethoxy-phenyl)-ethyl]-benzamide Plasma kallikrein Human 22 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200012 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200012&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185716 318589842 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355780 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](CC2CCCCC2)NCC(O)=O)cc1 InChI=1S/C28H38N4O4/c29-17-22-11-13-23(14-12-22)18-31-27(35)25(16-21-9-5-2-6-10-21)32-28(36)24(30-19-26(33)34)15-20-7-3-1-4-8-20/h2,5-6,9-14,20,24-25,30H,1,3-4,7-8,15-19,29H2,(H,31,35)(H,32,36)(H,33,34)/t24-,25+/m1/s1 CFVWQRMYGPSOPB-RPBOFIJWSA-N 200013 US9234000, 4 Plasma kallikrein Human 230 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200013 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200013&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185578 318589843 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355781 CCOc1ccc(C[C@@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C28H34N4O3/c1-2-35-24-14-12-21(13-15-24)16-25(30)27(33)32-26(17-20-6-4-3-5-7-20)28(34)31-19-23-10-8-22(18-29)9-11-23/h3-15,25-26H,2,16-19,29-30H2,1H3,(H,31,34)(H,32,33)/t25-,26+/m1/s1 CKNDVDLSIUTQOV-FTJBHMTQSA-N 200014 US9234000, 5 Plasma kallikrein Human 460 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200014 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200014&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185684 318589844 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355782 CCOc1ccc(C[C@@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(F)c2)cc1 InChI=1S/C28H33FN4O3/c1-2-36-23-12-9-20(10-13-23)15-25(31)27(34)33-26(16-19-6-4-3-5-7-19)28(35)32-18-21-8-11-22(17-30)24(29)14-21/h3-14,25-26H,2,15-18,30-31H2,1H3,(H,32,35)(H,33,34)/t25-,26+/m1/s1 DYSQLBNPCSMIDI-FTJBHMTQSA-N 200015 US9234000, 6 Plasma kallikrein Human 1000 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200015 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200015&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185696 318589845 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355783 CCOc1ccc(CC(=O)CNN([C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(F)c2)C(=O)CC)cc1 InChI=1S/C31H37FN4O4/c1-3-30(38)36(35-21-26(37)16-23-11-14-27(15-12-23)40-4-2)29(18-22-8-6-5-7-9-22)31(39)34-20-24-10-13-25(19-33)28(32)17-24/h5-15,17,29,35H,3-4,16,18-21,33H2,1-2H3,(H,34,39)/t29-/m0/s1 QGGICRDCUBZHLM-LJAQVGFWSA-N 200016 US9234000, 7 Plasma kallikrein Human 74 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200016 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200016&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185568 318589846 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355784 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](N)CC2CCCCC2)cc1 InChI=1S/C26H36N4O2/c27-17-21-11-13-22(14-12-21)18-29-26(32)24(16-20-9-5-2-6-10-20)30-25(31)23(28)15-19-7-3-1-4-8-19/h2,5-6,9-14,19,23-24H,1,3-4,7-8,15-18,27-28H2,(H,29,32)(H,30,31)/t23-,24+/m1/s1 DYXWMPUBPWGOBS-RPWUZVMVSA-N 200017 US9234000, 8 Plasma kallikrein Human 740 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200017 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200017&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185917 318589847 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355785 CN(C)[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C28H40N4O2/c1-32(2)26(18-22-11-7-4-8-12-22)28(34)31-25(17-21-9-5-3-6-10-21)27(33)30-20-24-15-13-23(19-29)14-16-24/h3,5-6,9-10,13-16,22,25-26H,4,7-8,11-12,17-20,29H2,1-2H3,(H,30,33)(H,31,34)/t25-,26+/m0/s1 YGGDYXYGFDZJQM-IZZNHLLZSA-N 200018 US9234000, 9 Plasma kallikrein Human 2000 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200018 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200018&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185478 318589848 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355786 CCC(=O)N[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C29H40N4O3/c1-2-27(34)32-26(18-22-11-7-4-8-12-22)29(36)33-25(17-21-9-5-3-6-10-21)28(35)31-20-24-15-13-23(19-30)14-16-24/h3,5-6,9-10,13-16,22,25-26H,2,4,7-8,11-12,17-20,30H2,1H3,(H,31,35)(H,32,34)(H,33,36)/t25-,26+/m0/s1 QLIXNVHPGDHCMQ-IZZNHLLZSA-N 200019 US9234000, 10 Plasma kallikrein Human 7200 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200019 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200019&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185589 318589849 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355787 CS(=O)(=O)N[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C27H38N4O4S/c1-36(34,35)31-25(17-21-10-6-3-7-11-21)27(33)30-24(16-20-8-4-2-5-9-20)26(32)29-19-23-14-12-22(18-28)13-15-23/h2,4-5,8-9,12-15,21,24-25,31H,3,6-7,10-11,16-19,28H2,1H3,(H,29,32)(H,30,33)/t24-,25+/m0/s1 BHGMFBIBURKARK-LOSJGSFVSA-N 200020 US9234000, 11 Plasma kallikrein Human 1700 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200020 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200020&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185506 318589850 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355788 CCOc1ccc(CC(=O)CNN([C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2Cl)C(=O)CC)cc1 InChI=1S/C31H37ClN4O4/c1-3-30(38)36(35-21-26(37)16-23-11-14-27(15-12-23)40-4-2)29(18-22-8-6-5-7-9-22)31(39)34-20-25-13-10-24(19-33)17-28(25)32/h5-15,17,29,35H,3-4,16,18-21,33H2,1-2H3,(H,34,39)/t29-/m0/s1 WLMGFSPBGBMIGW-LJAQVGFWSA-N 200021 US9234000, 12 Plasma kallikrein Human 290 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200021 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200021&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185705 318589851 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355789 CCOc1ccc(C[C@@H](N(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C30H38N4O3/c1-4-37-26-16-14-23(15-17-26)19-28(34(2)3)30(36)33-27(18-22-8-6-5-7-9-22)29(35)32-21-25-12-10-24(20-31)11-13-25/h5-17,27-28H,4,18-21,31H2,1-3H3,(H,32,35)(H,33,36)/t27-,28+/m0/s1 VTDDUYHUEDESOS-WUFINQPMSA-N 200022 US9234000, 13 Plasma kallikrein Human 10000 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200022 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200022&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185941 318589852 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355790 CCOc1ccc(C[C@@H](N)C(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C28H32Cl2N4O3/c1-2-37-22-10-7-18(8-11-22)14-25(32)27(35)34-26(15-21-9-12-23(29)24(30)13-21)28(36)33-17-20-5-3-19(16-31)4-6-20/h3-13,25-26H,2,14-17,31-32H2,1H3,(H,33,36)(H,34,35)/t25-,26+/m1/s1 VZESEHUJGZLJDE-FTJBHMTQSA-N 200023 US9234000, 14 Plasma kallikrein Human 400 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200023 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200023&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185604 318589853 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355791 CCOc1ccc(C[C@@H](NS(=O)(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H38N4O5S/c1-2-43-29-19-17-26(18-20-29)22-32(38-44(41,42)30-11-7-4-8-12-30)34(40)37-31(21-25-9-5-3-6-10-25)33(39)36-24-28-15-13-27(23-35)14-16-28/h3-20,31-32,38H,2,21-24,35H2,1H3,(H,36,39)(H,37,40)/t31-,32+/m0/s1 TYAFGBNTZJXKOW-AJQTZOPKSA-N 200024 US9234000, 15 Plasma kallikrein Human 470 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200024 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185519 318589854 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355792 CCOc1ccc(CC(=O)CNN([C@@H](Cc2ccc(Cl)c(Cl)c2)C(=O)NCc2ccc(CN)cc2)C(=O)CC)cc1 InChI=1S/C31H36Cl2N4O4/c1-3-30(39)37(36-20-25(38)15-21-9-12-26(13-10-21)41-4-2)29(17-24-11-14-27(32)28(33)16-24)31(40)35-19-23-7-5-22(18-34)6-8-23/h5-14,16,29,36H,3-4,15,17-20,34H2,1-2H3,(H,35,40)/t29-/m0/s1 VVTPHYNAXUAJJK-LJAQVGFWSA-N 200025 US9234000, 16 Plasma kallikrein Human 53 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200025 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200025&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185539 318589855 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355793 CCOc1ccc(C[C@@H](NCC(O)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C30H36N4O5/c1-2-39-25-14-12-22(13-15-25)16-26(32-20-28(35)36)30(38)34-27(17-21-6-4-3-5-7-21)29(37)33-19-24-10-8-23(18-31)9-11-24/h3-15,26-27,32H,2,16-20,31H2,1H3,(H,33,37)(H,34,38)(H,35,36)/t26-,27+/m1/s1 LCJSVWIPKDJPSR-SXOMAYOGSA-N 200026 US9234000, 17 Plasma kallikrein Human 5800 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200026 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200026&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 90302159 318589856 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355794 NCc1ccc(CNC(=O)[C@H](Cc2ccc(Cl)c(Cl)c2)NC(=O)[C@H](N)Cc2ccc(cc2)C(F)(F)F)cc1 InChI=1S/C27H27Cl2F3N4O2/c28-21-10-7-19(11-22(21)29)13-24(26(38)35-15-18-3-1-17(14-33)2-4-18)36-25(37)23(34)12-16-5-8-20(9-6-16)27(30,31)32/h1-11,23-24H,12-15,33-34H2,(H,35,38)(H,36,37)/t23-,24+/m1/s1 MSIDCYYMNINMSP-RPWUZVMVSA-N 200027 US9234000, 18 Plasma kallikrein Human 8800 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200027 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200027&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185666 318589857 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355795 CC(=O)CN([C@@H](Cc1ccc(Cl)c(Cl)c1)C(=O)NCc1ccc(CN)cc1)[C@H](CC(N)=O)c1ccc(cc1)C(F)(F)F InChI=1S/C30H31Cl2F3N4O3/c1-18(40)17-39(26(14-28(37)41)22-7-9-23(10-8-22)30(33,34)35)27(13-21-6-11-24(31)25(32)12-21)29(42)38-16-20-4-2-19(15-36)3-5-20/h2-12,26-27H,13-17,36H2,1H3,(H2,37,41)(H,38,42)/t26-,27+/m1/s1 STTPARYKVKFFLP-SXOMAYOGSA-N 200028 US9234000, 19 Plasma kallikrein Human 10000 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200028 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200028&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185662 318589858 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355796 NCc1ccc(CNC(=O)[C@H](Cc2ccc(Cl)c(Cl)c2)NC(=O)[C@H](N)CC2CCCCC2)cc1 InChI=1S/C26H34Cl2N4O2/c27-21-11-10-20(12-22(21)28)14-24(26(34)31-16-19-8-6-18(15-29)7-9-19)32-25(33)23(30)13-17-4-2-1-3-5-17/h6-12,17,23-24H,1-5,13-16,29-30H2,(H,31,34)(H,32,33)/t23-,24+/m1/s1 HGSLIAPVEOZQPN-RPWUZVMVSA-N 200029 US9234000, 20 Plasma kallikrein Human 730 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200029 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200029&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185567 318589859 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355797 NCc1ccc(CNC(=O)[C@H](Cc2ccc(Cl)c(Cl)c2)N(CCC(N)=O)CC(=O)CC2CCCCC2)cc1 InChI=1S/C29H38Cl2N4O3/c30-25-11-10-23(15-26(25)31)16-27(29(38)34-18-22-8-6-21(17-32)7-9-22)35(13-12-28(33)37)19-24(36)14-20-4-2-1-3-5-20/h6-11,15,20,27H,1-5,12-14,16-19,32H2,(H2,33,37)(H,34,38)/t27-/m0/s1 NJCMMYULSKXGQU-MHZLTWQESA-N 200030 US9234000, 21 Plasma kallikrein Human 5100 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200030 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200030&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 90301817 318589860 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355798 C[C@@H](NC(=O)c1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C27H30N4O3/c1-19(30-26(33)23-10-6-3-7-11-23)25(32)31-24(16-20-8-4-2-5-9-20)27(34)29-18-22-14-12-21(17-28)13-15-22/h2-15,19,24H,16-18,28H2,1H3,(H,29,34)(H,30,33)(H,31,32)/t19-,24+/m1/s1 ZVKJQLYOLHGKQK-DVECYGJZSA-N 200031 US9234000, 22 Plasma kallikrein Human 10000 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200031 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200031&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185645 318589861 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355799 CCOc1ccc(CC(=O)CNN([C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(Cl)c2)C(=O)CC)cc1 InChI=1S/C31H37ClN4O4/c1-3-30(38)36(35-21-26(37)16-23-11-14-27(15-12-23)40-4-2)29(18-22-8-6-5-7-9-22)31(39)34-20-24-10-13-25(19-33)28(32)17-24/h5-15,17,29,35H,3-4,16,18-21,33H2,1-2H3,(H,34,39)/t29-/m0/s1 SBMXVJAAZJABGK-LJAQVGFWSA-N 200032 US9234000, 23 Plasma kallikrein Human 31 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200032 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200032&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71186002 318589862 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355800 CCOc1ccc(CC(=O)CNN([C@@H](Cc2ccccc2)C(=O)N(C)Cc2ccc(CN)cc2)C(=O)CC)cc1 InChI=1S/C32H40N4O4/c1-4-31(38)36(34-22-28(37)19-25-15-17-29(18-16-25)40-5-2)30(20-24-9-7-6-8-10-24)32(39)35(3)23-27-13-11-26(21-33)12-14-27/h6-18,30,34H,4-5,19-23,33H2,1-3H3/t30-/m0/s1 RKOQPQPBBDKART-PMERELPUSA-N 200033 US9234000, 24 Plasma kallikrein Human 450 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200033 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200033&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185838 318589863 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355801 CCOc1ccc(C[C@@H](N)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C29H36N4O3/c1-3-36-25-15-13-22(14-16-25)17-26(31)29(35)33(2)27(18-21-7-5-4-6-8-21)28(34)32-20-24-11-9-23(19-30)10-12-24/h4-16,26-27H,3,17-20,30-31H2,1-2H3,(H,32,34)/t26-,27+/m1/s1 JQDLBRDUISCYPO-SXOMAYOGSA-N 200034 US9234000, 25 Plasma kallikrein Human 340 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200034 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200034&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185646 318589864 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355802 CCOc1ccc(CC(=O)CNCCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C32H40N4O4/c1-3-40-29-15-13-25(14-16-29)19-28(37)23-34-18-17-31(38)36(2)30(20-24-7-5-4-6-8-24)32(39)35-22-27-11-9-26(21-33)10-12-27/h4-16,30,34H,3,17-23,33H2,1-2H3,(H,35,39)/t30-/m0/s1 MFCPDGVWAVFAEY-PMERELPUSA-N 200035 US9234000, 26 Plasma kallikrein Human 81 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200035 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200035&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185879 318589865 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355803 CCOc1ccc(C[C@@H](NC)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C29H36N4O3/c1-3-36-25-15-13-22(14-16-25)17-26(31-2)29(35)33-27(18-21-7-5-4-6-8-21)28(34)32-20-24-11-9-23(19-30)10-12-24/h4-16,26-27,31H,3,17-20,30H2,1-2H3,(H,32,34)(H,33,35)/t26-,27+/m1/s1 ACUWRQFKSMMPOB-SXOMAYOGSA-N 200036 US9234000, 27 Plasma kallikrein Human 1300 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200036 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200036&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71186096 318589866 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355804 CC(C)C[C@@H](NCC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C25H34N4O4/c1-17(2)12-21(27-16-23(30)31)25(33)29-22(13-18-6-4-3-5-7-18)24(32)28-15-20-10-8-19(14-26)9-11-20/h3-11,17,21-22,27H,12-16,26H2,1-2H3,(H,28,32)(H,29,33)(H,30,31)/t21-,22+/m1/s1 NZZLBZLVTPDYDB-YADHBBJMSA-N 200037 US9234000, 28 Plasma kallikrein Human 8900 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200037 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200037&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185650 318589867 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355805 CN(CC(O)=O)[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C29H40N4O4/c1-33(20-27(34)35)26(17-22-10-6-3-7-11-22)29(37)32-25(16-21-8-4-2-5-9-21)28(36)31-19-24-14-12-23(18-30)13-15-24/h2,4-5,8-9,12-15,22,25-26H,3,6-7,10-11,16-20,30H2,1H3,(H,31,36)(H,32,37)(H,34,35)/t25-,26+/m0/s1 DOFSTNRBTSKYAL-IZZNHLLZSA-N 200038 US9234000, 29 Plasma kallikrein Human 300 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200038 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200038&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185561 318589868 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355806 CN([C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1)C(=O)[C@@H](CC1CCCCC1)NCC(O)=O InChI=1S/C29H40N4O4/c1-33(29(37)25(31-20-27(34)35)16-21-8-4-2-5-9-21)26(17-22-10-6-3-7-11-22)28(36)32-19-24-14-12-23(18-30)13-15-24/h3,6-7,10-15,21,25-26,31H,2,4-5,8-9,16-20,30H2,1H3,(H,32,36)(H,34,35)/t25-,26+/m1/s1 AEVWSCHVTRCRRI-FTJBHMTQSA-N 200039 US9234000, 30 Plasma kallikrein Human 580 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200039 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200039&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185756 318589869 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355807 CCOc1ccc(C[C@@H](N(C)C(=O)CC)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C32H40N4O4/c1-4-30(37)36(3)29(20-24-15-17-27(18-16-24)40-5-2)32(39)35-28(19-23-9-7-6-8-10-23)31(38)34-22-26-13-11-25(21-33)12-14-26/h6-18,28-29H,4-5,19-22,33H2,1-3H3,(H,34,38)(H,35,39)/t28-,29+/m0/s1 VCUKNDNIFAKRDT-URLMMPGGSA-N 200040 US9234000, 31 Plasma kallikrein Human 4300 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200040 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200040&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185842 318589870 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355808 CCOc1ccc(CC(=O)CNCCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(F)c2)cc1 InChI=1S/C32H39FN4O4/c1-3-41-28-13-10-24(11-14-28)17-27(38)22-35-16-15-31(39)37(2)30(19-23-7-5-4-6-8-23)32(40)36-21-25-9-12-26(20-34)29(33)18-25/h4-14,18,30,35H,3,15-17,19-22,34H2,1-2H3,(H,36,40)/t30-/m0/s1 QRDHDDSDKPGPTM-PMERELPUSA-N 200041 US9234000, 32 Plasma kallikrein Human 200 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200041 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200041&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185658 318589871 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355809 CN[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C27H38N4O2/c1-29-24(16-20-8-4-2-5-9-20)27(33)31-25(17-21-10-6-3-7-11-21)26(32)30-19-23-14-12-22(18-28)13-15-23/h3,6-7,10-15,20,24-25,29H,2,4-5,8-9,16-19,28H2,1H3,(H,30,32)(H,31,33)/t24-,25+/m1/s1 RQFBFAXVOLVFAX-RPBOFIJWSA-N 200042 US9234000, 33 Plasma kallikrein Human 1100 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200042 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200042&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185895 318589872 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355810 CN([C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)c(F)c1)C(=O)[C@@H](CC1CCCCC1)NCC(O)=O InChI=1S/C29H39FN4O4/c1-34(29(38)25(32-19-27(35)36)15-20-8-4-2-5-9-20)26(16-21-10-6-3-7-11-21)28(37)33-18-22-12-13-23(17-31)24(30)14-22/h3,6-7,10-14,20,25-26,32H,2,4-5,8-9,15-19,31H2,1H3,(H,33,37)(H,35,36)/t25-,26+/m1/s1 PGHCXWHUESPXEI-FTJBHMTQSA-N 200043 US9234000, 34 Plasma kallikrein Human 1400 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200043 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200043&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71186135 318589873 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355811 CCCN[C@H](Cc1ccc(OCC)cc1)C(=O)N(C)[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C32H42N4O3/c1-4-19-34-29(20-25-15-17-28(18-16-25)39-5-2)32(38)36(3)30(21-24-9-7-6-8-10-24)31(37)35-23-27-13-11-26(22-33)12-14-27/h6-18,29-30,34H,4-5,19-23,33H2,1-3H3,(H,35,37)/t29-,30+/m1/s1 RRCQNIGKGMQKJC-IHLOFXLRSA-N 200044 US9234000, 35 Plasma kallikrein Human 2000 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200044 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200044&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185610 318589874 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355812 CN(Cc1ccc(CN)cc1)C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CC1CCCCC1)NCC(O)=O InChI=1S/C29H40N4O4/c1-33(20-24-14-12-23(18-30)13-15-24)29(37)26(17-22-10-6-3-7-11-22)32-28(36)25(31-19-27(34)35)16-21-8-4-2-5-9-21/h3,6-7,10-15,21,25-26,31H,2,4-5,8-9,16-20,30H2,1H3,(H,32,36)(H,34,35)/t25-,26+/m1/s1 KHVBQTPTSZCNFR-FTJBHMTQSA-N 200045 US9234000, 36 Plasma kallikrein Human 8200 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200045 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200045&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71186065 318589875 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355813 CCCN[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C29H42N4O2/c1-2-17-31-26(18-22-9-5-3-6-10-22)29(35)33-27(19-23-11-7-4-8-12-23)28(34)32-21-25-15-13-24(20-30)14-16-25/h4,7-8,11-16,22,26-27,31H,2-3,5-6,9-10,17-21,30H2,1H3,(H,32,34)(H,33,35)/t26-,27+/m1/s1 YAKWNMILEUXLOF-SXOMAYOGSA-N 200046 US9234000, 37 Plasma kallikrein Human 910 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200046 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200046&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185698 318589876 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355814 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C36H40N4O4/c1-3-44-31-20-18-27(19-21-31)22-32(39-34(41)30-12-8-5-9-13-30)36(43)40(2)33(23-26-10-6-4-7-11-26)35(42)38-25-29-16-14-28(24-37)15-17-29/h4-21,32-33H,3,22-25,37H2,1-2H3,(H,38,42)(H,39,41)/t32-,33+/m1/s1 HQJNEZIZFKIRDE-SAIUNTKASA-N 200047 US9234000, 38 Plasma kallikrein Human 47 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200047 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200047&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185593 318589877 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355815 CCOc1ccc(C[C@@H](NC(C)=O)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C31H38N4O4/c1-4-39-27-16-14-24(15-17-27)18-28(34-22(2)36)31(38)35(3)29(19-23-8-6-5-7-9-23)30(37)33-21-26-12-10-25(20-32)11-13-26/h5-17,28-29H,4,18-21,32H2,1-3H3,(H,33,37)(H,34,36)/t28-,29+/m1/s1 GYGCSETUDMGRCZ-WDYNHAJCSA-N 200048 US9234000, 39 Plasma kallikrein Human 310 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200048 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200048&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185632 318589878 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355816 CN[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)c(F)c1 InChI=1S/C27H37FN4O2/c1-30-24(15-19-8-4-2-5-9-19)27(34)32-25(16-20-10-6-3-7-11-20)26(33)31-18-21-12-13-22(17-29)23(28)14-21/h3,6-7,10-14,19,24-25,30H,2,4-5,8-9,15-18,29H2,1H3,(H,31,33)(H,32,34)/t24-,25+/m1/s1 PNOIBJDGHAETSB-RPBOFIJWSA-N 200049 US9234000, 40 Plasma kallikrein Human 1800 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200049 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200049&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185943 318589879 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355817 CN[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccc(Cl)c(Cl)c1)C(=O)NCc1ccc(CN)c(F)c1 InChI=1S/C27H35Cl2FN4O2/c1-32-24(13-17-5-3-2-4-6-17)27(36)34-25(14-18-8-10-21(28)22(29)11-18)26(35)33-16-19-7-9-20(15-31)23(30)12-19/h7-12,17,24-25,32H,2-6,13-16,31H2,1H3,(H,33,35)(H,34,36)/t24-,25+/m1/s1 FYRDRWKGCKJBPX-RPBOFIJWSA-N 200050 US9234000, 41 Plasma kallikrein Human 1300 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200050 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200050&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71186174 318589880 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355818 CN(CC(O)=O)[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)c(F)c1 InChI=1S/C29H39FN4O4/c1-34(19-27(35)36)26(16-21-10-6-3-7-11-21)29(38)33-25(15-20-8-4-2-5-9-20)28(37)32-18-22-12-13-23(17-31)24(30)14-22/h2,4-5,8-9,12-14,21,25-26H,3,6-7,10-11,15-19,31H2,1H3,(H,32,37)(H,33,38)(H,35,36)/t25-,26+/m0/s1 DJSDHDNLNWSZRP-IZZNHLLZSA-N 200051 US9234000, 42 Plasma kallikrein Human 530 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200051 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200051&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185845 318589881 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355819 CN(CC(O)=O)[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccc(Cl)c(Cl)c1)C(=O)NCc1ccc(CN)c(F)c1 InChI=1S/C29H37Cl2FN4O4/c1-36(17-27(37)38)26(14-18-5-3-2-4-6-18)29(40)35-25(13-19-8-10-22(30)23(31)11-19)28(39)34-16-20-7-9-21(15-33)24(32)12-20/h7-12,18,25-26H,2-6,13-17,33H2,1H3,(H,34,39)(H,35,40)(H,37,38)/t25-,26+/m0/s1 ATUSQERKXIHTKL-IZZNHLLZSA-N 200052 US9234000, 43 Plasma kallikrein Human 1300 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200052 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200052&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185818 318589882 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355820 CCOc1ccc(C[C@@H](NC(=O)C(C)C)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H42N4O4/c1-5-41-28-17-15-25(16-18-28)19-29(36-31(38)23(2)3)33(40)37(4)30(20-24-9-7-6-8-10-24)32(39)35-22-27-13-11-26(21-34)12-14-27/h6-18,23,29-30H,5,19-22,34H2,1-4H3,(H,35,39)(H,36,38)/t29-,30+/m1/s1 FHGLIRVEEZTGIK-IHLOFXLRSA-N 200053 US9234000, 44 Plasma kallikrein Human 180 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200053 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200053&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185980 318589883 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355821 CCCN(C)[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C30H44N4O2/c1-3-18-34(2)28(20-24-12-8-5-9-13-24)30(36)33-27(19-23-10-6-4-7-11-23)29(35)32-22-26-16-14-25(21-31)15-17-26/h4,6-7,10-11,14-17,24,27-28H,3,5,8-9,12-13,18-22,31H2,1-2H3,(H,32,35)(H,33,36)/t27-,28+/m0/s1 MAPVPFDRQHBDES-WUFINQPMSA-N 200054 US9234000, 45 Plasma kallikrein Human 790 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200054 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200054&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185799 318589884 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355822 COC(=O)CN[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C29H40N4O4/c1-37-27(34)20-31-25(16-21-8-4-2-5-9-21)29(36)33-26(17-22-10-6-3-7-11-22)28(35)32-19-24-14-12-23(18-30)13-15-24/h3,6-7,10-15,21,25-26,31H,2,4-5,8-9,16-20,30H2,1H3,(H,32,35)(H,33,36)/t25-,26+/m1/s1 MLHZEVRUXMVMRU-FTJBHMTQSA-N 200055 US9234000, 46::US9234000, 47 Plasma kallikrein Human 1200 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200055 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200055&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185707 318589885 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355823 COC(=O)CN[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C29H40N4O4/c1-37-27(34)20-31-25(16-21-8-4-2-5-9-21)29(36)33-26(17-22-10-6-3-7-11-22)28(35)32-19-24-14-12-23(18-30)13-15-24/h3,6-7,10-15,21,25-26,31H,2,4-5,8-9,16-20,30H2,1H3,(H,32,35)(H,33,36)/t25-,26+/m1/s1 MLHZEVRUXMVMRU-FTJBHMTQSA-N 200055 US9234000, 46::US9234000, 47 Plasma kallikrein Human 2100 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200055 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200055&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185707 318589885 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355824 CN(CC(N)=O)[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C29H41N5O3/c1-34(20-27(31)35)26(17-22-10-6-3-7-11-22)29(37)33-25(16-21-8-4-2-5-9-21)28(36)32-19-24-14-12-23(18-30)13-15-24/h2,4-5,8-9,12-15,22,25-26H,3,6-7,10-11,16-20,30H2,1H3,(H2,31,35)(H,32,36)(H,33,37)/t25-,26+/m0/s1 VBCWKMGQHTXCLL-IZZNHLLZSA-N 200057 US9234000, 48 Plasma kallikrein Human 4700 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200057 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200057&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185545 318589886 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355825 CN(CCO)[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C29H42N4O3/c1-33(16-17-34)27(19-23-10-6-3-7-11-23)29(36)32-26(18-22-8-4-2-5-9-22)28(35)31-21-25-14-12-24(20-30)13-15-25/h2,4-5,8-9,12-15,23,26-27,34H,3,6-7,10-11,16-21,30H2,1H3,(H,31,35)(H,32,36)/t26-,27+/m0/s1 XOHMZWIMXZQRIG-RRPNLBNLSA-N 200058 US9234000, 49 Plasma kallikrein Human 2200 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200058 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200058&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71186020 318589887 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355826 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](CC2CCCCC2)NCC(N)=O)cc1 InChI=1S/C28H39N5O3/c29-17-22-11-13-23(14-12-22)18-32-27(35)25(16-21-9-5-2-6-10-21)33-28(36)24(31-19-26(30)34)15-20-7-3-1-4-8-20/h2,5-6,9-14,20,24-25,31H,1,3-4,7-8,15-19,29H2,(H2,30,34)(H,32,35)(H,33,36)/t24-,25+/m1/s1 AVERXCDVOOTDJJ-RPBOFIJWSA-N 200059 US9234000, 50 Plasma kallikrein Human 4300 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200059 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200059&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185878 318589888 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355827 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](CC2CCCCC2)NCCO)cc1 InChI=1S/C28H40N4O3/c29-19-23-11-13-24(14-12-23)20-31-27(34)26(18-22-9-5-2-6-10-22)32-28(35)25(30-15-16-33)17-21-7-3-1-4-8-21/h2,5-6,9-14,21,25-26,30,33H,1,3-4,7-8,15-20,29H2,(H,31,34)(H,32,35)/t25-,26+/m1/s1 ASILWFVMBOPQGU-FTJBHMTQSA-N 200060 US9234000, 51 Plasma kallikrein Human 1000 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200060 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200060&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71186165 318589889 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355828 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](N)C(C2CCCCC2)C2CCCCC2)cc1 InChI=1S/C32H46N4O2/c33-21-24-16-18-25(19-17-24)22-35-31(37)28(20-23-10-4-1-5-11-23)36-32(38)30(34)29(26-12-6-2-7-13-26)27-14-8-3-9-15-27/h1,4-5,10-11,16-19,26-30H,2-3,6-9,12-15,20-22,33-34H2,(H,35,37)(H,36,38)/t28-,30+/m0/s1 FIYJIRGYSCICSS-MFMCTBQISA-N 200061 US9234000, 52 Plasma kallikrein Human 860 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200061 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200061&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 118520054 318589890 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355829 CCCN(CCC)[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C32H48N4O2/c1-3-19-36(20-4-2)30(22-26-13-9-6-10-14-26)32(38)35-29(21-25-11-7-5-8-12-25)31(37)34-24-28-17-15-27(23-33)16-18-28/h5,7-8,11-12,15-18,26,29-30H,3-4,6,9-10,13-14,19-24,33H2,1-2H3,(H,34,37)(H,35,38)/t29-,30+/m0/s1 DBIDWJMCWRJUME-XZWHSSHBSA-N 200062 US9234000, 53 Plasma kallikrein Human 650 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200062 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200062&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185648 318589891 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355830 CCOc1ccc(C[C@@H](NC(=O)c2cccc3ccccc23)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C39H40N4O4/c1-2-47-32-21-19-28(20-22-32)24-36(42-37(44)34-14-8-12-31-11-6-7-13-33(31)34)39(46)43-35(23-27-9-4-3-5-10-27)38(45)41-26-30-17-15-29(25-40)16-18-30/h3-22,35-36H,2,23-26,40H2,1H3,(H,41,45)(H,42,44)(H,43,46)/t35-,36+/m0/s1 TYYQIBDJBZYMOH-MPQUPPDSSA-N 200063 US9234000, 54 Plasma kallikrein Human 83 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200063 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200063&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499476 318589892 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355831 CCOc1ccc(C[C@@H](NC(=O)c2ccc(Cl)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H37ClN4O4/c1-2-44-30-18-12-25(13-19-30)21-32(39-33(41)28-14-16-29(36)17-15-28)35(43)40-31(20-24-6-4-3-5-7-24)34(42)38-23-27-10-8-26(22-37)9-11-27/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 WQZFDLDYUJSANS-AJQTZOPKSA-N 200064 US9234000, 55 Plasma kallikrein Human 31 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200064 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200064&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185521 318589893 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355832 CCOc1ccc(C[C@@H](NC(=O)c2ccc(cc2)C(F)(F)F)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C36H37F3N4O4/c1-2-47-30-18-12-25(13-19-30)21-32(42-33(44)28-14-16-29(17-15-28)36(37,38)39)35(46)43-31(20-24-6-4-3-5-7-24)34(45)41-23-27-10-8-26(22-40)9-11-27/h3-19,31-32H,2,20-23,40H2,1H3,(H,41,45)(H,42,44)(H,43,46)/t31-,32+/m0/s1 RPLAYKBFXJXCRD-AJQTZOPKSA-N 200065 US9234000, 56 Plasma kallikrein Human 500 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200065 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200065&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185495 318589894 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355833 CCOc1ccc(C[C@@H](NC(=O)c2ccc(cc2)-c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C41H42N4O4/c1-2-49-36-23-17-30(18-24-36)26-38(44-39(46)35-21-19-34(20-22-35)33-11-7-4-8-12-33)41(48)45-37(25-29-9-5-3-6-10-29)40(47)43-28-32-15-13-31(27-42)14-16-32/h3-24,37-38H,2,25-28,42H2,1H3,(H,43,47)(H,44,46)(H,45,48)/t37-,38+/m0/s1 IHQOKEGBCZMVLO-QPPIDDCLSA-N 200066 US9234000, 57 Plasma kallikrein Human 10000 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200066 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200066&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 122199206 318589895 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355834 CCOc1ccc(C[C@@H](NC(=O)c2ccc(Cl)cc2Cl)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H36Cl2N4O4/c1-2-45-28-15-12-24(13-16-28)19-32(40-33(42)29-17-14-27(36)20-30(29)37)35(44)41-31(18-23-6-4-3-5-7-23)34(43)39-22-26-10-8-25(21-38)9-11-26/h3-17,20,31-32H,2,18-19,21-22,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t31-,32+/m0/s1 NXZSBRDPYXWYMY-AJQTZOPKSA-N 200067 US9234000, 58 Plasma kallikrein Human 170 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200067 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200067&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185771 318589896 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355835 CCOc1ccc(C[C@@H](NC(=O)c2ccc(F)c(F)c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H36F2N4O4/c1-2-45-28-15-12-24(13-16-28)19-32(40-33(42)27-14-17-29(36)30(37)20-27)35(44)41-31(18-23-6-4-3-5-7-23)34(43)39-22-26-10-8-25(21-38)9-11-26/h3-17,20,31-32H,2,18-19,21-22,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t31-,32+/m0/s1 QWEGEWLFUNVAFH-AJQTZOPKSA-N 200068 US9234000, 59 Plasma kallikrein Human 78 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200068 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200068&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185746 318589897 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355836 CCOc1ccc(C[C@@H](N)C(=O)N[C@H]([C@@H](O)c2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C28H34N4O4/c1-2-36-23-14-12-19(13-15-23)16-24(30)27(34)32-25(26(33)22-6-4-3-5-7-22)28(35)31-18-21-10-8-20(17-29)9-11-21/h3-15,24-26,33H,2,16-18,29-30H2,1H3,(H,31,35)(H,32,34)/t24-,25-,26+/m1/s1 PHBWBJVPZUGFDM-CYXNTTPDSA-N 200069 US9234000, 60 Plasma kallikrein Human 10000 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200069 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200069&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185766 318589898 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355837 CCOc1ccc(C[C@@H](N)C(=O)N[C@@H]([C@@H](O)c2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C28H34N4O4/c1-2-36-23-14-12-19(13-15-23)16-24(30)27(34)32-25(26(33)22-6-4-3-5-7-22)28(35)31-18-21-10-8-20(17-29)9-11-21/h3-15,24-26,33H,2,16-18,29-30H2,1H3,(H,31,35)(H,32,34)/t24-,25+,26+/m1/s1 PHBWBJVPZUGFDM-ZNZIZOMTSA-N 200070 US9234000, 61 Plasma kallikrein Human 220 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200070 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200070&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71187198 318589899 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355838 CCOc1ccc(CC(=O)CNN([C@H]([C@@H](O)c2ccccc2)C(=O)NCc2ccc(CN)cc2)C(=O)CC)cc1 InChI=1S/C31H38N4O5/c1-3-28(37)35(34-21-26(36)18-22-14-16-27(17-15-22)40-4-2)29(30(38)25-8-6-5-7-9-25)31(39)33-20-24-12-10-23(19-32)11-13-24/h5-17,29-30,34,38H,3-4,18-21,32H2,1-2H3,(H,33,39)/t29-,30+/m1/s1 BSPQPRZBRYQAEB-IHLOFXLRSA-N 200071 US9234000, 62 Plasma kallikrein Human 10000 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200071 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200071&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185712 318589900 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355839 CCOc1ccc(CC(=O)CNN([C@@H]([C@@H](O)c2ccccc2)C(=O)NCc2ccc(CN)cc2)C(=O)CC)cc1 InChI=1S/C31H38N4O5/c1-3-28(37)35(34-21-26(36)18-22-14-16-27(17-15-22)40-4-2)29(30(38)25-8-6-5-7-9-25)31(39)33-20-24-12-10-23(19-32)11-13-24/h5-17,29-30,34,38H,3-4,18-21,32H2,1-2H3,(H,33,39)/t29-,30-/m0/s1 BSPQPRZBRYQAEB-KYJUHHDHSA-N 200072 US9234000, 63 Plasma kallikrein Human 52 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200072 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200072&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185613 318589901 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355840 CCOc1ccc(CC(=O)CNCCC(=O)N(CC)[C@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H42N4O4/c1-3-37(32(39)18-19-35-24-29(38)20-26-14-16-30(17-15-26)41-4-2)31(21-25-8-6-5-7-9-25)33(40)36-23-28-12-10-27(22-34)11-13-28/h5-17,31,35H,3-4,18-24,34H2,1-2H3,(H,36,40)/t31-/m1/s1 RSCJURCKNJMFSM-WJOKGBTCSA-N 200073 US9234000, 64 Plasma kallikrein Human 3400 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200073 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200073&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185627 318589902 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355841 CCOc1ccc(CC(=O)CNCCC(=O)N(CC)[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H42N4O4/c1-3-37(32(39)18-19-35-24-29(38)20-26-14-16-30(17-15-26)41-4-2)31(21-25-8-6-5-7-9-25)33(40)36-23-28-12-10-27(22-34)11-13-28/h5-17,31,35H,3-4,18-24,34H2,1-2H3,(H,36,40)/t31-/m0/s1 RSCJURCKNJMFSM-HKBQPEDESA-N 200074 US9234000, 65 Plasma kallikrein Human 10000 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200074 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200074&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185720 318589903 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355842 CCOc1ccc(C[C@H](N(C)C(=O)CC)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C32H40N4O4/c1-4-30(37)36(3)29(20-24-15-17-27(18-16-24)40-5-2)32(39)35-28(19-23-9-7-6-8-10-23)31(38)34-22-26-13-11-25(21-33)12-14-26/h6-18,28-29H,4-5,19-22,33H2,1-3H3,(H,34,38)(H,35,39)/t28-,29-/m0/s1 VCUKNDNIFAKRDT-VMPREFPWSA-N 200075 US9234000, 66 Plasma kallikrein Human 10000 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200075 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200075&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185787 318589904 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355843 CCOc1ccc(C[C@@H](NC(=O)CC)C(=O)N2CC[C@@H]([C@H]2C(=O)NCc2ccc(CN)cc2)c2ccccc2)cc1 InChI=1S/C33H40N4O4/c1-3-30(38)36-29(20-23-14-16-27(17-15-23)41-4-2)33(40)37-19-18-28(26-8-6-5-7-9-26)31(37)32(39)35-22-25-12-10-24(21-34)11-13-25/h5-17,28-29,31H,3-4,18-22,34H2,1-2H3,(H,35,39)(H,36,38)/t28-,29-,31+/m1/s1 RBKLUGLZBDESOH-XQKNLLDYSA-N 200076 US9234000, 67 Plasma kallikrein Human 1600 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200076 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200076&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 90306458 318589905 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355844 CCOc1ccc(C[C@@H](NC(=O)NCc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C36H41N5O4/c1-2-45-31-19-17-27(18-20-31)22-33(41-36(44)39-25-29-11-7-4-8-12-29)35(43)40-32(21-26-9-5-3-6-10-26)34(42)38-24-30-15-13-28(23-37)14-16-30/h3-20,32-33H,2,21-25,37H2,1H3,(H,38,42)(H,40,43)(H2,39,41,44)/t32-,33+/m0/s1 HUDMDOPCYOIBRF-JHOUSYSJSA-N 200077 US9234000, 68 Plasma kallikrein Human 861 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200077 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200077&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71186043 318589906 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355845 CCOc1ccc(C[C@@H](NC(=O)Nc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O4/c1-2-44-30-19-17-26(18-20-30)22-32(40-35(43)38-29-11-7-4-8-12-29)34(42)39-31(21-25-9-5-3-6-10-25)33(41)37-24-28-15-13-27(23-36)14-16-28/h3-20,31-32H,2,21-24,36H2,1H3,(H,37,41)(H,39,42)(H2,38,40,43)/t31-,32+/m0/s1 ZYYGRTWFLBZSQX-AJQTZOPKSA-N 200078 US9234000, 69 Plasma kallikrein Human 621 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200078 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200078&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185798 318589907 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355846 CCOc1ccc(C[C@@H](NC(=O)c2cccnc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H37N5O4/c1-2-43-29-16-14-25(15-17-29)20-31(38-32(40)28-9-6-18-36-23-28)34(42)39-30(19-24-7-4-3-5-8-24)33(41)37-22-27-12-10-26(21-35)11-13-27/h3-18,23,30-31H,2,19-22,35H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t30-,31+/m0/s1 NBUOOLFOHRYQNL-IOWSJCHKSA-N 200079 US9234000, 70 Plasma kallikrein Human 126 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200079 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200079&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185653 318589908 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355847 CCOc1ccc(C[C@@H](NC(=O)c2ccncc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H37N5O4/c1-2-43-29-14-12-25(13-15-29)21-31(38-32(40)28-16-18-36-19-17-28)34(42)39-30(20-24-6-4-3-5-7-24)33(41)37-23-27-10-8-26(22-35)9-11-27/h3-19,30-31H,2,20-23,35H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t30-,31+/m0/s1 KUPKLNUHJXRSMI-IOWSJCHKSA-N 200080 US9234000, 71 Plasma kallikrein Human 77 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200080 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200080&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71186147 318589909 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355848 CCOc1ccc(C[C@@H](NC(=O)c2ccsc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H36N4O4S/c1-2-41-28-14-12-24(13-15-28)19-30(36-31(38)27-16-17-42-22-27)33(40)37-29(18-23-6-4-3-5-7-23)32(39)35-21-26-10-8-25(20-34)9-11-26/h3-17,22,29-30H,2,18-21,34H2,1H3,(H,35,39)(H,36,38)(H,37,40)/t29-,30+/m0/s1 GCFLQXXLUPHFNT-XZWHSSHBSA-N 200081 US9234000, 72 Plasma kallikrein Human 46 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200081 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200081&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185793 318589910 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355849 CCOc1ccc(C[C@@H](NC(=O)c2cccs2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H36N4O4S/c1-2-41-27-16-14-24(15-17-27)20-29(37-33(40)30-9-6-18-42-30)32(39)36-28(19-23-7-4-3-5-8-23)31(38)35-22-26-12-10-25(21-34)11-13-26/h3-18,28-29H,2,19-22,34H2,1H3,(H,35,38)(H,36,39)(H,37,40)/t28-,29+/m0/s1 DICZPEIYHIDRDH-URLMMPGGSA-N 200082 US9234000, 73 Plasma kallikrein Human 25 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200082 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200082&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499165 318589911 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355850 CCOc1ccc(C[C@@H](NC(=O)C2CC2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C32H38N4O4/c1-2-40-27-16-12-23(13-17-27)19-29(35-30(37)26-14-15-26)32(39)36-28(18-22-6-4-3-5-7-22)31(38)34-21-25-10-8-24(20-33)9-11-25/h3-13,16-17,26,28-29H,2,14-15,18-21,33H2,1H3,(H,34,38)(H,35,37)(H,36,39)/t28-,29+/m0/s1 DQVRDTGGMOXTHF-URLMMPGGSA-N 200083 US9234000, 74 Plasma kallikrein Human 545 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200083 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200083&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 122199207 318589912 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355851 CCOc1ccc(C[C@@H](NC(=O)C2CCCCC2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H44N4O4/c1-2-43-30-19-17-26(18-20-30)22-32(38-33(40)29-11-7-4-8-12-29)35(42)39-31(21-25-9-5-3-6-10-25)34(41)37-24-28-15-13-27(23-36)14-16-28/h3,5-6,9-10,13-20,29,31-32H,2,4,7-8,11-12,21-24,36H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t31-,32+/m0/s1 ZBMHBTNVTBWRGV-AJQTZOPKSA-N 200084 US9234000, 75 Plasma kallikrein Human 270 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200084 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200084&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499166 318589913 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355852 CCCCCC(=O)N[C@H](Cc1ccc(OCC)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C34H44N4O4/c1-3-5-7-12-32(39)37-31(22-26-17-19-29(20-18-26)42-4-2)34(41)38-30(21-25-10-8-6-9-11-25)33(40)36-24-28-15-13-27(23-35)14-16-28/h6,8-11,13-20,30-31H,3-5,7,12,21-24,35H2,1-2H3,(H,36,40)(H,37,39)(H,38,41)/t30-,31+/m0/s1 YWYFEVDIUZIFCH-IOWSJCHKSA-N 200085 US9234000, 76 Plasma kallikrein Human 452 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200085 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200085&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 122199208 318589914 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355853 CCOc1ccc(C[C@@H](NC(=O)NC(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C32H41N5O4/c1-4-41-27-16-14-24(15-17-27)19-29(37-32(40)35-22(2)3)31(39)36-28(18-23-8-6-5-7-9-23)30(38)34-21-26-12-10-25(20-33)11-13-26/h5-17,22,28-29H,4,18-21,33H2,1-3H3,(H,34,38)(H,36,39)(H2,35,37,40)/t28-,29+/m0/s1 SXAOLDSQZYCDDQ-URLMMPGGSA-N 200086 US9234000, 77 Plasma kallikrein Human 1959 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200086 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200086&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71186101 318589915 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355854 CCCCCCNC(=O)N[C@H](Cc1ccc(OCC)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C35H47N5O4/c1-3-5-6-10-21-37-35(43)40-32(23-27-17-19-30(20-18-27)44-4-2)34(42)39-31(22-26-11-8-7-9-12-26)33(41)38-25-29-15-13-28(24-36)14-16-29/h7-9,11-20,31-32H,3-6,10,21-25,36H2,1-2H3,(H,38,41)(H,39,42)(H2,37,40,43)/t31-,32+/m0/s1 KRKRLMQLCYJAFZ-AJQTZOPKSA-N 200087 US9234000, 78 Plasma kallikrein Human 10000 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200087 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200087&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71186011 318589916 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355855 CCOc1ccc(C[C@@H](NC(=O)c2ccno2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C32H35N5O5/c1-2-41-26-14-12-23(13-15-26)19-28(37-32(40)29-16-17-35-42-29)31(39)36-27(18-22-6-4-3-5-7-22)30(38)34-21-25-10-8-24(20-33)9-11-25/h3-17,27-28H,2,18-21,33H2,1H3,(H,34,38)(H,36,39)(H,37,40)/t27-,28+/m0/s1 FLWSQHNEOSDTLW-WUFINQPMSA-N 200088 US9234000, 79 Plasma kallikrein Human 38 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200088 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200088&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499167 318589917 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355856 CCOc1ccc(C[C@@H](NC(=O)c2ccc(OC(F)(F)F)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C36H37F3N4O5/c1-2-47-29-16-12-25(13-17-29)21-32(42-33(44)28-14-18-30(19-15-28)48-36(37,38)39)35(46)43-31(20-24-6-4-3-5-7-24)34(45)41-23-27-10-8-26(22-40)9-11-27/h3-19,31-32H,2,20-23,40H2,1H3,(H,41,45)(H,42,44)(H,43,46)/t31-,32+/m0/s1 DNNSVHAVKIOBSA-AJQTZOPKSA-N 200089 US9234000, 80 Plasma kallikrein Human 398 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200089 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200089&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185541 318589918 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355857 CCOc1ccc(C[C@@H](NC(=O)c2ccccn2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H37N5O4/c1-2-43-28-17-15-25(16-18-28)21-31(39-33(41)29-10-6-7-19-36-29)34(42)38-30(20-24-8-4-3-5-9-24)32(40)37-23-27-13-11-26(22-35)12-14-27/h3-19,30-31H,2,20-23,35H2,1H3,(H,37,40)(H,38,42)(H,39,41)/t30-,31+/m0/s1 LOIWWQRBLCDGHA-IOWSJCHKSA-N 200090 US9234000, 81 Plasma kallikrein Human 40 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200090 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200090&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499172 318589919 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355858 CCOc1ccc(C[C@@H](NC(=O)c2cc(C)nn2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H40N6O4/c1-4-44-28-16-14-25(15-17-28)20-30(38-34(43)31-18-23(2)39-40(31)3)33(42)37-29(19-24-8-6-5-7-9-24)32(41)36-22-27-12-10-26(21-35)11-13-27/h5-18,29-30H,4,19-22,35H2,1-3H3,(H,36,41)(H,37,42)(H,38,43)/t29-,30+/m0/s1 SGTZLYYWDILAOO-XZWHSSHBSA-N 200091 US9234000, 82 Plasma kallikrein Human 539 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200091 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200091&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 122199209 318589920 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355859 CCOc1ccc(C[C@@H](NC(=O)c2cc3ccccc3s2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C37H38N4O4S/c1-2-45-30-18-16-26(17-19-30)21-32(41-37(44)34-22-29-10-6-7-11-33(29)46-34)36(43)40-31(20-25-8-4-3-5-9-25)35(42)39-24-28-14-12-27(23-38)13-15-28/h3-19,22,31-32H,2,20-21,23-24,38H2,1H3,(H,39,42)(H,40,43)(H,41,44)/t31-,32+/m0/s1 OEGGOURQVSOADE-AJQTZOPKSA-N 200092 US9234000, 83 Plasma kallikrein Human 254 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200092 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200092&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185907 318589921 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355860 CCOc1ccc(C[C@@H](NS(=O)(=O)c2ccc(Cl)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H37ClN4O5S/c1-2-44-29-16-12-25(13-17-29)21-32(39-45(42,43)30-18-14-28(35)15-19-30)34(41)38-31(20-24-6-4-3-5-7-24)33(40)37-23-27-10-8-26(22-36)9-11-27/h3-19,31-32,39H,2,20-23,36H2,1H3,(H,37,40)(H,38,41)/t31-,32+/m0/s1 ACETVQBBGBLDQG-AJQTZOPKSA-N 200093 US9234000, 84 Plasma kallikrein Human 219 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200093 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200093&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185886 318589922 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355861 CCOc1ccc(cc1)[C@H](C(=O)NCCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1)c1ccccc1 InChI=1S/C36H40N4O4/c1-2-44-31-19-17-30(18-20-31)34(29-11-7-4-8-12-29)36(43)38-22-21-33(41)40-32(23-26-9-5-3-6-10-26)35(42)39-25-28-15-13-27(24-37)14-16-28/h3-20,32,34H,2,21-25,37H2,1H3,(H,38,43)(H,39,42)(H,40,41)/t32-,34+/m0/s1 SWVKHIKGEAHJDC-UZNNEEJFSA-N 200094 US9234000, 85 Plasma kallikrein Human 485 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200094 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200094&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 122199210 318589923 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355862 CCOc1ccc(C[C@@H](NC(=O)CCc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C37H42N4O4/c1-2-45-32-20-17-29(18-21-32)24-34(40-35(42)22-19-27-9-5-3-6-10-27)37(44)41-33(23-28-11-7-4-8-12-28)36(43)39-26-31-15-13-30(25-38)14-16-31/h3-18,20-21,33-34H,2,19,22-26,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t33-,34+/m0/s1 CQYKVCYPAHTPER-SZAHLOSFSA-N 200095 US9234000, 86 Plasma kallikrein Human 423 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200095 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200095&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71186092 318589924 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355863 CCOc1ccc(C[C@@H](NC(=O)CCCc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C38H44N4O4/c1-2-46-33-22-20-30(21-23-33)25-35(41-36(43)15-9-14-28-10-5-3-6-11-28)38(45)42-34(24-29-12-7-4-8-13-29)37(44)40-27-32-18-16-31(26-39)17-19-32/h3-8,10-13,16-23,34-35H,2,9,14-15,24-27,39H2,1H3,(H,40,44)(H,41,43)(H,42,45)/t34-,35+/m0/s1 SOQHHEZZSQAXRS-OIDHKYIRSA-N 200096 US9234000, 87 Plasma kallikrein Human 755 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200096 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200096&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185839 318589925 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355864 CCOc1ccc(C[C@@H](NC(=O)c2cccc(Cl)c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H37ClN4O4/c1-2-44-30-17-15-25(16-18-30)20-32(39-33(41)28-9-6-10-29(36)21-28)35(43)40-31(19-24-7-4-3-5-8-24)34(42)38-23-27-13-11-26(22-37)12-14-27/h3-18,21,31-32H,2,19-20,22-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 SGUFCVJNEPZKMW-AJQTZOPKSA-N 200097 US9234000, 88 Plasma kallikrein Human 90 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200097 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200097&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185964 318589926 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355865 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2Cl)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H37ClN4O4/c1-2-44-28-18-16-25(17-19-28)21-32(39-33(41)29-10-6-7-11-30(29)36)35(43)40-31(20-24-8-4-3-5-9-24)34(42)38-23-27-14-12-26(22-37)13-15-27/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 ZJPROBBYIUYLCH-AJQTZOPKSA-N 200098 US9234000, 89 Plasma kallikrein Human 99 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200098 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200098&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185775 318589927 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355866 CCOc1ccc(C[C@@H](NC(=O)c2cccc(c2)C(F)(F)F)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C36H37F3N4O4/c1-2-47-30-17-15-25(16-18-30)20-32(42-33(44)28-9-6-10-29(21-28)36(37,38)39)35(46)43-31(19-24-7-4-3-5-8-24)34(45)41-23-27-13-11-26(22-40)12-14-27/h3-18,21,31-32H,2,19-20,22-23,40H2,1H3,(H,41,45)(H,42,44)(H,43,46)/t31-,32+/m0/s1 TYGDGTFXXYUGSN-AJQTZOPKSA-N 200099 US9234000, 90::US9234000, 91 Plasma kallikrein Human 276 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200099 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200099&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185601 318589928 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355867 CCOc1ccc(C[C@@H](NC(=O)C23CC4CC(CC(C4)C2)C3)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C39H48N4O4/c1-2-47-33-14-12-27(13-15-33)20-35(43-38(46)39-21-30-16-31(22-39)18-32(17-30)23-39)37(45)42-34(19-26-6-4-3-5-7-26)36(44)41-25-29-10-8-28(24-40)9-11-29/h3-15,30-32,34-35H,2,16-25,40H2,1H3,(H,41,44)(H,42,45)(H,43,46)/t30?,31?,32?,34-,35+,39?/m0/s1 XNXBICLEPKJLOV-VLRPPYJTSA-N 60914 US9234000, 91 Plasma kallikrein Human 2083 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=60914 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=60914&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 122362656 319494464 ZINC15952940 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355868 CCOc1ccc(C[C@@H](NC(=O)c2ccc(C)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C36H40N4O4/c1-3-44-31-19-15-27(16-20-31)22-33(39-34(41)30-17-9-25(2)10-18-30)36(43)40-32(21-26-7-5-4-6-8-26)35(42)38-24-29-13-11-28(23-37)12-14-29/h4-20,32-33H,3,21-24,37H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t32-,33+/m0/s1 PQYXYUJVSKCKFL-JHOUSYSJSA-N 200101 US9234000, 92 Plasma kallikrein Human 32 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200101 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200101&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185979 318589929 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355869 CCOc1ccc(C[C@@H](NC(=O)c2ccc(Cl)c(Cl)c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H36Cl2N4O4/c1-2-45-28-15-12-24(13-16-28)19-32(40-33(42)27-14-17-29(36)30(37)20-27)35(44)41-31(18-23-6-4-3-5-7-23)34(43)39-22-26-10-8-25(21-38)9-11-26/h3-17,20,31-32H,2,18-19,21-22,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t31-,32+/m0/s1 MOIZOCHEDGLANE-AJQTZOPKSA-N 200102 US9234000, 93 Plasma kallikrein Human 175 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200102 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200102&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185695 318589930 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355870 CCOc1ccc(C[C@@H](NC(=O)c2cc(Cl)cc(Cl)c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H36Cl2N4O4/c1-2-45-30-14-12-24(13-15-30)17-32(40-33(42)27-18-28(36)20-29(37)19-27)35(44)41-31(16-23-6-4-3-5-7-23)34(43)39-22-26-10-8-25(21-38)9-11-26/h3-15,18-20,31-32H,2,16-17,21-22,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t31-,32+/m0/s1 SLIWSHXFSMCYGU-AJQTZOPKSA-N 200103 US9234000, 94 Plasma kallikrein Human 1080 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200103 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200103&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 90302844 318589931 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355871 CCOc1ccc(C[C@@H](NC(=O)c2ccc(OC)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C36H40N4O5/c1-3-45-31-17-13-26(14-18-31)22-33(39-34(41)29-15-19-30(44-2)20-16-29)36(43)40-32(21-25-7-5-4-6-8-25)35(42)38-24-28-11-9-27(23-37)10-12-28/h4-20,32-33H,3,21-24,37H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t32-,33+/m0/s1 HODNEEJOSRVWQT-JHOUSYSJSA-N 200104 US9234000, 95 Plasma kallikrein Human 46 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200104 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200104&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185996 318589932 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355872 CCOc1ccc(C[C@@H](NC(=O)\C=C\c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C37H40N4O4/c1-2-45-32-20-17-29(18-21-32)24-34(40-35(42)22-19-27-9-5-3-6-10-27)37(44)41-33(23-28-11-7-4-8-12-28)36(43)39-26-31-15-13-30(25-38)14-16-31/h3-22,33-34H,2,23-26,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/b22-19+/t33-,34+/m0/s1 CQESEBINUPDTGP-FCVYXQAUSA-N 200105 US9234000, 96 Plasma kallikrein Human 764 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200105 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200105&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 89350829 318589933 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355873 CCOc1ccc(C[C@@H](N(NC(=O)Cc2ccccc2)C(C)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C38H43N5O5/c1-3-48-33-20-18-30(19-21-33)23-35(43(27(2)44)42-36(45)24-29-12-8-5-9-13-29)38(47)41-34(22-28-10-6-4-7-11-28)37(46)40-26-32-16-14-31(25-39)15-17-32/h4-21,34-35H,3,22-26,39H2,1-2H3,(H,40,46)(H,41,47)(H,42,45)/t34-,35+/m0/s1 KNHURXIHYWTCFE-OIDHKYIRSA-N 200106 US9234000, 97 Plasma kallikrein Human 241 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200106 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200106&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185507 318589934 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355874 CCOc1ccc(C[C@@H](NC(=O)CNC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C37H41N5O5/c1-2-47-31-19-17-27(18-20-31)22-33(41-34(43)25-40-35(44)30-11-7-4-8-12-30)37(46)42-32(21-26-9-5-3-6-10-26)36(45)39-24-29-15-13-28(23-38)14-16-29/h3-20,32-33H,2,21-25,38H2,1H3,(H,39,45)(H,40,44)(H,41,43)(H,42,46)/t32-,33+/m0/s1 TZECEBPYZPAKRE-JHOUSYSJSA-N 200107 US9234000, 98 Plasma kallikrein Human 576 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200107 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200107&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71186105 318589935 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355875 CCOc1ccc(C[C@@H](NC(=O)c2ccc(F)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H37FN4O4/c1-2-44-30-18-12-25(13-19-30)21-32(39-33(41)28-14-16-29(36)17-15-28)35(43)40-31(20-24-6-4-3-5-7-24)34(42)38-23-27-10-8-26(22-37)9-11-27/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 HAVAYEXOBKJLDE-AJQTZOPKSA-N 200108 US9234000, 99 Plasma kallikrein Human 95 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200108 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200108&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185850 318589936 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355876 CCOc1ccc(C[C@@H](NS(=O)(=O)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H40N4O5S/c1-2-44-31-19-17-27(18-20-31)22-33(39-45(42,43)25-30-11-7-4-8-12-30)35(41)38-32(21-26-9-5-3-6-10-26)34(40)37-24-29-15-13-28(23-36)14-16-29/h3-20,32-33,39H,2,21-25,36H2,1H3,(H,37,40)(H,38,41)/t32-,33+/m0/s1 HUGJQCPQXGEXGY-JHOUSYSJSA-N 200109 US9234000, 100 Plasma kallikrein Human 474 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200109 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200109&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71186063 318589937 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355877 CCOc1ccc(C[C@@H](NC(=O)CNS(=O)(=O)c2ccc(C)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C37H43N5O6S/c1-3-48-31-17-15-28(16-18-31)22-34(41-35(43)25-40-49(46,47)32-19-9-26(2)10-20-32)37(45)42-33(21-27-7-5-4-6-8-27)36(44)39-24-30-13-11-29(23-38)12-14-30/h4-20,33-34,40H,3,21-25,38H2,1-2H3,(H,39,44)(H,41,43)(H,42,45)/t33-,34+/m0/s1 CFJPNXPRDSFZJB-SZAHLOSFSA-N 200110 US9234000, 101 Plasma kallikrein Human 1113 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200110 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200110&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185485 318589938 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355878 CCOc1ccc(C[C@@H](NC(=O)Nc2ccc(Cl)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H38ClN5O4/c1-2-45-30-18-12-25(13-19-30)21-32(41-35(44)39-29-16-14-28(36)15-17-29)34(43)40-31(20-24-6-4-3-5-7-24)33(42)38-23-27-10-8-26(22-37)9-11-27/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,40,43)(H2,39,41,44)/t31-,32+/m0/s1 ZXWPCHGBHJMEBT-AJQTZOPKSA-N 200111 US9234000, 102 Plasma kallikrein Human 10000 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200111 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200111&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185801 318589939 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355879 CCOc1ccc(C[C@@H](NC(=O)N(CC)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C38H45N5O4/c1-3-43(27-32-13-9-6-10-14-32)38(46)42-35(24-29-19-21-33(22-20-29)47-4-2)37(45)41-34(23-28-11-7-5-8-12-28)36(44)40-26-31-17-15-30(25-39)16-18-31/h5-22,34-35H,3-4,23-27,39H2,1-2H3,(H,40,44)(H,41,45)(H,42,46)/t34-,35+/m0/s1 YNTCROSKIQJMBI-OIDHKYIRSA-N 200112 US9234000, 103 Plasma kallikrein Human 10000 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200112 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200112&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185811 318589940 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355880 CCOc1ccc(C[C@@H](NC(=O)c2ccc(C)nc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O4/c1-3-44-30-17-14-26(15-18-30)20-32(39-33(41)29-16-9-24(2)37-23-29)35(43)40-31(19-25-7-5-4-6-8-25)34(42)38-22-28-12-10-27(21-36)11-13-28/h4-18,23,31-32H,3,19-22,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 AWZDEIQJFXSYJV-AJQTZOPKSA-N 200113 US9234000, 104 Plasma kallikrein Human 159 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200113 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200113&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185969 318589941 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355881 CCOc1ccc(C[C@@H](NC(=O)c2cccnc2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O4/c1-3-44-29-17-15-26(16-18-29)21-32(39-33(41)30-10-7-19-37-24(30)2)35(43)40-31(20-25-8-5-4-6-9-25)34(42)38-23-28-13-11-27(22-36)12-14-28/h4-19,31-32H,3,20-23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 ALBLURFVONFERJ-AJQTZOPKSA-N 200114 US9234000, 105 Plasma kallikrein Human 185 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200114&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185978 318589942 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355882 CCOc1ccc(C[C@@H](NC(=O)c2ccc(Cl)nc2Cl)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H35Cl2N5O4/c1-2-45-26-14-12-23(13-15-26)19-29(39-32(42)27-16-17-30(35)41-31(27)36)34(44)40-28(18-22-6-4-3-5-7-22)33(43)38-21-25-10-8-24(20-37)9-11-25/h3-17,28-29H,2,18-21,37H2,1H3,(H,38,43)(H,39,42)(H,40,44)/t28-,29+/m0/s1 QQYJHIVCRMOELR-URLMMPGGSA-N 200115 US9234000, 106 Plasma kallikrein Human 256 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200115 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200115&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499475 318589943 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355883 CCOc1ccc(C[C@@H](NC(=O)c2cnc(Cl)c(Cl)c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H35Cl2N5O4/c1-2-45-27-14-12-23(13-15-27)17-30(40-32(42)26-18-28(35)31(36)38-21-26)34(44)41-29(16-22-6-4-3-5-7-22)33(43)39-20-25-10-8-24(19-37)9-11-25/h3-15,18,21,29-30H,2,16-17,19-20,37H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t29-,30+/m0/s1 XKUREAYXZXNALY-XZWHSSHBSA-N 200116 US9234000, 107 Plasma kallikrein Human 133 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200116 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200116&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499184 318589944 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355884 CCOc1ccc(C[C@@H](NC(=O)c2cc(F)nc(F)c2F)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H34F3N5O4/c1-2-46-25-14-12-22(13-15-25)17-28(40-32(43)26-18-29(35)42-31(37)30(26)36)34(45)41-27(16-21-6-4-3-5-7-21)33(44)39-20-24-10-8-23(19-38)9-11-24/h3-15,18,27-28H,2,16-17,19-20,38H2,1H3,(H,39,44)(H,40,43)(H,41,45)/t27-,28+/m0/s1 DCOSMQNHYNPFQB-WUFINQPMSA-N 200117 US9234000, 108 Plasma kallikrein Human 232 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200117 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200117&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185751 318589945 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355885 CCOc1ccc(C[C@@H](NC(=O)CC(F)(F)F)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C31H35F3N4O4/c1-2-42-25-14-12-22(13-15-25)17-27(37-28(39)18-31(32,33)34)30(41)38-26(16-21-6-4-3-5-7-21)29(40)36-20-24-10-8-23(19-35)9-11-24/h3-15,26-27H,2,16-20,35H2,1H3,(H,36,40)(H,37,39)(H,38,41)/t26-,27+/m0/s1 DBUIROVIMOGHBT-RRPNLBNLSA-N 200118 US9234000, 109 Plasma kallikrein Human 155 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200118 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200118&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185989 318589946 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355886 CCOc1ccc(C[C@@H](NC(=O)c2cc(C)nc(Cl)c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H38ClN5O4/c1-3-45-29-15-13-25(14-16-29)19-31(40-33(42)28-17-23(2)39-32(36)20-28)35(44)41-30(18-24-7-5-4-6-8-24)34(43)38-22-27-11-9-26(21-37)10-12-27/h4-17,20,30-31H,3,18-19,21-22,37H2,1-2H3,(H,38,43)(H,40,42)(H,41,44)/t30-,31+/m0/s1 ZAYPOTLKQDKQAV-IOWSJCHKSA-N 200119 US9234000, 110 Plasma kallikrein Human 598 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200119 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200119&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 89350754 318589947 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355887 CCOc1ccc(C[C@@H](NC(=O)c2sc(C)nc2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H39N5O4S/c1-4-43-28-16-14-25(15-17-28)19-30(39-34(42)31-22(2)37-23(3)44-31)33(41)38-29(18-24-8-6-5-7-9-24)32(40)36-21-27-12-10-26(20-35)11-13-27/h5-17,29-30H,4,18-21,35H2,1-3H3,(H,36,40)(H,38,41)(H,39,42)/t29-,30+/m0/s1 WBCSMOPGOQKPQY-XZWHSSHBSA-N 200120 US9234000, 111 Plasma kallikrein Human 58 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200120 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200120&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499173 318589948 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355888 CCOc1ccc(C[C@@H](NC(=O)c2cnc(C)s2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H37N5O4S/c1-3-42-27-15-13-24(14-16-27)18-29(38-33(41)30-21-35-22(2)43-30)32(40)37-28(17-23-7-5-4-6-8-23)31(39)36-20-26-11-9-25(19-34)10-12-26/h4-16,21,28-29H,3,17-20,34H2,1-2H3,(H,36,39)(H,37,40)(H,38,41)/t28-,29+/m0/s1 DQAPTUCUKSNJTQ-URLMMPGGSA-N 200121 US9234000, 112 Plasma kallikrein Human 298 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200121 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200121&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499183 318589949 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355889 CCOc1ccc(C[C@@H](NC(=O)c2nc(C)oc2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H39N5O5/c1-4-43-28-16-14-25(15-17-28)19-30(39-34(42)31-22(2)44-23(3)37-31)33(41)38-29(18-24-8-6-5-7-9-24)32(40)36-21-27-12-10-26(20-35)11-13-27/h5-17,29-30H,4,18-21,35H2,1-3H3,(H,36,40)(H,38,41)(H,39,42)/t29-,30+/m0/s1 NHVBFYCADPVHQX-XZWHSSHBSA-N 200122 US9234000, 113 Plasma kallikrein Human 455 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200122 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200122&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 122199211 318589950 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355890 CCOc1ccc(C[C@@H](NC(=O)c2ccc3nc(C)ccc3c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C39H41N5O4/c1-3-48-33-18-14-28(15-19-33)22-36(43-37(45)32-17-20-34-31(23-32)16-9-26(2)42-34)39(47)44-35(21-27-7-5-4-6-8-27)38(46)41-25-30-12-10-29(24-40)11-13-30/h4-20,23,35-36H,3,21-22,24-25,40H2,1-2H3,(H,41,46)(H,43,45)(H,44,47)/t35-,36+/m0/s1 WBYJFERZJIJQIQ-MPQUPPDSSA-N 200123 US9234000, 114 Plasma kallikrein Human 427 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200123 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200123&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 122199212 318589951 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355891 CCOc1ccc(C[C@@H](NC(=O)c2cnc3cc(Cl)ccc3c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C38H38ClN5O4/c1-2-48-32-16-12-26(13-17-32)19-35(43-36(45)30-20-29-14-15-31(39)21-33(29)41-24-30)38(47)44-34(18-25-6-4-3-5-7-25)37(46)42-23-28-10-8-27(22-40)9-11-28/h3-17,20-21,24,34-35H,2,18-19,22-23,40H2,1H3,(H,42,46)(H,43,45)(H,44,47)/t34-,35+/m0/s1 GRBCXZQPXFWSKI-OIDHKYIRSA-N 200124 US9234000, 115 Plasma kallikrein Human 417 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200124 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200124&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 122199213 318589952 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355892 CCOc1ccc(C[C@@H](NC(=O)c2sccc2Cl)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H35ClN4O4S/c1-2-42-26-14-12-23(13-15-26)19-29(38-33(41)30-27(34)16-17-43-30)32(40)37-28(18-22-6-4-3-5-7-22)31(39)36-21-25-10-8-24(20-35)9-11-25/h3-17,28-29H,2,18-21,35H2,1H3,(H,36,39)(H,37,40)(H,38,41)/t28-,29+/m0/s1 PUJHQMNZVXXXHE-URLMMPGGSA-N 200125 US9234000, 116 Plasma kallikrein Human 18 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200125 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200125&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499185 318589953 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355893 CCOc1ccc(C[C@@H](NC(=O)c2scnc2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H37N5O4S/c1-3-42-27-15-13-24(14-16-27)18-29(38-33(41)30-22(2)36-21-43-30)32(40)37-28(17-23-7-5-4-6-8-23)31(39)35-20-26-11-9-25(19-34)10-12-26/h4-16,21,28-29H,3,17-20,34H2,1-2H3,(H,35,39)(H,37,40)(H,38,41)/t28-,29+/m0/s1 NKONHEXDLBKQFF-URLMMPGGSA-N 200126 US9234000, 117 Plasma kallikrein Human 48 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200126 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200126&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185569 318589954 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355894 CCOc1ccc(C[C@@H](NC(=O)c2ccco2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H36N4O5/c1-2-41-27-16-14-24(15-17-27)20-29(37-33(40)30-9-6-18-42-30)32(39)36-28(19-23-7-4-3-5-8-23)31(38)35-22-26-12-10-25(21-34)11-13-26/h3-18,28-29H,2,19-22,34H2,1H3,(H,35,38)(H,36,39)(H,37,40)/t28-,29+/m0/s1 KXEHMWWWSGDRNZ-URLMMPGGSA-N 200127 US9234000, 118 Plasma kallikrein Human 61 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200127 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200127&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499200 318589955 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355895 CCOc1ccc(C[C@@H](NC(=O)c2sccc2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H38N4O4S/c1-3-42-28-15-13-25(14-16-28)20-30(38-34(41)31-23(2)17-18-43-31)33(40)37-29(19-24-7-5-4-6-8-24)32(39)36-22-27-11-9-26(21-35)10-12-27/h4-18,29-30H,3,19-22,35H2,1-2H3,(H,36,39)(H,37,40)(H,38,41)/t29-,30+/m0/s1 HBWHYKRQSALKFK-XZWHSSHBSA-N 200128 US9234000, 119 Plasma kallikrein Human 15 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200128 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200128&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499201 318589956 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355896 CCOc1ccc(C[C@@H](NC(=O)c2cccc(OC)n2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O5/c1-3-45-28-18-16-25(17-19-28)21-31(40-34(42)29-10-7-11-32(38-29)44-2)35(43)39-30(20-24-8-5-4-6-9-24)33(41)37-23-27-14-12-26(22-36)13-15-27/h4-19,30-31H,3,20-23,36H2,1-2H3,(H,37,41)(H,39,43)(H,40,42)/t30-,31+/m0/s1 QJNCCZAUPWBOQN-IOWSJCHKSA-N 200129 US9234000, 120 Plasma kallikrein Human 540 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200129 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200129&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 122199214 318589957 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355897 CCOc1ccc(C[C@@H](NC(=O)c2cncc(OC)c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O5/c1-3-45-29-15-13-25(14-16-29)18-32(39-33(41)28-19-30(44-2)23-37-22-28)35(43)40-31(17-24-7-5-4-6-8-24)34(42)38-21-27-11-9-26(20-36)10-12-27/h4-16,19,22-23,31-32H,3,17-18,20-21,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 OGBRQNGKSNMMFK-AJQTZOPKSA-N 200130 US9234000, 121 Plasma kallikrein Human 310 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200130 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200130&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71186187 318589958 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355898 CCOc1ccc(C[C@@H](NC(=O)c2sccc2OC)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H38N4O5S/c1-3-43-27-15-13-24(14-16-27)20-29(38-34(41)31-30(42-2)17-18-44-31)33(40)37-28(19-23-7-5-4-6-8-23)32(39)36-22-26-11-9-25(21-35)10-12-26/h4-18,28-29H,3,19-22,35H2,1-2H3,(H,36,39)(H,37,40)(H,38,41)/t28-,29+/m0/s1 WVUHHNJRARDZRJ-URLMMPGGSA-N 200131 US9234000, 122 Plasma kallikrein Human 519 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200131 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200131&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 122199215 318589959 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355899 CCOc1ccc(C[C@@H](NC(=O)c2ccnc(OC)c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O5/c1-3-45-29-15-13-25(14-16-29)20-31(39-33(41)28-17-18-37-32(21-28)44-2)35(43)40-30(19-24-7-5-4-6-8-24)34(42)38-23-27-11-9-26(22-36)10-12-27/h4-18,21,30-31H,3,19-20,22-23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t30-,31+/m0/s1 MHNXCQNJTDJPBJ-IOWSJCHKSA-N 200132 US9234000, 123 Plasma kallikrein Human 214 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200132 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200132&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185938 318589960 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355900 CCOc1ccc(C[C@@H](NC(=O)c2[nH]ccc2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H39N5O4/c1-3-43-28-15-13-25(14-16-28)20-30(39-34(42)31-23(2)17-18-36-31)33(41)38-29(19-24-7-5-4-6-8-24)32(40)37-22-27-11-9-26(21-35)10-12-27/h4-18,29-30,36H,3,19-22,35H2,1-2H3,(H,37,40)(H,38,41)(H,39,42)/t29-,30+/m0/s1 CIHUARIXQZFRDX-XZWHSSHBSA-N 200133 US9234000, 124 Plasma kallikrein Human 20 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200133 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200133&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499278 318589961 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355901 CCOc1ccc(C[C@@H](NC(=O)c2sccc2N)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H37N5O4S/c1-2-42-26-14-12-23(13-15-26)19-29(38-33(41)30-27(35)16-17-43-30)32(40)37-28(18-22-6-4-3-5-7-22)31(39)36-21-25-10-8-24(20-34)9-11-25/h3-17,28-29H,2,18-21,34-35H2,1H3,(H,36,39)(H,37,40)(H,38,41)/t28-,29+/m0/s1 YNMNVDUWPIIZMN-URLMMPGGSA-N 200134 US9234000, 125 Plasma kallikrein Human 10 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200134 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200134&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499277 318589962 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355902 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](CC2CCCCC2)NC(=O)c2ccccc2)cc1 InChI=1S/C33H40N4O3/c34-22-26-16-18-27(19-17-26)23-35-32(39)29(20-24-10-4-1-5-11-24)37-33(40)30(21-25-12-6-2-7-13-25)36-31(38)28-14-8-3-9-15-28/h1,3-5,8-11,14-19,25,29-30H,2,6-7,12-13,20-23,34H2,(H,35,39)(H,36,38)(H,37,40)/t29-,30+/m0/s1 YIFIDQFIPIUXTH-XZWHSSHBSA-N 200135 US9234000, 126 Plasma kallikrein Human 4013 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200135&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185486 318589963 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355903 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)c2ccccc2)cc1 InChI=1S/C33H33ClN4O3/c34-28-17-15-24(16-18-28)20-30(37-31(39)27-9-5-2-6-10-27)33(41)38-29(19-23-7-3-1-4-8-23)32(40)36-22-26-13-11-25(21-35)12-14-26/h1-18,29-30H,19-22,35H2,(H,36,40)(H,37,39)(H,38,41)/t29-,30+/m0/s1 DFTDXVAGVUMEML-XZWHSSHBSA-N 200136 US9234000, 127 Plasma kallikrein Human 521 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200136 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200136&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71186001 318589964 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355904 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccc(OCc3ccc(Cl)cc3)cc2)NC(=O)c2ccccc2)cc1 InChI=1S/C40H39ClN4O4/c41-34-19-15-32(16-20-34)27-49-35-21-17-29(18-22-35)24-37(44-38(46)33-9-5-2-6-10-33)40(48)45-36(23-28-7-3-1-4-8-28)39(47)43-26-31-13-11-30(25-42)12-14-31/h1-22,36-37H,23-27,42H2,(H,43,47)(H,44,46)(H,45,48)/t36-,37+/m0/s1 IHLBOTCKEIVMGZ-PQQNNWGCSA-N 200137 US9234000, 128 Plasma kallikrein Human 2009 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200137 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200137&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71186172 318589965 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355905 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)c2ccccc2)cc1 InChI=1S/C33H34N4O4/c34-21-25-11-13-26(14-12-25)22-35-32(40)29(19-23-7-3-1-4-8-23)37-33(41)30(20-24-15-17-28(38)18-16-24)36-31(39)27-9-5-2-6-10-27/h1-18,29-30,38H,19-22,34H2,(H,35,40)(H,36,39)(H,37,41)/t29-,30+/m0/s1 ZDQNDZXAURUSJI-XZWHSSHBSA-N 200138 US9234000, 129 Plasma kallikrein Human 10000 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200138 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200138&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185520 318589966 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355906 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccc(OCc3ccc(F)cc3)cc2)NC(=O)c2ccccc2)cc1 InChI=1S/C40H39FN4O4/c41-34-19-15-32(16-20-34)27-49-35-21-17-29(18-22-35)24-37(44-38(46)33-9-5-2-6-10-33)40(48)45-36(23-28-7-3-1-4-8-28)39(47)43-26-31-13-11-30(25-42)12-14-31/h1-22,36-37H,23-27,42H2,(H,43,47)(H,44,46)(H,45,48)/t36-,37+/m0/s1 WEVQLDNHQXUOLS-PQQNNWGCSA-N 200139 US9234000, 130 Plasma kallikrein Human 2491 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200139 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200139&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71186175 318589967 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355907 CCCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C36H40N4O4/c1-2-21-44-31-19-17-27(18-20-31)23-33(39-34(41)30-11-7-4-8-12-30)36(43)40-32(22-26-9-5-3-6-10-26)35(42)38-25-29-15-13-28(24-37)14-16-29/h3-20,32-33H,2,21-25,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t32-,33+/m0/s1 OTUOSRRHYVCHTB-JHOUSYSJSA-N 200140 US9234000, 131 Plasma kallikrein Human 40 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200140 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200140&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185674 318589968 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355908 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccc(OCc3ccccc3)cc2)NC(=O)c2ccccc2)cc1 InChI=1S/C40H40N4O4/c41-26-31-16-18-32(19-17-31)27-42-39(46)36(24-29-10-4-1-5-11-29)44-40(47)37(43-38(45)34-14-8-3-9-15-34)25-30-20-22-35(23-21-30)48-28-33-12-6-2-7-13-33/h1-23,36-37H,24-28,41H2,(H,42,46)(H,43,45)(H,44,47)/t36-,37+/m0/s1 QGCXWVPWNLGRGP-PQQNNWGCSA-N 200141 US9234000, 132 Plasma kallikrein Human 1209 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200141 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200141&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185535 318589969 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355909 CC(C)C[C@@H](NC(=O)c1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C30H36N4O3/c1-21(2)17-26(33-28(35)25-11-7-4-8-12-25)30(37)34-27(18-22-9-5-3-6-10-22)29(36)32-20-24-15-13-23(19-31)14-16-24/h3-16,21,26-27H,17-20,31H2,1-2H3,(H,32,36)(H,33,35)(H,34,37)/t26-,27+/m1/s1 SWCPUEOSXZSMHD-SXOMAYOGSA-N 200142 US9234000, 133 Plasma kallikrein Human 10000 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200142 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200142&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185530 318589970 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355910 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccc(OCc3c(Cl)cccc3Cl)cc2)NC(=O)c2ccccc2)cc1 InChI=1S/C40H38Cl2N4O4/c41-34-12-7-13-35(42)33(34)26-50-32-20-18-28(19-21-32)23-37(45-38(47)31-10-5-2-6-11-31)40(49)46-36(22-27-8-3-1-4-9-27)39(48)44-25-30-16-14-29(24-43)15-17-30/h1-21,36-37H,22-26,43H2,(H,44,48)(H,45,47)(H,46,49)/t36-,37+/m0/s1 XCVRNFXSJAMNSP-PQQNNWGCSA-N 200143 US9234000, 134 Plasma kallikrein Human 10000 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200143 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200143&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71186163 318589971 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355911 Cc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H36N4O3/c1-24-12-14-26(15-13-24)21-31(37-32(39)29-10-6-3-7-11-29)34(41)38-30(20-25-8-4-2-5-9-25)33(40)36-23-28-18-16-27(22-35)17-19-28/h2-19,30-31H,20-23,35H2,1H3,(H,36,40)(H,37,39)(H,38,41)/t30-,31+/m0/s1 HXMCBSSHSYKQRK-IOWSJCHKSA-N 200144 US9234000, 135 Plasma kallikrein Human 424 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200144 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200144&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185534 318589972 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355912 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccc(OCc3cccc(F)c3)cc2)NC(=O)c2ccccc2)cc1 InChI=1S/C40H39FN4O4/c41-34-13-7-10-32(22-34)27-49-35-20-18-29(19-21-35)24-37(44-38(46)33-11-5-2-6-12-33)40(48)45-36(23-28-8-3-1-4-9-28)39(47)43-26-31-16-14-30(25-42)15-17-31/h1-22,36-37H,23-27,42H2,(H,43,47)(H,44,46)(H,45,48)/t36-,37+/m0/s1 QLUQCWBEOZNKTG-PQQNNWGCSA-N 200145 US9234000, 136 Plasma kallikrein Human 1017 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200145 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200145&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185576 318589973 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355913 COc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cn1 InChI=1S/C33H35N5O4/c1-42-30-17-16-26(22-35-30)19-29(37-31(39)27-10-6-3-7-11-27)33(41)38-28(18-23-8-4-2-5-9-23)32(40)36-21-25-14-12-24(20-34)13-15-25/h2-17,22,28-29H,18-21,34H2,1H3,(H,36,40)(H,37,39)(H,38,41)/t28-,29+/m0/s1 WVHMGGCVTKVQNI-URLMMPGGSA-N 200146 US9234000, 137 Plasma kallikrein Human 7540 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200146 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200146&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185782 318589974 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355914 COc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H36N4O4/c1-42-29-18-16-25(17-19-29)21-31(37-32(39)28-10-6-3-7-11-28)34(41)38-30(20-24-8-4-2-5-9-24)33(40)36-23-27-14-12-26(22-35)13-15-27/h2-19,30-31H,20-23,35H2,1H3,(H,36,40)(H,37,39)(H,38,41)/t30-,31+/m0/s1 YOYSQDNQEZYVLQ-IOWSJCHKSA-N 200147 US9234000, 138 Plasma kallikrein Human 310 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200147 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200147&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185997 318589975 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355915 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)c2ccccc2)cc1 InChI=1S/C33H34N4O3/c34-22-26-16-18-27(19-17-26)23-35-32(39)29(20-24-10-4-1-5-11-24)37-33(40)30(21-25-12-6-2-7-13-25)36-31(38)28-14-8-3-9-15-28/h1-19,29-30H,20-23,34H2,(H,35,39)(H,36,38)(H,37,40)/t29-,30+/m0/s1 NGTNYFZFCLPYMX-XZWHSSHBSA-N 200148 US9234000, 139 Plasma kallikrein Human 1141 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200148 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200148&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185608 318589976 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355916 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccn2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H37N5O4/c1-2-43-29-17-15-24(16-18-29)20-30(38-32(40)27-8-4-3-5-9-27)34(42)39-31(21-28-10-6-7-19-36-28)33(41)37-23-26-13-11-25(22-35)12-14-26/h3-19,30-31H,2,20-23,35H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t30-,31+/m1/s1 BHVUGAWTPFXTSW-JSOSNVBQSA-N 200149 US9234000, 140 Plasma kallikrein Human 45 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200149&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499250 318589977 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355917 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H36Cl2N4O4/c1-2-45-28-15-12-23(13-16-28)19-32(40-33(42)27-6-4-3-5-7-27)35(44)41-31(20-26-14-17-29(36)30(37)18-26)34(43)39-22-25-10-8-24(21-38)9-11-25/h3-18,31-32H,2,19-22,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t31-,32+/m0/s1 MZNWXAJMLAFTSG-AJQTZOPKSA-N 200150 US9234000, 141 Plasma kallikrein Human 55 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200150 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200150&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499248 318589978 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355918 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H37ClN4O4/c1-2-44-30-18-14-25(15-19-30)21-32(39-33(41)28-6-4-3-5-7-28)35(43)40-31(20-24-12-16-29(36)17-13-24)34(42)38-23-27-10-8-26(22-37)9-11-27/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 XRXPBLITZSRMPK-AJQTZOPKSA-N 200151 US9234000, 142 Plasma kallikrein Human 96 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200151 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200151&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499249 318589979 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355919 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccc(F)cc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H37FN4O4/c1-2-44-30-18-14-25(15-19-30)21-32(39-33(41)28-6-4-3-5-7-28)35(43)40-31(20-24-12-16-29(36)17-13-24)34(42)38-23-27-10-8-26(22-37)9-11-27/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 OVUYMWPCQQBURI-AJQTZOPKSA-N 200152 US9234000, 143 Plasma kallikrein Human 83 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200152&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185963 318589980 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355920 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2cccc(c2)C(F)(F)F)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C36H37F3N4O4/c1-2-47-30-17-15-24(16-18-30)20-32(42-33(44)28-8-4-3-5-9-28)35(46)43-31(21-27-7-6-10-29(19-27)36(37,38)39)34(45)41-23-26-13-11-25(22-40)12-14-26/h3-19,31-32H,2,20-23,40H2,1H3,(H,41,45)(H,42,44)(H,43,46)/t31-,32+/m0/s1 NAYGGTQDFNWPNS-AJQTZOPKSA-N 200153 US9234000, 144 Plasma kallikrein Human 340 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200153 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200153&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185586 318589981 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355921 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H37N5O4/c1-2-43-29-16-14-24(15-17-29)19-31(38-32(40)28-8-4-3-5-9-28)34(42)39-30(20-27-7-6-18-36-22-27)33(41)37-23-26-12-10-25(21-35)11-13-26/h3-18,22,30-31H,2,19-21,23,35H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t30-,31+/m0/s1 IOKOMILCLYAEGO-IOWSJCHKSA-N 200154 US9234000, 145 Plasma kallikrein Human 25 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200154 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200154&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185660 318589982 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355922 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccc(OC)cc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C36H40N4O5/c1-3-45-31-19-15-26(16-20-31)22-33(39-34(41)29-7-5-4-6-8-29)36(43)40-32(21-25-13-17-30(44-2)18-14-25)35(42)38-24-28-11-9-27(23-37)10-12-28/h4-20,32-33H,3,21-24,37H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t32-,33+/m0/s1 MNENVOCWAYYIHM-JHOUSYSJSA-N 200155 US9234000, 146 Plasma kallikrein Human 232 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200155 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200155&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499276 318589983 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355923 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccncc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H37N5O4/c1-2-43-29-14-12-24(13-15-29)20-31(38-32(40)28-6-4-3-5-7-28)34(42)39-30(21-25-16-18-36-19-17-25)33(41)37-23-27-10-8-26(22-35)9-11-27/h3-19,30-31H,2,20-23,35H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t30-,31+/m0/s1 MGPOPQVVNMABOI-IOWSJCHKSA-N 200156 US9234000, 147 Plasma kallikrein Human 284 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200156 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200156&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499304 318589984 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355924 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccc(cc2)C(F)(F)F)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C36H37F3N4O4/c1-2-47-30-18-14-25(15-19-30)21-32(42-33(44)28-6-4-3-5-7-28)35(46)43-31(20-24-12-16-29(17-13-24)36(37,38)39)34(45)41-23-27-10-8-26(22-40)9-11-27/h3-19,31-32H,2,20-23,40H2,1H3,(H,41,45)(H,42,44)(H,43,46)/t31-,32+/m0/s1 KMFPQSSNRGUHHI-AJQTZOPKSA-N 200157 US9234000, 148 Plasma kallikrein Human 934 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200157 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200157&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185663 318589985 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355925 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2cccc(F)c2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H37FN4O4/c1-2-44-30-17-15-24(16-18-30)20-32(39-33(41)28-8-4-3-5-9-28)35(43)40-31(21-27-7-6-10-29(36)19-27)34(42)38-23-26-13-11-25(22-37)12-14-26/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 OYMHEDPIXZJWGT-AJQTZOPKSA-N 200158 US9234000, 149 Plasma kallikrein Human 91 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200158&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71186117 318589986 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355926 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2cccs2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H36N4O4S/c1-2-41-27-16-14-23(15-17-27)19-29(36-31(38)26-7-4-3-5-8-26)33(40)37-30(20-28-9-6-18-42-28)32(39)35-22-25-12-10-24(21-34)11-13-25/h3-18,29-30H,2,19-22,34H2,1H3,(H,35,39)(H,36,38)(H,37,40)/t29-,30+/m1/s1 IBCRPNPROJRPGD-IHLOFXLRSA-N 200159 US9234000, 150 Plasma kallikrein Human 51 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200159 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200159&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499399 318589987 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355927 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccsc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H36N4O4S/c1-2-41-28-14-12-23(13-15-28)18-30(36-31(38)27-6-4-3-5-7-27)33(40)37-29(19-26-16-17-42-22-26)32(39)35-21-25-10-8-24(20-34)9-11-25/h3-17,22,29-30H,2,18-21,34H2,1H3,(H,35,39)(H,36,38)(H,37,40)/t29-,30+/m0/s1 FEEFLICHCNTQCS-XZWHSSHBSA-N 200160 US9234000, 151 Plasma kallikrein Human 9 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200160 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200160&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499365 318589988 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355928 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2cscn2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C32H35N5O4S/c1-2-41-27-14-12-22(13-15-27)16-28(36-30(38)25-6-4-3-5-7-25)32(40)37-29(17-26-20-42-21-35-26)31(39)34-19-24-10-8-23(18-33)9-11-24/h3-15,20-21,28-29H,2,16-19,33H2,1H3,(H,34,39)(H,36,38)(H,37,40)/t28-,29+/m1/s1 FHHIRUSMTLKWSO-WDYNHAJCSA-N 200161 US9234000, 152 Plasma kallikrein Human 23 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200161&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499363 318589989 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355929 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2csc3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C37H38N4O4S/c1-2-45-30-18-16-25(17-19-30)20-32(40-35(42)28-8-4-3-5-9-28)37(44)41-33(21-29-24-46-34-11-7-6-10-31(29)34)36(43)39-23-27-14-12-26(22-38)13-15-27/h3-19,24,32-33H,2,20-23,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t32-,33+/m1/s1 XQQTZKDEZFNLED-SAIUNTKASA-N 200162 US9234000, 153 Plasma kallikrein Human 10 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200162&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499364 318589990 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355930 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(F)c2)cc1 InChI=1S/C35H37FN4O4/c1-2-44-29-17-14-25(15-18-29)21-32(39-33(41)27-11-7-4-8-12-27)35(43)40-31(20-24-9-5-3-6-10-24)34(42)38-23-26-13-16-28(22-37)30(36)19-26/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 UXHKCWBMPOSFQY-AJQTZOPKSA-N 200163 US9234000, 154 Plasma kallikrein Human 21 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200163 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200163&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185721 318589991 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355931 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(Cl)c2)cc1 InChI=1S/C35H37ClN4O4/c1-2-44-29-17-14-25(15-18-29)21-32(39-33(41)27-11-7-4-8-12-27)35(43)40-31(20-24-9-5-3-6-10-24)34(42)38-23-26-13-16-28(22-37)30(36)19-26/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 NOORMTUTGSQYIZ-AJQTZOPKSA-N 200164 US9234000, 155 Plasma kallikrein Human 22 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200164 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200164&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499400 318589992 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355932 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(c2)C(F)(F)F)cc1 InChI=1S/C36H37F3N4O4/c1-2-47-29-17-14-25(15-18-29)21-32(42-33(44)27-11-7-4-8-12-27)35(46)43-31(20-24-9-5-3-6-10-24)34(45)41-23-26-13-16-28(22-40)30(19-26)36(37,38)39/h3-19,31-32H,2,20-23,40H2,1H3,(H,41,45)(H,42,44)(H,43,46)/t31-,32+/m0/s1 KEMDZFGHDRNLTH-AJQTZOPKSA-N 200165 US9234000, 156 Plasma kallikrein Human 1083 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200165 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200165&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185671 318589993 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355933 CCOc1ccc(C[C@@H](NC(=O)c2ccccn2)C(=O)N[C@@H](Cc2cccs2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C32H35N5O4S/c1-2-41-25-14-12-22(13-15-25)18-28(36-31(39)27-7-3-4-16-34-27)32(40)37-29(19-26-6-5-17-42-26)30(38)35-21-24-10-8-23(20-33)9-11-24/h3-17,28-29H,2,18-21,33H2,1H3,(H,35,38)(H,36,39)(H,37,40)/t28-,29+/m1/s1 DOEHDNHECCZREA-WDYNHAJCSA-N 200166 US9234000, 157 Plasma kallikrein Human 36 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200166&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499431 318589994 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355934 CCOc1ccc(C[C@@H](NC(=O)c2ccc(OC)cc2)C(=O)N[C@@H](Cc2ccccn2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O5/c1-3-45-30-15-11-24(12-16-30)20-31(39-33(41)27-13-17-29(44-2)18-14-27)35(43)40-32(21-28-6-4-5-19-37-28)34(42)38-23-26-9-7-25(22-36)8-10-26/h4-19,31-32H,3,20-23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m1/s1 KGASRYBCGZUNAS-ZWXJPIIXSA-N 200167 US9234000, 158 Plasma kallikrein Human 47 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200167 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200167&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499401 318589995 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355935 CCOc1ccc(C[C@@H](NC(=O)c2ccccn2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(Cl)c2)cc1 InChI=1S/C34H36ClN5O4/c1-2-44-27-15-12-24(13-16-27)20-31(40-33(42)29-10-6-7-17-37-29)34(43)39-30(19-23-8-4-3-5-9-23)32(41)38-22-25-11-14-26(21-36)28(35)18-25/h3-18,30-31H,2,19-22,36H2,1H3,(H,38,41)(H,39,43)(H,40,42)/t30-,31+/m0/s1 GBUZITZBMSHALN-IOWSJCHKSA-N 200168 US9234000, 159 Plasma kallikrein Human 15 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200168 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200168&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499432 318589996 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355936 CCOc1ccc(C[C@@H](NC(=O)c2ccc(OC)cc2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O5/c1-3-45-30-14-10-24(11-15-30)19-32(39-33(41)28-12-16-29(44-2)17-13-28)35(43)40-31(20-27-5-4-18-37-22-27)34(42)38-23-26-8-6-25(21-36)7-9-26/h4-18,22,31-32H,3,19-21,23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 AJYZUIMBRBUFPQ-AJQTZOPKSA-N 200169 US9234000, 160 Plasma kallikrein Human 10 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200169&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185939 318589997 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355937 CCOc1ccc(C[C@@H](NC(=O)c2ccncc2)C(=O)N[C@@H](Cc2ccc(F)c(F)c2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H35F2N5O4/c1-2-45-27-10-7-22(8-11-27)18-31(40-32(42)26-13-15-38-16-14-26)34(44)41-30(19-25-9-12-28(35)29(36)17-25)33(43)39-21-24-5-3-23(20-37)4-6-24/h3-17,30-31H,2,18-21,37H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t30-,31+/m0/s1 UIKVVUURJYWPFD-IOWSJCHKSA-N 200170 US9234000, 161 Plasma kallikrein Human 49 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200170 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200170&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499433 318589998 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355938 CCOc1ccc(C[C@@H](NC(=O)c2cccs2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C32H35N5O4S/c1-2-41-26-13-11-22(12-14-26)17-28(37-32(40)29-6-4-16-42-29)31(39)36-27(18-25-5-3-15-34-20-25)30(38)35-21-24-9-7-23(19-33)8-10-24/h3-16,20,27-28H,2,17-19,21,33H2,1H3,(H,35,38)(H,36,39)(H,37,40)/t27-,28+/m0/s1 QICJOCRBSRBUHC-WUFINQPMSA-N 200171 US9234000, 162 Plasma kallikrein Human 10 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200171 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200171&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499451 318589999 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355939 CCOc1ccc(C[C@@H](NC(=O)c2ccc(Cl)cc2)C(=O)N[C@@H](Cc2ccccn2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H36ClN5O4/c1-2-44-29-16-10-23(11-17-29)19-30(39-32(41)26-12-14-27(35)15-13-26)34(43)40-31(20-28-5-3-4-18-37-28)33(42)38-22-25-8-6-24(21-36)7-9-25/h3-18,30-31H,2,19-22,36H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t30-,31+/m1/s1 SJQWETDPGAMVES-JSOSNVBQSA-N 200172 US9234000, 163 Plasma kallikrein Human 64 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200172 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200172&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185934 318590000 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355940 CCOc1ccc(C[C@@H](NC(=O)c2ccc(C)cc2)C(=O)N[C@@H](Cc2ccccn2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O4/c1-3-44-30-17-13-25(14-18-30)20-31(39-33(41)28-15-7-24(2)8-16-28)35(43)40-32(21-29-6-4-5-19-37-29)34(42)38-23-27-11-9-26(22-36)10-12-27/h4-19,31-32H,3,20-23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m1/s1 XTDUCJDRKRNRPM-ZWXJPIIXSA-N 200173 US9234000, 164 Plasma kallikrein Human 50 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200173&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185860 318590001 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355941 CCOc1ccc(C[C@@H](NC(=O)c2ccccn2)C(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H35Cl2N5O4/c1-2-45-26-13-10-22(11-14-26)18-31(41-33(43)29-5-3-4-16-38-29)34(44)40-30(19-25-12-15-27(35)28(36)17-25)32(42)39-21-24-8-6-23(20-37)7-9-24/h3-17,30-31H,2,18-21,37H2,1H3,(H,39,42)(H,40,44)(H,41,43)/t30-,31+/m0/s1 ORHWIOJJYJCEEN-IOWSJCHKSA-N 200174 US9234000, 165 Plasma kallikrein Human 70 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200174&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499452 318590002 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355942 CCOc1ccc(CC(=O)CN(CCC(N)=O)[C@@H](Cc2ccccn2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C30H37N5O4/c1-2-39-27-12-10-22(11-13-27)17-26(36)21-35(16-14-29(32)37)28(18-25-5-3-4-15-33-25)30(38)34-20-24-8-6-23(19-31)7-9-24/h3-13,15,28H,2,14,16-21,31H2,1H3,(H2,32,37)(H,34,38)/t28-/m0/s1 DILSGXCGLKYUGX-NDEPHWFRSA-N 200175 US9234000, 166 Plasma kallikrein Human 262 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200175&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185872 318590003 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355943 CCOc1ccc(C[C@@H](NC(=O)c2ccncc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(F)c2)cc1 InChI=1S/C34H36FN5O4/c1-2-44-28-12-9-24(10-13-28)20-31(39-32(41)26-14-16-37-17-15-26)34(43)40-30(19-23-6-4-3-5-7-23)33(42)38-22-25-8-11-27(21-36)29(35)18-25/h3-18,30-31H,2,19-22,36H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t30-,31+/m0/s1 LVBXETRZHVPVHL-IOWSJCHKSA-N 200176 US9234000, 167 Plasma kallikrein Human 80 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200176&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71186140 318590004 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355944 CCOc1ccc(C[C@@H](NC(=O)c2ccccn2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(F)c2)cc1 InChI=1S/C34H36FN5O4/c1-2-44-27-15-12-24(13-16-27)20-31(40-33(42)29-10-6-7-17-37-29)34(43)39-30(19-23-8-4-3-5-9-23)32(41)38-22-25-11-14-26(21-36)28(35)18-25/h3-18,30-31H,2,19-22,36H2,1H3,(H,38,41)(H,39,43)(H,40,42)/t30-,31+/m0/s1 JJQFJIAMVLGSKU-IOWSJCHKSA-N 200177 US9234000, 168 Plasma kallikrein Human 76 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200177 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200177&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499222 318590005 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355945 CCOc1ccc(C[C@@H](NC(=O)c2cccs2)C(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H34Cl2N4O4S/c1-2-43-25-12-9-21(10-13-25)17-29(39-33(42)30-4-3-15-44-30)32(41)38-28(18-24-11-14-26(34)27(35)16-24)31(40)37-20-23-7-5-22(19-36)6-8-23/h3-16,28-29H,2,17-20,36H2,1H3,(H,37,40)(H,38,41)(H,39,42)/t28-,29+/m0/s1 GBOFJZGDOGSEJK-URLMMPGGSA-N 200178 US9234000, 169 Plasma kallikrein Human 44 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200178&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499221 318590006 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355946 CCOc1ccc(CC(=O)CN(CCC(N)=O)[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C30H37N5O4/c1-2-39-27-11-9-22(10-12-27)16-26(36)21-35(15-13-29(32)37)28(17-25-4-3-14-33-19-25)30(38)34-20-24-7-5-23(18-31)6-8-24/h3-12,14,19,28H,2,13,15-18,20-21,31H2,1H3,(H2,32,37)(H,34,38)/t28-/m0/s1 VDZMJOARFXFULW-NDEPHWFRSA-N 200179 US9234000, 170 Plasma kallikrein Human 51 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200179&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 90302182 318590007 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355947 CCOc1ccc(C[C@@H](NC(=O)c2ccncc2)C(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H35Cl2N5O4/c1-2-45-27-10-7-22(8-11-27)18-31(40-32(42)26-13-15-38-16-14-26)34(44)41-30(19-25-9-12-28(35)29(36)17-25)33(43)39-21-24-5-3-23(20-37)4-6-24/h3-17,30-31H,2,18-21,37H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t30-,31+/m0/s1 OKGHJSOTBPWZDZ-IOWSJCHKSA-N 200180 US9234000, 171 Plasma kallikrein Human 123 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200180&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499303 318590008 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355948 CCOc1ccc(C[C@@H](NC(=O)CC(F)(F)F)C(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C31H33Cl2F3N4O4/c1-2-44-23-10-7-19(8-11-23)14-27(39-28(41)16-31(34,35)36)30(43)40-26(15-22-9-12-24(32)25(33)13-22)29(42)38-18-21-5-3-20(17-37)4-6-21/h3-13,26-27H,2,14-18,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t26-,27+/m0/s1 BAAMDLCQQMJQAZ-RRPNLBNLSA-N 200181 US9234000, 172 Plasma kallikrein Human 881 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200181 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200181&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499332 318590009 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355949 CCOc1ccc(C[C@@H](NC(=O)c2ccc(Cl)cc2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H36ClN5O4/c1-2-44-29-15-9-23(10-16-29)18-31(39-32(41)27-11-13-28(35)14-12-27)34(43)40-30(19-26-4-3-17-37-21-26)33(42)38-22-25-7-5-24(20-36)6-8-25/h3-17,21,30-31H,2,18-20,22,36H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t30-,31+/m0/s1 COXMDBLAIZHMPI-IOWSJCHKSA-N 200182 US9234000, 173 Plasma kallikrein Human 213 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200182 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200182&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499330 318590010 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355950 CCOc1ccc(C[C@@H](NC(=O)c2ccno2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C31H34N6O5/c1-2-41-25-11-9-21(10-12-25)16-27(37-31(40)28-13-15-35-42-28)30(39)36-26(17-24-4-3-14-33-19-24)29(38)34-20-23-7-5-22(18-32)6-8-23/h3-15,19,26-27H,2,16-18,20,32H2,1H3,(H,34,38)(H,36,39)(H,37,40)/t26-,27+/m0/s1 GWSFNRAHPBVBJY-RRPNLBNLSA-N 200183 US9234000, 174 Plasma kallikrein Human 45 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200183&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499331 318590011 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355951 CCOc1ccc(C[C@@H](NC(=O)c2sccc2Cl)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C32H34ClN5O4S/c1-2-42-25-11-9-21(10-12-25)16-28(38-32(41)29-26(33)13-15-43-29)31(40)37-27(17-24-4-3-14-35-19-24)30(39)36-20-23-7-5-22(18-34)6-8-23/h3-15,19,27-28H,2,16-18,20,34H2,1H3,(H,36,39)(H,37,40)(H,38,41)/t27-,28+/m0/s1 YYYMEQVUGUUKPY-WUFINQPMSA-N 200184 US9234000, 175 Plasma kallikrein Human 3 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200184 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200184&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499477 318590012 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355952 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C37H39N5O4/c1-2-46-30-18-16-25(17-19-30)20-33(41-35(43)28-8-4-3-5-9-28)37(45)42-34(21-29-24-39-32-11-7-6-10-31(29)32)36(44)40-23-27-14-12-26(22-38)13-15-27/h3-19,24,33-34,39H,2,20-23,38H2,1H3,(H,40,44)(H,41,43)(H,42,45)/t33-,34+/m1/s1 GAEPCQZQRDPARJ-NOCHOARKSA-N 200185 US9234000, 176 Plasma kallikrein Human 28 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200185 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200185&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71187144 318590013 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355953 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C32H36N6O4/c1-2-42-27-14-12-22(13-15-27)16-28(37-30(39)25-6-4-3-5-7-25)32(41)38-29(17-26-20-34-21-36-26)31(40)35-19-24-10-8-23(18-33)9-11-24/h3-15,20-21,28-29H,2,16-19,33H2,1H3,(H,34,36)(H,35,40)(H,37,39)(H,38,41)/t28-,29+/m1/s1 AEYJQJFQRCNAIM-WDYNHAJCSA-N 200186 US9234000, 177 Plasma kallikrein Human 457 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200186&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71187364 318590014 C00615 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355954 CCOc1ccc(C[C@@H](NC(=O)c2ccncc2)C(=O)N[C@@H](Cc2csc3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C36H37N5O4S/c1-2-45-29-13-11-24(12-14-29)19-31(40-34(42)27-15-17-38-18-16-27)36(44)41-32(20-28-23-46-33-6-4-3-5-30(28)33)35(43)39-22-26-9-7-25(21-37)8-10-26/h3-18,23,31-32H,2,19-22,37H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t31-,32+/m1/s1 ZLHMUZNFVDTJHM-ZWXJPIIXSA-N 200187 US9234000, 178 Plasma kallikrein Human 42 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200187&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 76901379 318590015 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355955 CCOc1ccc(C[C@@H](NC(=O)c2sccc2NC(C)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O5S/c1-3-45-28-15-13-25(14-16-28)20-31(40-35(44)32-29(17-18-46-32)38-23(2)41)34(43)39-30(19-24-7-5-4-6-8-24)33(42)37-22-27-11-9-26(21-36)10-12-27/h4-18,30-31H,3,19-22,36H2,1-2H3,(H,37,42)(H,38,41)(H,39,43)(H,40,44)/t30-,31+/m0/s1 KDRURSLBLPTKEJ-IOWSJCHKSA-N 200188 US9234000, 179 Plasma kallikrein Human 22 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200188 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200188&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185867 318590016 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355956 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2F)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H37FN4O4/c1-2-44-29-18-16-24(17-19-29)20-31(39-33(41)27-8-4-3-5-9-27)35(43)40-32(21-28-10-6-7-11-30(28)36)34(42)38-23-26-14-12-25(22-37)13-15-26/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m1/s1 SYUQOCGTPPIJGB-ZWXJPIIXSA-N 200189 US9234000, 180 Plasma kallikrein Human 73 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200189&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499497 318590017 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355957 CCOc1ccc(C[C@@H](NC(=O)c2sccc2C)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H37N5O4S/c1-3-42-27-12-10-23(11-13-27)17-29(38-33(41)30-22(2)14-16-43-30)32(40)37-28(18-26-5-4-15-35-20-26)31(39)36-21-25-8-6-24(19-34)7-9-25/h4-16,20,28-29H,3,17-19,21,34H2,1-2H3,(H,36,39)(H,37,40)(H,38,41)/t28-,29+/m0/s1 VEGWZKIUWVMXBY-URLMMPGGSA-N 200190 US9234000, 181 Plasma kallikrein Human 10 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200190 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200190&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499479 318590018 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355958 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(C)c2)cc1 InChI=1S/C36H40N4O4/c1-3-44-31-18-15-27(16-19-31)22-33(39-34(41)29-12-8-5-9-13-29)36(43)40-32(21-26-10-6-4-7-11-26)35(42)38-24-28-14-17-30(23-37)25(2)20-28/h4-20,32-33H,3,21-24,37H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t32-,33+/m0/s1 ZSQXKFNZFSFYRJ-JHOUSYSJSA-N 200191 US9234000, 182 Plasma kallikrein Human 15 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200191 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200191&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499478 318590019 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355959 CCOc1ccc(C[C@@H](NC(=O)c2sccc2N)C(=O)N[C@@H](Cc2cscn2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C30H34N6O4S2/c1-2-40-23-9-7-19(8-10-23)13-25(36-30(39)27-24(32)11-12-42-27)29(38)35-26(14-22-17-41-18-34-22)28(37)33-16-21-5-3-20(15-31)4-6-21/h3-12,17-18,25-26H,2,13-16,31-32H2,1H3,(H,33,37)(H,35,38)(H,36,39)/t25-,26+/m1/s1 HDDOGAGGUYGJLQ-FTJBHMTQSA-N 200192 US9234000, 183::US9234000, 187 Plasma kallikrein Human 16 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200192&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 76901757 318590020 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355960 CCOc1ccc(C[C@@H](NC(=O)c2sccc2Cl)C(=O)N[C@@H](Cc2cscn2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C30H32ClN5O4S2/c1-2-40-23-9-7-19(8-10-23)13-25(36-30(39)27-24(31)11-12-42-27)29(38)35-26(14-22-17-41-18-34-22)28(37)33-16-21-5-3-20(15-32)4-6-21/h3-12,17-18,25-26H,2,13-16,32H2,1H3,(H,33,37)(H,35,38)(H,36,39)/t25-,26+/m1/s1 PMTPLZNRQDJDQN-FTJBHMTQSA-N 200193 US9234000, 184 Plasma kallikrein Human 10 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200193 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200193&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 90302004 318590021 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355961 CCOc1ccc(C[C@@H](NC(=O)c2ccc(C)cc2)C(=O)N[C@@H](Cc2cscn2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H37N5O4S/c1-3-42-28-14-10-23(11-15-28)16-29(37-31(39)26-12-4-22(2)5-13-26)33(41)38-30(17-27-20-43-21-36-27)32(40)35-19-25-8-6-24(18-34)7-9-25/h4-15,20-21,29-30H,3,16-19,34H2,1-2H3,(H,35,40)(H,37,39)(H,38,41)/t29-,30+/m1/s1 XXXMZDCXONCQMR-IHLOFXLRSA-N 200194 US9234000, 185 Plasma kallikrein Human 49 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200194 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200194&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499498 318590022 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355962 CCOc1ccc(C[C@@H](NC(=O)c2[nH]ccc2C)C(=O)N[C@@H](Cc2csc3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C36H39N5O4S/c1-3-45-28-14-12-24(13-15-28)18-30(41-36(44)33-23(2)16-17-38-33)35(43)40-31(19-27-22-46-32-7-5-4-6-29(27)32)34(42)39-21-26-10-8-25(20-37)9-11-26/h4-17,22,30-31,38H,3,18-21,37H2,1-2H3,(H,39,42)(H,40,43)(H,41,44)/t30-,31+/m1/s1 GCTFSBZKSCJATJ-JSOSNVBQSA-N 200195 US9234000, 186 Plasma kallikrein Human 14 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200195&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499499 318590023 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355963 CCOc1ccc(C[C@@H](NC(=O)c2sccc2N)C(=O)N[C@@H](Cc2cscn2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C30H34N6O4S2/c1-2-40-23-9-7-19(8-10-23)13-25(36-30(39)27-24(32)11-12-42-27)29(38)35-26(14-22-17-41-18-34-22)28(37)33-16-21-5-3-20(15-31)4-6-21/h3-12,17-18,25-26H,2,13-16,31-32H2,1H3,(H,33,37)(H,35,38)(H,36,39)/t25-,26+/m1/s1 HDDOGAGGUYGJLQ-FTJBHMTQSA-N 200192 US9234000, 183::US9234000, 187 Plasma kallikrein Human 7 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200192&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 76901757 318590020 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355964 CCOc1ccc(C[C@@H](NC(=O)c2sccc2NC(C)=O)C(=O)N[C@@H](Cc2csc3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C37H39N5O5S2/c1-3-47-28-14-12-24(13-15-28)18-31(42-37(46)34-30(16-17-48-34)40-23(2)43)36(45)41-32(19-27-22-49-33-7-5-4-6-29(27)33)35(44)39-21-26-10-8-25(20-38)9-11-26/h4-17,22,31-32H,3,18-21,38H2,1-2H3,(H,39,44)(H,40,43)(H,41,45)(H,42,46)/t31-,32+/m1/s1 GKOAHNGAVMWGNA-ZWXJPIIXSA-N 200197 US9234000, 188::US9234000, 195 Plasma kallikrein Human 36 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200197 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200197&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499156 318590024 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355965 CCOc1ccc(C[C@@H](NC(=O)c2cccc(C)c2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O4/c1-3-44-30-15-13-25(14-16-30)19-32(39-33(41)29-8-4-6-24(2)18-29)35(43)40-31(20-28-7-5-17-37-22-28)34(42)38-23-27-11-9-26(21-36)10-12-27/h4-18,22,31-32H,3,19-21,23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 SYHVZEPQLZQVQE-AJQTZOPKSA-N 200198 US9234000, 189 Plasma kallikrein Human 23 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200198 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200198&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499155 318590025 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355966 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2C)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O4/c1-3-44-29-16-14-25(15-17-29)19-32(39-33(41)30-9-5-4-7-24(30)2)35(43)40-31(20-28-8-6-18-37-22-28)34(42)38-23-27-12-10-26(21-36)11-13-27/h4-18,22,31-32H,3,19-21,23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 YBYIYRFQMSDYKZ-AJQTZOPKSA-N 200199 US9234000, 190 Plasma kallikrein Human 28 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200199 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200199&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499500 318590026 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355967 CCOc1ccc(C[C@@H](NC(=O)c2[nH]c(C)cc2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H41N5O4/c1-4-44-29-16-14-26(15-17-29)20-31(40-35(43)32-23(2)18-24(3)38-32)34(42)39-30(19-25-8-6-5-7-9-25)33(41)37-22-28-12-10-27(21-36)11-13-28/h5-18,30-31,38H,4,19-22,36H2,1-3H3,(H,37,41)(H,39,42)(H,40,43)/t30-,31+/m0/s1 WJCYGURKBSTJEJ-IOWSJCHKSA-N 200200 US9234000, 191 Plasma kallikrein Human 20 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200200 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200200&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499157 318590027 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355968 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)c(C)c2)cc1 InChI=1S/C35H39N5O4/c1-3-44-30-15-12-25(13-16-30)19-32(39-33(41)28-9-5-4-6-10-28)35(43)40-31(20-26-8-7-17-37-22-26)34(42)38-23-27-11-14-29(21-36)24(2)18-27/h4-18,22,31-32H,3,19-21,23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 KFOYMQXIDOVWGR-AJQTZOPKSA-N 200201 US9234000, 192 Plasma kallikrein Human 12 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200201&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499168 318590028 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355969 CCOc1ccc(C[C@@H](NC(=O)c2sccc2NC(C)=O)C(=O)N[C@@H](Cc2ccsc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H37N5O5S2/c1-3-43-26-10-8-22(9-11-26)16-29(38-33(42)30-27(13-15-45-30)36-21(2)39)32(41)37-28(17-25-12-14-44-20-25)31(40)35-19-24-6-4-23(18-34)5-7-24/h4-15,20,28-29H,3,16-19,34H2,1-2H3,(H,35,40)(H,36,39)(H,37,41)(H,38,42)/t28-,29+/m0/s1 FQQAMJLKTANPGO-URLMMPGGSA-N 200202 US9234000, 193 Plasma kallikrein Human 25 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200202&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499158 318590029 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355970 CCOc1ccc(C[C@@H](NC(=O)c2sccc2N)C(=O)N[C@@H](Cc2csc3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H37N5O4S2/c1-2-44-26-13-11-22(12-14-26)17-29(40-35(43)32-28(37)15-16-45-32)34(42)39-30(18-25-21-46-31-6-4-3-5-27(25)31)33(41)38-20-24-9-7-23(19-36)8-10-24/h3-16,21,29-30H,2,17-20,36-37H2,1H3,(H,38,41)(H,39,42)(H,40,43)/t29-,30+/m1/s1 CYVSDXJVCZURLD-IHLOFXLRSA-N 200203 US9234000, 194 Plasma kallikrein Human 13 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200203&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 76901380 318590030 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355971 CCOc1ccc(C[C@@H](NC(=O)c2sccc2NC(C)=O)C(=O)N[C@@H](Cc2csc3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C37H39N5O5S2/c1-3-47-28-14-12-24(13-15-28)18-31(42-37(46)34-30(16-17-48-34)40-23(2)43)36(45)41-32(19-27-22-49-33-7-5-4-6-29(27)33)35(44)39-21-26-10-8-25(20-38)9-11-26/h4-17,22,31-32H,3,18-21,38H2,1-2H3,(H,39,44)(H,40,43)(H,41,45)(H,42,46)/t31-,32+/m1/s1 GKOAHNGAVMWGNA-ZWXJPIIXSA-N 200197 US9234000, 188::US9234000, 195 Plasma kallikrein Human 14 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200197 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200197&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71499156 318590024 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355972 CCOc1ccc(C[C@@H](NC(=O)c2sccc2Cl)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H37ClN4O4S/c1-3-43-27-15-13-24(14-16-27)19-29(38-33(41)31-28(35)17-18-44-31)34(42)39(2)30(20-23-7-5-4-6-8-23)32(40)37-22-26-11-9-25(21-36)10-12-26/h4-18,29-30H,3,19-22,36H2,1-2H3,(H,37,40)(H,38,41)/t29-,30+/m1/s1 OQLWNLNQMCZSSV-IHLOFXLRSA-N 200205 US9234000, 196 Plasma kallikrein Human 32 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200205&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 76901566 318590031 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355973 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H]([C@H](O)c2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H38N4O5/c1-2-44-29-19-17-24(18-20-29)21-30(38-33(41)28-11-7-4-8-12-28)34(42)39-31(32(40)27-9-5-3-6-10-27)35(43)37-23-26-15-13-25(22-36)14-16-26/h3-20,30-32,40H,2,21-23,36H2,1H3,(H,37,43)(H,38,41)(H,39,42)/t30-,31+,32-/m1/s1 BCBPQVFOASQXEY-YKILCQELSA-N 200206 US9234000, 197 Plasma kallikrein Human 12 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200206 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200206&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71185740 318590032 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355974 CCOc1ccc(C[C@@H](NC(=O)c2sccc2Cl)C(=O)N[C@@H]([C@H](O)c2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H35ClN4O5S/c1-2-43-25-14-12-21(13-15-25)18-27(37-33(42)30-26(34)16-17-44-30)31(40)38-28(29(39)24-6-4-3-5-7-24)32(41)36-20-23-10-8-22(19-35)9-11-23/h3-17,27-29,39H,2,18-20,35H2,1H3,(H,36,41)(H,37,42)(H,38,40)/t27-,28+,29-/m1/s1 JPIQGCNQXOHJHE-SSBOKUKZSA-N 200207 US9234000, 198 Plasma kallikrein Human 7 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200207 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200207&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 76901567 318590033 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355975 CCOc1ccc(C[C@@H](NC(=O)c2ccc(C)cc2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O4/c1-3-44-30-16-12-25(13-17-30)19-32(39-33(41)29-14-6-24(2)7-15-29)35(43)40-31(20-28-5-4-18-37-22-28)34(42)38-23-27-10-8-26(21-36)9-11-27/h4-18,22,31-32H,3,19-21,23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 QLQUHMZRFARDGM-AJQTZOPKSA-N 200208 US9234000, 199 Plasma kallikrein Human 10 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200208 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200208&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71204163 318590034 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355976 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccc(F)c(F)c2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H36F2N4O4/c1-2-45-28-15-12-23(13-16-28)19-32(40-33(42)27-6-4-3-5-7-27)35(44)41-31(20-26-14-17-29(36)30(37)18-26)34(43)39-22-25-10-8-24(21-38)9-11-25/h3-18,31-32H,2,19-22,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t31-,32+/m0/s1 WOXROINLYXJADA-AJQTZOPKSA-N 200209 US9234000, 200 Plasma kallikrein Human 45 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200209 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200209&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71204124 318590035 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355977 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)C(Cc2ccc(OCC(F)(F)F)cc2)NC(=O)c2ccccc2)cc1 InChI=1S/C35H35F3N4O4/c36-35(37,38)23-46-29-17-15-25(16-18-29)20-31(41-32(43)28-9-5-2-6-10-28)34(45)42-30(19-24-7-3-1-4-8-24)33(44)40-22-27-13-11-26(21-39)12-14-27/h1-18,30-31H,19-23,39H2,(H,40,44)(H,41,43)(H,42,45)/t30-,31?/m0/s1 ZFMHHRGGDRODQQ-FSRLHOSWSA-N 200210 US9234000, 201 Plasma kallikrein Human 12 US Patent 10.7270/Q2X065W0 aid1802099 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200210&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 71186113 318590036 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 355978 CCOc1ccc(CC(=O)CNN([C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)C(=O)CC)cc1 InChI=1S/C31H38N4O4/c1-3-30(37)35(34-22-27(36)18-24-14-16-28(17-15-24)39-4-2)29(19-23-8-6-5-7-9-23)31(38)33-21-26-12-10-25(20-32)11-13-26/h5-17,29,34H,3-4,18-22,32H2,1-2H3,(H,33,38)/t29-/m0/s1 HIZICQRQZNAZQO-LJAQVGFWSA-N 200010 US9234000, 1 Kallikrein-1 Human >1000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200010 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200010&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71186049 318589840 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 355979 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H38N4O4/c1-2-43-30-19-17-26(18-20-30)22-32(38-33(40)29-11-7-4-8-12-29)35(42)39-31(21-25-9-5-3-6-10-25)34(41)37-24-28-15-13-27(23-36)14-16-28/h3-20,31-32H,2,21-24,36H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t31-,32+/m0/s1 UCIXIQRCAGGOJY-AJQTZOPKSA-N 200012 US9234000, 3::US9512065, N-[(R)-1-[(S)-1-(4-aminomethyl-benzylcarbamoyl)-2-phenyl-ethylcarbamoyl]-2-(4-ethoxy-phenyl)-ethyl]-benzamide Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200012 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200012&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185716 318589842 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 355980 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](CC2CCCCC2)NCC(O)=O)cc1 InChI=1S/C28H38N4O4/c29-17-22-11-13-23(14-12-22)18-31-27(35)25(16-21-9-5-2-6-10-21)32-28(36)24(30-19-26(33)34)15-20-7-3-1-4-8-20/h2,5-6,9-14,20,24-25,30H,1,3-4,7-8,15-19,29H2,(H,31,35)(H,32,36)(H,33,34)/t24-,25+/m1/s1 CFVWQRMYGPSOPB-RPBOFIJWSA-N 200013 US9234000, 4 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200013 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200013&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185578 318589843 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 355981 CCOc1ccc(C[C@@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C28H34N4O3/c1-2-35-24-14-12-21(13-15-24)16-25(30)27(33)32-26(17-20-6-4-3-5-7-20)28(34)31-19-23-10-8-22(18-29)9-11-23/h3-15,25-26H,2,16-19,29-30H2,1H3,(H,31,34)(H,32,33)/t25-,26+/m1/s1 CKNDVDLSIUTQOV-FTJBHMTQSA-N 200014 US9234000, 5 Kallikrein-1 Human 160 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200014 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200014&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185684 318589844 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 355982 CCOc1ccc(C[C@@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(F)c2)cc1 InChI=1S/C28H33FN4O3/c1-2-36-23-12-9-20(10-13-23)15-25(31)27(34)33-26(16-19-6-4-3-5-7-19)28(35)32-18-21-8-11-22(17-30)24(29)14-21/h3-14,25-26H,2,15-18,30-31H2,1H3,(H,32,35)(H,33,34)/t25-,26+/m1/s1 DYSQLBNPCSMIDI-FTJBHMTQSA-N 200015 US9234000, 6 Kallikrein-1 Human >1000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200015 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200015&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185696 318589845 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 355983 CCOc1ccc(CC(=O)CNN([C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(F)c2)C(=O)CC)cc1 InChI=1S/C31H37FN4O4/c1-3-30(38)36(35-21-26(37)16-23-11-14-27(15-12-23)40-4-2)29(18-22-8-6-5-7-9-22)31(39)34-20-24-10-13-25(19-33)28(32)17-24/h5-15,17,29,35H,3-4,16,18-21,33H2,1-2H3,(H,34,39)/t29-/m0/s1 QGGICRDCUBZHLM-LJAQVGFWSA-N 200016 US9234000, 7 Kallikrein-1 Human >1000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200016 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200016&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185568 318589846 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 355984 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](N)CC2CCCCC2)cc1 InChI=1S/C26H36N4O2/c27-17-21-11-13-22(14-12-21)18-29-26(32)24(16-20-9-5-2-6-10-20)30-25(31)23(28)15-19-7-3-1-4-8-19/h2,5-6,9-14,19,23-24H,1,3-4,7-8,15-18,27-28H2,(H,29,32)(H,30,31)/t23-,24+/m1/s1 DYXWMPUBPWGOBS-RPWUZVMVSA-N 200017 US9234000, 8 Kallikrein-1 Human >1000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200017 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200017&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185917 318589847 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 355985 CN(C)[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C28H40N4O2/c1-32(2)26(18-22-11-7-4-8-12-22)28(34)31-25(17-21-9-5-3-6-10-21)27(33)30-20-24-15-13-23(19-29)14-16-24/h3,5-6,9-10,13-16,22,25-26H,4,7-8,11-12,17-20,29H2,1-2H3,(H,30,33)(H,31,34)/t25-,26+/m0/s1 YGGDYXYGFDZJQM-IZZNHLLZSA-N 200018 US9234000, 9 Kallikrein-1 Human >1000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200018 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200018&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185478 318589848 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 355986 CCOc1ccc(C[C@@H](N)C(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C28H32Cl2N4O3/c1-2-37-22-10-7-18(8-11-22)14-25(32)27(35)34-26(15-21-9-12-23(29)24(30)13-21)28(36)33-17-20-5-3-19(16-31)4-6-20/h3-13,25-26H,2,14-17,31-32H2,1H3,(H,33,36)(H,34,35)/t25-,26+/m1/s1 VZESEHUJGZLJDE-FTJBHMTQSA-N 200023 US9234000, 14 Kallikrein-1 Human 3700 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200023 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200023&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185604 318589853 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 355987 CCOc1ccc(C[C@@H](NS(=O)(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H38N4O5S/c1-2-43-29-19-17-26(18-20-29)22-32(38-44(41,42)30-11-7-4-8-12-30)34(40)37-31(21-25-9-5-3-6-10-25)33(39)36-24-28-15-13-27(23-35)14-16-28/h3-20,31-32,38H,2,21-24,35H2,1H3,(H,36,39)(H,37,40)/t31-,32+/m0/s1 TYAFGBNTZJXKOW-AJQTZOPKSA-N 200024 US9234000, 15 Kallikrein-1 Human 2200 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200024 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200024&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185519 318589854 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 355988 CCOc1ccc(CC(=O)CNN([C@@H](Cc2ccc(Cl)c(Cl)c2)C(=O)NCc2ccc(CN)cc2)C(=O)CC)cc1 InChI=1S/C31H36Cl2N4O4/c1-3-30(39)37(36-20-25(38)15-21-9-12-26(13-10-21)41-4-2)29(17-24-11-14-27(32)28(33)16-24)31(40)35-19-23-7-5-22(18-34)6-8-23/h5-14,16,29,36H,3-4,15,17-20,34H2,1-2H3,(H,35,40)/t29-/m0/s1 VVTPHYNAXUAJJK-LJAQVGFWSA-N 200025 US9234000, 16 Kallikrein-1 Human 4900 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200025 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200025&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185539 318589855 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 355989 CCOc1ccc(C[C@@H](NCC(O)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C30H36N4O5/c1-2-39-25-14-12-22(13-15-25)16-26(32-20-28(35)36)30(38)34-27(17-21-6-4-3-5-7-21)29(37)33-19-24-10-8-23(18-31)9-11-24/h3-15,26-27,32H,2,16-20,31H2,1H3,(H,33,37)(H,34,38)(H,35,36)/t26-,27+/m1/s1 LCJSVWIPKDJPSR-SXOMAYOGSA-N 200026 US9234000, 17 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200026 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200026&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 90302159 318589856 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 355990 NCc1ccc(CNC(=O)[C@H](Cc2ccc(Cl)c(Cl)c2)NC(=O)[C@H](N)Cc2ccc(cc2)C(F)(F)F)cc1 InChI=1S/C27H27Cl2F3N4O2/c28-21-10-7-19(11-22(21)29)13-24(26(38)35-15-18-3-1-17(14-33)2-4-18)36-25(37)23(34)12-16-5-8-20(9-6-16)27(30,31)32/h1-11,23-24H,12-15,33-34H2,(H,35,38)(H,36,37)/t23-,24+/m1/s1 MSIDCYYMNINMSP-RPWUZVMVSA-N 200027 US9234000, 18 Kallikrein-1 Human 1600 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200027 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200027&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185666 318589857 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 355991 CC(=O)CN([C@@H](Cc1ccc(Cl)c(Cl)c1)C(=O)NCc1ccc(CN)cc1)[C@H](CC(N)=O)c1ccc(cc1)C(F)(F)F InChI=1S/C30H31Cl2F3N4O3/c1-18(40)17-39(26(14-28(37)41)22-7-9-23(10-8-22)30(33,34)35)27(13-21-6-11-24(31)25(32)12-21)29(42)38-16-20-4-2-19(15-36)3-5-20/h2-12,26-27H,13-17,36H2,1H3,(H2,37,41)(H,38,42)/t26-,27+/m1/s1 STTPARYKVKFFLP-SXOMAYOGSA-N 200028 US9234000, 19 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200028 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200028&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185662 318589858 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 355992 NCc1ccc(CNC(=O)[C@H](Cc2ccc(Cl)c(Cl)c2)NC(=O)[C@H](N)CC2CCCCC2)cc1 InChI=1S/C26H34Cl2N4O2/c27-21-11-10-20(12-22(21)28)14-24(26(34)31-16-19-8-6-18(15-29)7-9-19)32-25(33)23(30)13-17-4-2-1-3-5-17/h6-12,17,23-24H,1-5,13-16,29-30H2,(H,31,34)(H,32,33)/t23-,24+/m1/s1 HGSLIAPVEOZQPN-RPWUZVMVSA-N 200029 US9234000, 20 Kallikrein-1 Human 3700 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200029 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200029&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185567 318589859 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 355993 NCc1ccc(CNC(=O)[C@H](Cc2ccc(Cl)c(Cl)c2)N(CCC(N)=O)CC(=O)CC2CCCCC2)cc1 InChI=1S/C29H38Cl2N4O3/c30-25-11-10-23(15-26(25)31)16-27(29(38)34-18-22-8-6-21(17-32)7-9-22)35(13-12-28(33)37)19-24(36)14-20-4-2-1-3-5-20/h6-11,15,20,27H,1-5,12-14,16-19,32H2,(H2,33,37)(H,34,38)/t27-/m0/s1 NJCMMYULSKXGQU-MHZLTWQESA-N 200030 US9234000, 21 Kallikrein-1 Human 10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200030 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200030&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 90301817 318589860 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 355994 C[C@@H](NC(=O)c1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C27H30N4O3/c1-19(30-26(33)23-10-6-3-7-11-23)25(32)31-24(16-20-8-4-2-5-9-20)27(34)29-18-22-14-12-21(17-28)13-15-22/h2-15,19,24H,16-18,28H2,1H3,(H,29,34)(H,30,33)(H,31,32)/t19-,24+/m1/s1 ZVKJQLYOLHGKQK-DVECYGJZSA-N 200031 US9234000, 22 Kallikrein-1 Human 9600 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200031 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200031&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185645 318589861 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 355995 CCOc1ccc(CC(=O)CNN([C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(Cl)c2)C(=O)CC)cc1 InChI=1S/C31H37ClN4O4/c1-3-30(38)36(35-21-26(37)16-23-11-14-27(15-12-23)40-4-2)29(18-22-8-6-5-7-9-22)31(39)34-20-24-10-13-25(19-33)28(32)17-24/h5-15,17,29,35H,3-4,16,18-21,33H2,1-2H3,(H,34,39)/t29-/m0/s1 SBMXVJAAZJABGK-LJAQVGFWSA-N 200032 US9234000, 23 Kallikrein-1 Human 5600 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200032 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200032&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71186002 318589862 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 355996 CCOc1ccc(CC(=O)CNN([C@@H](Cc2ccccc2)C(=O)N(C)Cc2ccc(CN)cc2)C(=O)CC)cc1 InChI=1S/C32H40N4O4/c1-4-31(38)36(34-22-28(37)19-25-15-17-29(18-16-25)40-5-2)30(20-24-9-7-6-8-10-24)32(39)35(3)23-27-13-11-26(21-33)12-14-27/h6-18,30,34H,4-5,19-23,33H2,1-3H3/t30-/m0/s1 RKOQPQPBBDKART-PMERELPUSA-N 200033 US9234000, 24 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200033 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200033&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185838 318589863 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 355997 CCOc1ccc(C[C@@H](N)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C29H36N4O3/c1-3-36-25-15-13-22(14-16-25)17-26(31)29(35)33(2)27(18-21-7-5-4-6-8-21)28(34)32-20-24-11-9-23(19-30)10-12-24/h4-16,26-27H,3,17-20,30-31H2,1-2H3,(H,32,34)/t26-,27+/m1/s1 JQDLBRDUISCYPO-SXOMAYOGSA-N 200034 US9234000, 25 Kallikrein-1 Human 6300 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200034 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200034&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185646 318589864 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 355998 CCOc1ccc(CC(=O)CNCCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C32H40N4O4/c1-3-40-29-15-13-25(14-16-29)19-28(37)23-34-18-17-31(38)36(2)30(20-24-7-5-4-6-8-24)32(39)35-22-27-11-9-26(21-33)10-12-27/h4-16,30,34H,3,17-23,33H2,1-2H3,(H,35,39)/t30-/m0/s1 MFCPDGVWAVFAEY-PMERELPUSA-N 200035 US9234000, 26 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200035 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200035&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185879 318589865 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 355999 CCOc1ccc(C[C@@H](NC)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C29H36N4O3/c1-3-36-25-15-13-22(14-16-25)17-26(31-2)29(35)33-27(18-21-7-5-4-6-8-21)28(34)32-20-24-11-9-23(19-30)10-12-24/h4-16,26-27,31H,3,17-20,30H2,1-2H3,(H,32,34)(H,33,35)/t26-,27+/m1/s1 ACUWRQFKSMMPOB-SXOMAYOGSA-N 200036 US9234000, 27 Kallikrein-1 Human 4000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200036 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200036&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71186096 318589866 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356000 CC(C)C[C@@H](NCC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C25H34N4O4/c1-17(2)12-21(27-16-23(30)31)25(33)29-22(13-18-6-4-3-5-7-18)24(32)28-15-20-10-8-19(14-26)9-11-20/h3-11,17,21-22,27H,12-16,26H2,1-2H3,(H,28,32)(H,29,33)(H,30,31)/t21-,22+/m1/s1 NZZLBZLVTPDYDB-YADHBBJMSA-N 200037 US9234000, 28 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200037 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200037&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185650 318589867 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356001 CN(CC(O)=O)[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C29H40N4O4/c1-33(20-27(34)35)26(17-22-10-6-3-7-11-22)29(37)32-25(16-21-8-4-2-5-9-21)28(36)31-19-24-14-12-23(18-30)13-15-24/h2,4-5,8-9,12-15,22,25-26H,3,6-7,10-11,16-20,30H2,1H3,(H,31,36)(H,32,37)(H,34,35)/t25-,26+/m0/s1 DOFSTNRBTSKYAL-IZZNHLLZSA-N 200038 US9234000, 29 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200038 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200038&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185561 318589868 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356002 CN([C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1)C(=O)[C@@H](CC1CCCCC1)NCC(O)=O InChI=1S/C29H40N4O4/c1-33(29(37)25(31-20-27(34)35)16-21-8-4-2-5-9-21)26(17-22-10-6-3-7-11-22)28(36)32-19-24-14-12-23(18-30)13-15-24/h3,6-7,10-15,21,25-26,31H,2,4-5,8-9,16-20,30H2,1H3,(H,32,36)(H,34,35)/t25-,26+/m1/s1 AEVWSCHVTRCRRI-FTJBHMTQSA-N 200039 US9234000, 30 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200039 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200039&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185756 318589869 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356003 CCOc1ccc(C[C@@H](N(C)C(=O)CC)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C32H40N4O4/c1-4-30(37)36(3)29(20-24-15-17-27(18-16-24)40-5-2)32(39)35-28(19-23-9-7-6-8-10-23)31(38)34-22-26-13-11-25(21-33)12-14-26/h6-18,28-29H,4-5,19-22,33H2,1-3H3,(H,34,38)(H,35,39)/t28-,29+/m0/s1 VCUKNDNIFAKRDT-URLMMPGGSA-N 200040 US9234000, 31 Kallikrein-1 Human 9600 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200040 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200040&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185842 318589870 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356004 CCOc1ccc(CC(=O)CNCCC(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(F)c2)cc1 InChI=1S/C32H39FN4O4/c1-3-41-28-13-10-24(11-14-28)17-27(38)22-35-16-15-31(39)37(2)30(19-23-7-5-4-6-8-23)32(40)36-21-25-9-12-26(20-34)29(33)18-25/h4-14,18,30,35H,3,15-17,19-22,34H2,1-2H3,(H,36,40)/t30-/m0/s1 QRDHDDSDKPGPTM-PMERELPUSA-N 200041 US9234000, 32 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200041 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200041&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185658 318589871 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356005 CN[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C27H38N4O2/c1-29-24(16-20-8-4-2-5-9-20)27(33)31-25(17-21-10-6-3-7-11-21)26(32)30-19-23-14-12-22(18-28)13-15-23/h3,6-7,10-15,20,24-25,29H,2,4-5,8-9,16-19,28H2,1H3,(H,30,32)(H,31,33)/t24-,25+/m1/s1 RQFBFAXVOLVFAX-RPBOFIJWSA-N 200042 US9234000, 33 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200042 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200042&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185895 318589872 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356006 CN([C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)c(F)c1)C(=O)[C@@H](CC1CCCCC1)NCC(O)=O InChI=1S/C29H39FN4O4/c1-34(29(38)25(32-19-27(35)36)15-20-8-4-2-5-9-20)26(16-21-10-6-3-7-11-21)28(37)33-18-22-12-13-23(17-31)24(30)14-22/h3,6-7,10-14,20,25-26,32H,2,4-5,8-9,15-19,31H2,1H3,(H,33,37)(H,35,36)/t25-,26+/m1/s1 PGHCXWHUESPXEI-FTJBHMTQSA-N 200043 US9234000, 34 Kallikrein-1 Human 7700 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200043 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200043&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71186135 318589873 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356007 CCCN[C@H](Cc1ccc(OCC)cc1)C(=O)N(C)[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C32H42N4O3/c1-4-19-34-29(20-25-15-17-28(18-16-25)39-5-2)32(38)36(3)30(21-24-9-7-6-8-10-24)31(37)35-23-27-13-11-26(22-33)12-14-27/h6-18,29-30,34H,4-5,19-23,33H2,1-3H3,(H,35,37)/t29-,30+/m1/s1 RRCQNIGKGMQKJC-IHLOFXLRSA-N 200044 US9234000, 35 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200044 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200044&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185610 318589874 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356008 CN(Cc1ccc(CN)cc1)C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CC1CCCCC1)NCC(O)=O InChI=1S/C29H40N4O4/c1-33(20-24-14-12-23(18-30)13-15-24)29(37)26(17-22-10-6-3-7-11-22)32-28(36)25(31-19-27(34)35)16-21-8-4-2-5-9-21/h3,6-7,10-15,21,25-26,31H,2,4-5,8-9,16-20,30H2,1H3,(H,32,36)(H,34,35)/t25-,26+/m1/s1 KHVBQTPTSZCNFR-FTJBHMTQSA-N 200045 US9234000, 36 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200045 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200045&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71186065 318589875 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356009 CCCN[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C29H42N4O2/c1-2-17-31-26(18-22-9-5-3-6-10-22)29(35)33-27(19-23-11-7-4-8-12-23)28(34)32-21-25-15-13-24(20-30)14-16-25/h4,7-8,11-16,22,26-27,31H,2-3,5-6,9-10,17-21,30H2,1H3,(H,32,34)(H,33,35)/t26-,27+/m1/s1 YAKWNMILEUXLOF-SXOMAYOGSA-N 200046 US9234000, 37 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200046 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200046&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185698 318589876 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356010 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C36H40N4O4/c1-3-44-31-20-18-27(19-21-31)22-32(39-34(41)30-12-8-5-9-13-30)36(43)40(2)33(23-26-10-6-4-7-11-26)35(42)38-25-29-16-14-28(24-37)15-17-29/h4-21,32-33H,3,22-25,37H2,1-2H3,(H,38,42)(H,39,41)/t32-,33+/m1/s1 HQJNEZIZFKIRDE-SAIUNTKASA-N 200047 US9234000, 38 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200047 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200047&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185593 318589877 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356011 CCOc1ccc(C[C@@H](NC(C)=O)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C31H38N4O4/c1-4-39-27-16-14-24(15-17-27)18-28(34-22(2)36)31(38)35(3)29(19-23-8-6-5-7-9-23)30(37)33-21-26-12-10-25(20-32)11-13-26/h5-17,28-29H,4,18-21,32H2,1-3H3,(H,33,37)(H,34,36)/t28-,29+/m1/s1 GYGCSETUDMGRCZ-WDYNHAJCSA-N 200048 US9234000, 39 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200048 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200048&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185632 318589878 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356012 CN[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)c(F)c1 InChI=1S/C27H37FN4O2/c1-30-24(15-19-8-4-2-5-9-19)27(34)32-25(16-20-10-6-3-7-11-20)26(33)31-18-21-12-13-22(17-29)23(28)14-21/h3,6-7,10-14,19,24-25,30H,2,4-5,8-9,15-18,29H2,1H3,(H,31,33)(H,32,34)/t24-,25+/m1/s1 PNOIBJDGHAETSB-RPBOFIJWSA-N 200049 US9234000, 40 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200049 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200049&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185943 318589879 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356013 CN[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccc(Cl)c(Cl)c1)C(=O)NCc1ccc(CN)c(F)c1 InChI=1S/C27H35Cl2FN4O2/c1-32-24(13-17-5-3-2-4-6-17)27(36)34-25(14-18-8-10-21(28)22(29)11-18)26(35)33-16-19-7-9-20(15-31)23(30)12-19/h7-12,17,24-25,32H,2-6,13-16,31H2,1H3,(H,33,35)(H,34,36)/t24-,25+/m1/s1 FYRDRWKGCKJBPX-RPBOFIJWSA-N 200050 US9234000, 41 Kallikrein-1 Human 2500 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200050 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200050&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71186174 318589880 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356014 CN(CC(O)=O)[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)c(F)c1 InChI=1S/C29H39FN4O4/c1-34(19-27(35)36)26(16-21-10-6-3-7-11-21)29(38)33-25(15-20-8-4-2-5-9-20)28(37)32-18-22-12-13-23(17-31)24(30)14-22/h2,4-5,8-9,12-14,21,25-26H,3,6-7,10-11,15-19,31H2,1H3,(H,32,37)(H,33,38)(H,35,36)/t25-,26+/m0/s1 DJSDHDNLNWSZRP-IZZNHLLZSA-N 200051 US9234000, 42 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200051 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200051&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185845 318589881 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356015 CN(CC(O)=O)[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccc(Cl)c(Cl)c1)C(=O)NCc1ccc(CN)c(F)c1 InChI=1S/C29H37Cl2FN4O4/c1-36(17-27(37)38)26(14-18-5-3-2-4-6-18)29(40)35-25(13-19-8-10-22(30)23(31)11-19)28(39)34-16-20-7-9-21(15-33)24(32)12-20/h7-12,18,25-26H,2-6,13-17,33H2,1H3,(H,34,39)(H,35,40)(H,37,38)/t25-,26+/m0/s1 ATUSQERKXIHTKL-IZZNHLLZSA-N 200052 US9234000, 43 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200052 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200052&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185818 318589882 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356016 CCOc1ccc(C[C@@H](NC(=O)C(C)C)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H42N4O4/c1-5-41-28-17-15-25(16-18-28)19-29(36-31(38)23(2)3)33(40)37(4)30(20-24-9-7-6-8-10-24)32(39)35-22-27-13-11-26(21-34)12-14-27/h6-18,23,29-30H,5,19-22,34H2,1-4H3,(H,35,39)(H,36,38)/t29-,30+/m1/s1 FHGLIRVEEZTGIK-IHLOFXLRSA-N 200053 US9234000, 44 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200053 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200053&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185980 318589883 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356017 CCCN(C)[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C30H44N4O2/c1-3-18-34(2)28(20-24-12-8-5-9-13-24)30(36)33-27(19-23-10-6-4-7-11-23)29(35)32-22-26-16-14-25(21-31)15-17-26/h4,6-7,10-11,14-17,24,27-28H,3,5,8-9,12-13,18-22,31H2,1-2H3,(H,32,35)(H,33,36)/t27-,28+/m0/s1 MAPVPFDRQHBDES-WUFINQPMSA-N 200054 US9234000, 45 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200054 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200054&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185799 318589884 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356018 COC(=O)CN[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C29H40N4O4/c1-37-27(34)20-31-25(16-21-8-4-2-5-9-21)29(36)33-26(17-22-10-6-3-7-11-22)28(35)32-19-24-14-12-23(18-30)13-15-24/h3,6-7,10-15,21,25-26,31H,2,4-5,8-9,16-20,30H2,1H3,(H,32,35)(H,33,36)/t25-,26+/m1/s1 MLHZEVRUXMVMRU-FTJBHMTQSA-N 200055 US9234000, 46::US9234000, 47 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200055 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200055&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185707 318589885 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356019 COC(=O)CN[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C29H40N4O4/c1-37-27(34)20-31-25(16-21-8-4-2-5-9-21)29(36)33-26(17-22-10-6-3-7-11-22)28(35)32-19-24-14-12-23(18-30)13-15-24/h3,6-7,10-15,21,25-26,31H,2,4-5,8-9,16-20,30H2,1H3,(H,32,35)(H,33,36)/t25-,26+/m1/s1 MLHZEVRUXMVMRU-FTJBHMTQSA-N 200055 US9234000, 46::US9234000, 47 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200055 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200055&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185707 318589885 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356020 CN(CC(N)=O)[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C29H41N5O3/c1-34(20-27(31)35)26(17-22-10-6-3-7-11-22)29(37)33-25(16-21-8-4-2-5-9-21)28(36)32-19-24-14-12-23(18-30)13-15-24/h2,4-5,8-9,12-15,22,25-26H,3,6-7,10-11,16-20,30H2,1H3,(H2,31,35)(H,32,36)(H,33,37)/t25-,26+/m0/s1 VBCWKMGQHTXCLL-IZZNHLLZSA-N 200057 US9234000, 48 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200057 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200057&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185545 318589886 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356021 CN(CCO)[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C29H42N4O3/c1-33(16-17-34)27(19-23-10-6-3-7-11-23)29(36)32-26(18-22-8-4-2-5-9-22)28(35)31-21-25-14-12-24(20-30)13-15-25/h2,4-5,8-9,12-15,23,26-27,34H,3,6-7,10-11,16-21,30H2,1H3,(H,31,35)(H,32,36)/t26-,27+/m0/s1 XOHMZWIMXZQRIG-RRPNLBNLSA-N 200058 US9234000, 49 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200058 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200058&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71186020 318589887 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356022 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](CC2CCCCC2)NCC(N)=O)cc1 InChI=1S/C28H39N5O3/c29-17-22-11-13-23(14-12-22)18-32-27(35)25(16-21-9-5-2-6-10-21)33-28(36)24(31-19-26(30)34)15-20-7-3-1-4-8-20/h2,5-6,9-14,20,24-25,31H,1,3-4,7-8,15-19,29H2,(H2,30,34)(H,32,35)(H,33,36)/t24-,25+/m1/s1 AVERXCDVOOTDJJ-RPBOFIJWSA-N 200059 US9234000, 50 Kallikrein-1 Human 5000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200059 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200059&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185878 318589888 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356023 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](CC2CCCCC2)NCCO)cc1 InChI=1S/C28H40N4O3/c29-19-23-11-13-24(14-12-23)20-31-27(34)26(18-22-9-5-2-6-10-22)32-28(35)25(30-15-16-33)17-21-7-3-1-4-8-21/h2,5-6,9-14,21,25-26,30,33H,1,3-4,7-8,15-20,29H2,(H,31,34)(H,32,35)/t25-,26+/m1/s1 ASILWFVMBOPQGU-FTJBHMTQSA-N 200060 US9234000, 51 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200060 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200060&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71186165 318589889 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356024 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](N)C(C2CCCCC2)C2CCCCC2)cc1 InChI=1S/C32H46N4O2/c33-21-24-16-18-25(19-17-24)22-35-31(37)28(20-23-10-4-1-5-11-23)36-32(38)30(34)29(26-12-6-2-7-13-26)27-14-8-3-9-15-27/h1,4-5,10-11,16-19,26-30H,2-3,6-9,12-15,20-22,33-34H2,(H,35,37)(H,36,38)/t28-,30+/m0/s1 FIYJIRGYSCICSS-MFMCTBQISA-N 200061 US9234000, 52 Kallikrein-1 Human 9500 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200061 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200061&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 118520054 318589890 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356025 CCCN(CCC)[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C32H48N4O2/c1-3-19-36(20-4-2)30(22-26-13-9-6-10-14-26)32(38)35-29(21-25-11-7-5-8-12-25)31(37)34-24-28-17-15-27(23-33)16-18-28/h5,7-8,11-12,15-18,26,29-30H,3-4,6,9-10,13-14,19-24,33H2,1-2H3,(H,34,37)(H,35,38)/t29-,30+/m0/s1 DBIDWJMCWRJUME-XZWHSSHBSA-N 200062 US9234000, 53 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200062 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200062&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185648 318589891 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356026 CCOc1ccc(C[C@H](N(C)C(=O)CC)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C32H40N4O4/c1-4-30(37)36(3)29(20-24-15-17-27(18-16-24)40-5-2)32(39)35-28(19-23-9-7-6-8-10-23)31(38)34-22-26-13-11-25(21-33)12-14-26/h6-18,28-29H,4-5,19-22,33H2,1-3H3,(H,34,38)(H,35,39)/t28-,29-/m0/s1 VCUKNDNIFAKRDT-VMPREFPWSA-N 200075 US9234000, 66 Kallikrein-1 Human 8400 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200075 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200075&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185787 318589904 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356027 CCOc1ccc(C[C@@H](NC(=O)CC)C(=O)N2CC[C@@H]([C@H]2C(=O)NCc2ccc(CN)cc2)c2ccccc2)cc1 InChI=1S/C33H40N4O4/c1-3-30(38)36-29(20-23-14-16-27(17-15-23)41-4-2)33(40)37-19-18-28(26-8-6-5-7-9-26)31(37)32(39)35-22-25-12-10-24(21-34)11-13-25/h5-17,28-29,31H,3-4,18-22,34H2,1-2H3,(H,35,39)(H,36,38)/t28-,29-,31+/m1/s1 RBKLUGLZBDESOH-XQKNLLDYSA-N 200076 US9234000, 67 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200076 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200076&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 90306458 318589905 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356028 CCOc1ccc(C[C@@H](NC(=O)NCc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C36H41N5O4/c1-2-45-31-19-17-27(18-20-31)22-33(41-36(44)39-25-29-11-7-4-8-12-29)35(43)40-32(21-26-9-5-3-6-10-26)34(42)38-24-30-15-13-28(23-37)14-16-30/h3-20,32-33H,2,21-25,37H2,1H3,(H,38,42)(H,40,43)(H2,39,41,44)/t32-,33+/m0/s1 HUDMDOPCYOIBRF-JHOUSYSJSA-N 200077 US9234000, 68 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200077 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200077&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71186043 318589906 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356029 CCOc1ccc(C[C@@H](NC(=O)Nc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O4/c1-2-44-30-19-17-26(18-20-30)22-32(40-35(43)38-29-11-7-4-8-12-29)34(42)39-31(21-25-9-5-3-6-10-25)33(41)37-24-28-15-13-27(23-36)14-16-28/h3-20,31-32H,2,21-24,36H2,1H3,(H,37,41)(H,39,42)(H2,38,40,43)/t31-,32+/m0/s1 ZYYGRTWFLBZSQX-AJQTZOPKSA-N 200078 US9234000, 69 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200078 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200078&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185798 318589907 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356030 CCOc1ccc(C[C@@H](NC(=O)c2cccnc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H37N5O4/c1-2-43-29-16-14-25(15-17-29)20-31(38-32(40)28-9-6-18-36-23-28)34(42)39-30(19-24-7-4-3-5-8-24)33(41)37-22-27-12-10-26(21-35)11-13-27/h3-18,23,30-31H,2,19-22,35H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t30-,31+/m0/s1 NBUOOLFOHRYQNL-IOWSJCHKSA-N 200079 US9234000, 70 Kallikrein-1 Human 7500 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200079 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200079&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185653 318589908 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356031 CCOc1ccc(C[C@@H](NC(=O)c2ccncc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H37N5O4/c1-2-43-29-14-12-25(13-15-29)21-31(38-32(40)28-16-18-36-19-17-28)34(42)39-30(20-24-6-4-3-5-7-24)33(41)37-23-27-10-8-26(22-35)9-11-27/h3-19,30-31H,2,20-23,35H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t30-,31+/m0/s1 KUPKLNUHJXRSMI-IOWSJCHKSA-N 200080 US9234000, 71 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200080 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200080&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71186147 318589909 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356032 CCOc1ccc(C[C@@H](NC(=O)c2ccsc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H36N4O4S/c1-2-41-28-14-12-24(13-15-28)19-30(36-31(38)27-16-17-42-22-27)33(40)37-29(18-23-6-4-3-5-7-23)32(39)35-21-26-10-8-25(20-34)9-11-26/h3-17,22,29-30H,2,18-21,34H2,1H3,(H,35,39)(H,36,38)(H,37,40)/t29-,30+/m0/s1 GCFLQXXLUPHFNT-XZWHSSHBSA-N 200081 US9234000, 72 Kallikrein-1 Human 9100 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200081 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200081&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185793 318589910 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356033 CCOc1ccc(C[C@@H](NC(=O)c2cccs2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H36N4O4S/c1-2-41-27-16-14-24(15-17-27)20-29(37-33(40)30-9-6-18-42-30)32(39)36-28(19-23-7-4-3-5-8-23)31(38)35-22-26-12-10-25(21-34)11-13-26/h3-18,28-29H,2,19-22,34H2,1H3,(H,35,38)(H,36,39)(H,37,40)/t28-,29+/m0/s1 DICZPEIYHIDRDH-URLMMPGGSA-N 200082 US9234000, 73 Kallikrein-1 Human 9300 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200082 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200082&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499165 318589911 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356034 CCOc1ccc(C[C@@H](NC(=O)C2CC2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C32H38N4O4/c1-2-40-27-16-12-23(13-17-27)19-29(35-30(37)26-14-15-26)32(39)36-28(18-22-6-4-3-5-7-22)31(38)34-21-25-10-8-24(20-33)9-11-25/h3-13,16-17,26,28-29H,2,14-15,18-21,33H2,1H3,(H,34,38)(H,35,37)(H,36,39)/t28-,29+/m0/s1 DQVRDTGGMOXTHF-URLMMPGGSA-N 200083 US9234000, 74 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200083 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200083&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 122199207 318589912 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356035 CCOc1ccc(C[C@@H](NC(=O)C2CCCCC2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H44N4O4/c1-2-43-30-19-17-26(18-20-30)22-32(38-33(40)29-11-7-4-8-12-29)35(42)39-31(21-25-9-5-3-6-10-25)34(41)37-24-28-15-13-27(23-36)14-16-28/h3,5-6,9-10,13-20,29,31-32H,2,4,7-8,11-12,21-24,36H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t31-,32+/m0/s1 ZBMHBTNVTBWRGV-AJQTZOPKSA-N 200084 US9234000, 75 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200084 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200084&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499166 318589913 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356036 CCCCCC(=O)N[C@H](Cc1ccc(OCC)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C34H44N4O4/c1-3-5-7-12-32(39)37-31(22-26-17-19-29(20-18-26)42-4-2)34(41)38-30(21-25-10-8-6-9-11-25)33(40)36-24-28-15-13-27(23-35)14-16-28/h6,8-11,13-20,30-31H,3-5,7,12,21-24,35H2,1-2H3,(H,36,40)(H,37,39)(H,38,41)/t30-,31+/m0/s1 YWYFEVDIUZIFCH-IOWSJCHKSA-N 200085 US9234000, 76 Kallikrein-1 Human 3600 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200085 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200085&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 122199208 318589914 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356037 CCOc1ccc(C[C@@H](NC(=O)NC(C)C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C32H41N5O4/c1-4-41-27-16-14-24(15-17-27)19-29(37-32(40)35-22(2)3)31(39)36-28(18-23-8-6-5-7-9-23)30(38)34-21-26-12-10-25(20-33)11-13-26/h5-17,22,28-29H,4,18-21,33H2,1-3H3,(H,34,38)(H,36,39)(H2,35,37,40)/t28-,29+/m0/s1 SXAOLDSQZYCDDQ-URLMMPGGSA-N 200086 US9234000, 77 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200086 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200086&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71186101 318589915 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356038 CCCCCCNC(=O)N[C@H](Cc1ccc(OCC)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C35H47N5O4/c1-3-5-6-10-21-37-35(43)40-32(23-27-17-19-30(20-18-27)44-4-2)34(42)39-31(22-26-11-8-7-9-12-26)33(41)38-25-29-15-13-28(24-36)14-16-29/h7-9,11-20,31-32H,3-6,10,21-25,36H2,1-2H3,(H,38,41)(H,39,42)(H2,37,40,43)/t31-,32+/m0/s1 KRKRLMQLCYJAFZ-AJQTZOPKSA-N 200087 US9234000, 78 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200087 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200087&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71186011 318589916 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356039 CCOc1ccc(C[C@@H](NC(=O)c2ccno2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C32H35N5O5/c1-2-41-26-14-12-23(13-15-26)19-28(37-32(40)29-16-17-35-42-29)31(39)36-27(18-22-6-4-3-5-7-22)30(38)34-21-25-10-8-24(20-33)9-11-25/h3-17,27-28H,2,18-21,33H2,1H3,(H,34,38)(H,36,39)(H,37,40)/t27-,28+/m0/s1 FLWSQHNEOSDTLW-WUFINQPMSA-N 200088 US9234000, 79 Kallikrein-1 Human 8600 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200088 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200088&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499167 318589917 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356040 CCOc1ccc(C[C@@H](NC(=O)c2ccc(OC(F)(F)F)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C36H37F3N4O5/c1-2-47-29-16-12-25(13-17-29)21-32(42-33(44)28-14-18-30(19-15-28)48-36(37,38)39)35(46)43-31(20-24-6-4-3-5-7-24)34(45)41-23-27-10-8-26(22-40)9-11-27/h3-19,31-32H,2,20-23,40H2,1H3,(H,41,45)(H,42,44)(H,43,46)/t31-,32+/m0/s1 DNNSVHAVKIOBSA-AJQTZOPKSA-N 200089 US9234000, 80 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200089 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200089&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185541 318589918 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356041 CCOc1ccc(C[C@@H](NC(=O)c2ccccn2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H37N5O4/c1-2-43-28-17-15-25(16-18-28)21-31(39-33(41)29-10-6-7-19-36-29)34(42)38-30(20-24-8-4-3-5-9-24)32(40)37-23-27-13-11-26(22-35)12-14-27/h3-19,30-31H,2,20-23,35H2,1H3,(H,37,40)(H,38,42)(H,39,41)/t30-,31+/m0/s1 LOIWWQRBLCDGHA-IOWSJCHKSA-N 200090 US9234000, 81 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200090 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200090&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499172 318589919 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356042 CCOc1ccc(C[C@@H](NC(=O)c2cc(C)nn2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H40N6O4/c1-4-44-28-16-14-25(15-17-28)20-30(38-34(43)31-18-23(2)39-40(31)3)33(42)37-29(19-24-8-6-5-7-9-24)32(41)36-22-27-12-10-26(21-35)11-13-27/h5-18,29-30H,4,19-22,35H2,1-3H3,(H,36,41)(H,37,42)(H,38,43)/t29-,30+/m0/s1 SGTZLYYWDILAOO-XZWHSSHBSA-N 200091 US9234000, 82 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200091 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200091&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 122199209 318589920 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356043 CCOc1ccc(C[C@@H](NC(=O)c2cc3ccccc3s2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C37H38N4O4S/c1-2-45-30-18-16-26(17-19-30)21-32(41-37(44)34-22-29-10-6-7-11-33(29)46-34)36(43)40-31(20-25-8-4-3-5-9-25)35(42)39-24-28-14-12-27(23-38)13-15-28/h3-19,22,31-32H,2,20-21,23-24,38H2,1H3,(H,39,42)(H,40,43)(H,41,44)/t31-,32+/m0/s1 OEGGOURQVSOADE-AJQTZOPKSA-N 200092 US9234000, 83 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200092 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200092&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185907 318589921 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356044 CCOc1ccc(C[C@@H](NS(=O)(=O)c2ccc(Cl)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H37ClN4O5S/c1-2-44-29-16-12-25(13-17-29)21-32(39-45(42,43)30-18-14-28(35)15-19-30)34(41)38-31(20-24-6-4-3-5-7-24)33(40)37-23-27-10-8-26(22-36)9-11-27/h3-19,31-32,39H,2,20-23,36H2,1H3,(H,37,40)(H,38,41)/t31-,32+/m0/s1 ACETVQBBGBLDQG-AJQTZOPKSA-N 200093 US9234000, 84 Kallikrein-1 Human 1200 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200093 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200093&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185886 318589922 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356045 CCOc1ccc(cc1)[C@H](C(=O)NCCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1)c1ccccc1 InChI=1S/C36H40N4O4/c1-2-44-31-19-17-30(18-20-31)34(29-11-7-4-8-12-29)36(43)38-22-21-33(41)40-32(23-26-9-5-3-6-10-26)35(42)39-25-28-15-13-27(24-37)14-16-28/h3-20,32,34H,2,21-25,37H2,1H3,(H,38,43)(H,39,42)(H,40,41)/t32-,34+/m0/s1 SWVKHIKGEAHJDC-UZNNEEJFSA-N 200094 US9234000, 85 Kallikrein-1 Human 2900 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200094 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200094&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 122199210 318589923 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356046 CCOc1ccc(C[C@@H](NC(=O)CCc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C37H42N4O4/c1-2-45-32-20-17-29(18-21-32)24-34(40-35(42)22-19-27-9-5-3-6-10-27)37(44)41-33(23-28-11-7-4-8-12-28)36(43)39-26-31-15-13-30(25-38)14-16-31/h3-18,20-21,33-34H,2,19,22-26,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t33-,34+/m0/s1 CQYKVCYPAHTPER-SZAHLOSFSA-N 200095 US9234000, 86 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200095 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200095&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71186092 318589924 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356047 CCOc1ccc(C[C@@H](NC(=O)CCCc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C38H44N4O4/c1-2-46-33-22-20-30(21-23-33)25-35(41-36(43)15-9-14-28-10-5-3-6-11-28)38(45)42-34(24-29-12-7-4-8-13-29)37(44)40-27-32-18-16-31(26-39)17-19-32/h3-8,10-13,16-23,34-35H,2,9,14-15,24-27,39H2,1H3,(H,40,44)(H,41,43)(H,42,45)/t34-,35+/m0/s1 SOQHHEZZSQAXRS-OIDHKYIRSA-N 200096 US9234000, 87 Kallikrein-1 Human 3400 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200096 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200096&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185839 318589925 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356048 CCOc1ccc(C[C@@H](NC(=O)c2cccc(Cl)c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H37ClN4O4/c1-2-44-30-17-15-25(16-18-30)20-32(39-33(41)28-9-6-10-29(36)21-28)35(43)40-31(19-24-7-4-3-5-8-24)34(42)38-23-27-13-11-26(22-37)12-14-27/h3-18,21,31-32H,2,19-20,22-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 SGUFCVJNEPZKMW-AJQTZOPKSA-N 200097 US9234000, 88 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200097 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200097&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185964 318589926 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356049 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2Cl)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H37ClN4O4/c1-2-44-28-18-16-25(17-19-28)21-32(39-33(41)29-10-6-7-11-30(29)36)35(43)40-31(20-24-8-4-3-5-9-24)34(42)38-23-27-14-12-26(22-37)13-15-27/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 ZJPROBBYIUYLCH-AJQTZOPKSA-N 200098 US9234000, 89 Kallikrein-1 Human 3700 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200098 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200098&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185775 318589927 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356050 CCOc1ccc(C[C@@H](NC(=O)C23CC4CC(CC(C4)C2)C3)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C39H48N4O4/c1-2-47-33-14-12-27(13-15-33)20-35(43-38(46)39-21-30-16-31(22-39)18-32(17-30)23-39)37(45)42-34(19-26-6-4-3-5-7-26)36(44)41-25-29-10-8-28(24-40)9-11-29/h3-15,30-32,34-35H,2,16-25,40H2,1H3,(H,41,44)(H,42,45)(H,43,46)/t30?,31?,32?,34-,35+,39?/m0/s1 XNXBICLEPKJLOV-VLRPPYJTSA-N 60914 US9234000, 91 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=60914 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=60914&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 122362656 319494464 ZINC15952940 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356051 CCOc1ccc(C[C@@H](NC(=O)c2cccc(c2)C(F)(F)F)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C36H37F3N4O4/c1-2-47-30-17-15-25(16-18-30)20-32(42-33(44)28-9-6-10-29(21-28)36(37,38)39)35(46)43-31(19-24-7-4-3-5-8-24)34(45)41-23-27-13-11-26(22-40)12-14-27/h3-18,21,31-32H,2,19-20,22-23,40H2,1H3,(H,41,45)(H,42,44)(H,43,46)/t31-,32+/m0/s1 TYGDGTFXXYUGSN-AJQTZOPKSA-N 200099 US9234000, 90::US9234000, 91 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200099 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200099&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185601 318589928 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356052 CCOc1ccc(C[C@@H](NC(=O)c2ccc(C)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C36H40N4O4/c1-3-44-31-19-15-27(16-20-31)22-33(39-34(41)30-17-9-25(2)10-18-30)36(43)40-32(21-26-7-5-4-6-8-26)35(42)38-24-29-13-11-28(23-37)12-14-29/h4-20,32-33H,3,21-24,37H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t32-,33+/m0/s1 PQYXYUJVSKCKFL-JHOUSYSJSA-N 200101 US9234000, 92 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200101 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200101&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185979 318589929 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356053 CCOc1ccc(C[C@@H](NC(=O)c2ccc(Cl)c(Cl)c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H36Cl2N4O4/c1-2-45-28-15-12-24(13-16-28)19-32(40-33(42)27-14-17-29(36)30(37)20-27)35(44)41-31(18-23-6-4-3-5-7-23)34(43)39-22-26-10-8-25(21-38)9-11-26/h3-17,20,31-32H,2,18-19,21-22,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t31-,32+/m0/s1 MOIZOCHEDGLANE-AJQTZOPKSA-N 200102 US9234000, 93 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200102 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200102&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185695 318589930 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356054 CCOc1ccc(C[C@@H](NC(=O)c2cc(Cl)cc(Cl)c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H36Cl2N4O4/c1-2-45-30-14-12-24(13-15-30)17-32(40-33(42)27-18-28(36)20-29(37)19-27)35(44)41-31(16-23-6-4-3-5-7-23)34(43)39-22-26-10-8-25(21-38)9-11-26/h3-15,18-20,31-32H,2,16-17,21-22,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t31-,32+/m0/s1 SLIWSHXFSMCYGU-AJQTZOPKSA-N 200103 US9234000, 94 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200103 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200103&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 90302844 318589931 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356055 CCOc1ccc(C[C@@H](NC(=O)c2ccc(OC)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C36H40N4O5/c1-3-45-31-17-13-26(14-18-31)22-33(39-34(41)29-15-19-30(44-2)20-16-29)36(43)40-32(21-25-7-5-4-6-8-25)35(42)38-24-28-11-9-27(23-37)10-12-28/h4-20,32-33H,3,21-24,37H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t32-,33+/m0/s1 HODNEEJOSRVWQT-JHOUSYSJSA-N 200104 US9234000, 95 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200104 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200104&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185996 318589932 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356056 CCOc1ccc(C[C@@H](NC(=O)\C=C\c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C37H40N4O4/c1-2-45-32-20-17-29(18-21-32)24-34(40-35(42)22-19-27-9-5-3-6-10-27)37(44)41-33(23-28-11-7-4-8-12-28)36(43)39-26-31-15-13-30(25-38)14-16-31/h3-22,33-34H,2,23-26,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/b22-19+/t33-,34+/m0/s1 CQESEBINUPDTGP-FCVYXQAUSA-N 200105 US9234000, 96 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200105 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200105&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 89350829 318589933 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356057 CCOc1ccc(C[C@@H](N(NC(=O)Cc2ccccc2)C(C)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C38H43N5O5/c1-3-48-33-20-18-30(19-21-33)23-35(43(27(2)44)42-36(45)24-29-12-8-5-9-13-29)38(47)41-34(22-28-10-6-4-7-11-28)37(46)40-26-32-16-14-31(25-39)15-17-32/h4-21,34-35H,3,22-26,39H2,1-2H3,(H,40,46)(H,41,47)(H,42,45)/t34-,35+/m0/s1 KNHURXIHYWTCFE-OIDHKYIRSA-N 200106 US9234000, 97 Kallikrein-1 Human 4700 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200106 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200106&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185507 318589934 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356058 CCOc1ccc(C[C@@H](NC(=O)CNC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C37H41N5O5/c1-2-47-31-19-17-27(18-20-31)22-33(41-34(43)25-40-35(44)30-11-7-4-8-12-30)37(46)42-32(21-26-9-5-3-6-10-26)36(45)39-24-29-15-13-28(23-38)14-16-29/h3-20,32-33H,2,21-25,38H2,1H3,(H,39,45)(H,40,44)(H,41,43)(H,42,46)/t32-,33+/m0/s1 TZECEBPYZPAKRE-JHOUSYSJSA-N 200107 US9234000, 98 Kallikrein-1 Human 5100 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200107 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200107&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71186105 318589935 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356059 CCOc1ccc(C[C@@H](NC(=O)c2ccc(F)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H37FN4O4/c1-2-44-30-18-12-25(13-19-30)21-32(39-33(41)28-14-16-29(36)17-15-28)35(43)40-31(20-24-6-4-3-5-7-24)34(42)38-23-27-10-8-26(22-37)9-11-27/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 HAVAYEXOBKJLDE-AJQTZOPKSA-N 200108 US9234000, 99 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200108 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200108&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185850 318589936 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356060 CCOc1ccc(C[C@@H](NS(=O)(=O)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H40N4O5S/c1-2-44-31-19-17-27(18-20-31)22-33(39-45(42,43)25-30-11-7-4-8-12-30)35(41)38-32(21-26-9-5-3-6-10-26)34(40)37-24-29-15-13-28(23-36)14-16-29/h3-20,32-33,39H,2,21-25,36H2,1H3,(H,37,40)(H,38,41)/t32-,33+/m0/s1 HUGJQCPQXGEXGY-JHOUSYSJSA-N 200109 US9234000, 100 Kallikrein-1 Human 2900 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200109 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200109&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71186063 318589937 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356061 CCOc1ccc(C[C@@H](NC(=O)CNS(=O)(=O)c2ccc(C)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C37H43N5O6S/c1-3-48-31-17-15-28(16-18-31)22-34(41-35(43)25-40-49(46,47)32-19-9-26(2)10-20-32)37(45)42-33(21-27-7-5-4-6-8-27)36(44)39-24-30-13-11-29(23-38)12-14-30/h4-20,33-34,40H,3,21-25,38H2,1-2H3,(H,39,44)(H,41,43)(H,42,45)/t33-,34+/m0/s1 CFJPNXPRDSFZJB-SZAHLOSFSA-N 200110 US9234000, 101 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200110 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200110&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185485 318589938 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356062 CCOc1ccc(C[C@@H](NC(=O)Nc2ccc(Cl)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H38ClN5O4/c1-2-45-30-18-12-25(13-19-30)21-32(41-35(44)39-29-16-14-28(36)15-17-29)34(43)40-31(20-24-6-4-3-5-7-24)33(42)38-23-27-10-8-26(22-37)9-11-27/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,40,43)(H2,39,41,44)/t31-,32+/m0/s1 ZXWPCHGBHJMEBT-AJQTZOPKSA-N 200111 US9234000, 102 Kallikrein-1 Human 9000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200111 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200111&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185801 318589939 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356063 CCOc1ccc(C[C@@H](NC(=O)N(CC)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C38H45N5O4/c1-3-43(27-32-13-9-6-10-14-32)38(46)42-35(24-29-19-21-33(22-20-29)47-4-2)37(45)41-34(23-28-11-7-5-8-12-28)36(44)40-26-31-17-15-30(25-39)16-18-31/h5-22,34-35H,3-4,23-27,39H2,1-2H3,(H,40,44)(H,41,45)(H,42,46)/t34-,35+/m0/s1 YNTCROSKIQJMBI-OIDHKYIRSA-N 200112 US9234000, 103 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200112 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200112&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185811 318589940 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356064 CCOc1ccc(C[C@@H](NC(=O)c2ccc(C)nc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O4/c1-3-44-30-17-14-26(15-18-30)20-32(39-33(41)29-16-9-24(2)37-23-29)35(43)40-31(19-25-7-5-4-6-8-25)34(42)38-22-28-12-10-27(21-36)11-13-28/h4-18,23,31-32H,3,19-22,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 AWZDEIQJFXSYJV-AJQTZOPKSA-N 200113 US9234000, 104 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200113 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200113&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185969 318589941 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356065 CCOc1ccc(C[C@@H](NC(=O)c2cccnc2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O4/c1-3-44-29-17-15-26(16-18-29)21-32(39-33(41)30-10-7-19-37-24(30)2)35(43)40-31(20-25-8-5-4-6-9-25)34(42)38-23-28-13-11-27(22-36)12-14-28/h4-19,31-32H,3,20-23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 ALBLURFVONFERJ-AJQTZOPKSA-N 200114 US9234000, 105 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200114&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185978 318589942 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356066 CCOc1ccc(C[C@@H](NC(=O)c2ccc(Cl)nc2Cl)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H35Cl2N5O4/c1-2-45-26-14-12-23(13-15-26)19-29(39-32(42)27-16-17-30(35)41-31(27)36)34(44)40-28(18-22-6-4-3-5-7-22)33(43)38-21-25-10-8-24(20-37)9-11-25/h3-17,28-29H,2,18-21,37H2,1H3,(H,38,43)(H,39,42)(H,40,44)/t28-,29+/m0/s1 QQYJHIVCRMOELR-URLMMPGGSA-N 200115 US9234000, 106 Kallikrein-1 Human 8400 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200115 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200115&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499475 318589943 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356067 CCOc1ccc(C[C@@H](NC(=O)c2cnc(Cl)c(Cl)c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H35Cl2N5O4/c1-2-45-27-14-12-23(13-15-27)17-30(40-32(42)26-18-28(35)31(36)38-21-26)34(44)41-29(16-22-6-4-3-5-7-22)33(43)39-20-25-10-8-24(19-37)9-11-25/h3-15,18,21,29-30H,2,16-17,19-20,37H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t29-,30+/m0/s1 XKUREAYXZXNALY-XZWHSSHBSA-N 200116 US9234000, 107 Kallikrein-1 Human 7500 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200116 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200116&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499184 318589944 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356068 CCOc1ccc(C[C@@H](NC(=O)c2cc(F)nc(F)c2F)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H34F3N5O4/c1-2-46-25-14-12-22(13-15-25)17-28(40-32(43)26-18-29(35)42-31(37)30(26)36)34(45)41-27(16-21-6-4-3-5-7-21)33(44)39-20-24-10-8-23(19-38)9-11-24/h3-15,18,27-28H,2,16-17,19-20,38H2,1H3,(H,39,44)(H,40,43)(H,41,45)/t27-,28+/m0/s1 DCOSMQNHYNPFQB-WUFINQPMSA-N 200117 US9234000, 108 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200117 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200117&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185751 318589945 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356069 CCOc1ccc(C[C@@H](NC(=O)CC(F)(F)F)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C31H35F3N4O4/c1-2-42-25-14-12-22(13-15-25)17-27(37-28(39)18-31(32,33)34)30(41)38-26(16-21-6-4-3-5-7-21)29(40)36-20-24-10-8-23(19-35)9-11-24/h3-15,26-27H,2,16-20,35H2,1H3,(H,36,40)(H,37,39)(H,38,41)/t26-,27+/m0/s1 DBUIROVIMOGHBT-RRPNLBNLSA-N 200118 US9234000, 109 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200118 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200118&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185989 318589946 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356070 CCOc1ccc(C[C@@H](NC(=O)c2cc(C)nc(Cl)c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H38ClN5O4/c1-3-45-29-15-13-25(14-16-29)19-31(40-33(42)28-17-23(2)39-32(36)20-28)35(44)41-30(18-24-7-5-4-6-8-24)34(43)38-22-27-11-9-26(21-37)10-12-27/h4-17,20,30-31H,3,18-19,21-22,37H2,1-2H3,(H,38,43)(H,40,42)(H,41,44)/t30-,31+/m0/s1 ZAYPOTLKQDKQAV-IOWSJCHKSA-N 200119 US9234000, 110 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200119 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200119&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 89350754 318589947 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356071 CCOc1ccc(C[C@@H](NC(=O)c2sc(C)nc2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H39N5O4S/c1-4-43-28-16-14-25(15-17-28)19-30(39-34(42)31-22(2)37-23(3)44-31)33(41)38-29(18-24-8-6-5-7-9-24)32(40)36-21-27-12-10-26(20-35)11-13-27/h5-17,29-30H,4,18-21,35H2,1-3H3,(H,36,40)(H,38,41)(H,39,42)/t29-,30+/m0/s1 WBCSMOPGOQKPQY-XZWHSSHBSA-N 200120 US9234000, 111 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200120 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200120&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499173 318589948 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356072 CCOc1ccc(C[C@@H](NC(=O)c2cnc(C)s2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H37N5O4S/c1-3-42-27-15-13-24(14-16-27)18-29(38-33(41)30-21-35-22(2)43-30)32(40)37-28(17-23-7-5-4-6-8-23)31(39)36-20-26-11-9-25(19-34)10-12-26/h4-16,21,28-29H,3,17-20,34H2,1-2H3,(H,36,39)(H,37,40)(H,38,41)/t28-,29+/m0/s1 DQAPTUCUKSNJTQ-URLMMPGGSA-N 200121 US9234000, 112 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200121 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200121&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499183 318589949 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356073 CCOc1ccc(C[C@@H](NC(=O)c2nc(C)oc2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H39N5O5/c1-4-43-28-16-14-25(15-17-28)19-30(39-34(42)31-22(2)44-23(3)37-31)33(41)38-29(18-24-8-6-5-7-9-24)32(40)36-21-27-12-10-26(20-35)11-13-27/h5-17,29-30H,4,18-21,35H2,1-3H3,(H,36,40)(H,38,41)(H,39,42)/t29-,30+/m0/s1 NHVBFYCADPVHQX-XZWHSSHBSA-N 200122 US9234000, 113 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200122 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200122&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 122199211 318589950 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356074 CCOc1ccc(C[C@@H](NC(=O)c2ccc3nc(C)ccc3c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C39H41N5O4/c1-3-48-33-18-14-28(15-19-33)22-36(43-37(45)32-17-20-34-31(23-32)16-9-26(2)42-34)39(47)44-35(21-27-7-5-4-6-8-27)38(46)41-25-30-12-10-29(24-40)11-13-30/h4-20,23,35-36H,3,21-22,24-25,40H2,1-2H3,(H,41,46)(H,43,45)(H,44,47)/t35-,36+/m0/s1 WBYJFERZJIJQIQ-MPQUPPDSSA-N 200123 US9234000, 114 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200123 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200123&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 122199212 318589951 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356075 CCOc1ccc(C[C@@H](NC(=O)c2cnc3cc(Cl)ccc3c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C38H38ClN5O4/c1-2-48-32-16-12-26(13-17-32)19-35(43-36(45)30-20-29-14-15-31(39)21-33(29)41-24-30)38(47)44-34(18-25-6-4-3-5-7-25)37(46)42-23-28-10-8-27(22-40)9-11-28/h3-17,20-21,24,34-35H,2,18-19,22-23,40H2,1H3,(H,42,46)(H,43,45)(H,44,47)/t34-,35+/m0/s1 GRBCXZQPXFWSKI-OIDHKYIRSA-N 200124 US9234000, 115 Kallikrein-1 Human 9000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200124 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200124&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 122199213 318589952 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356076 CCOc1ccc(C[C@@H](NC(=O)c2sccc2Cl)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H35ClN4O4S/c1-2-42-26-14-12-23(13-15-26)19-29(38-33(41)30-27(34)16-17-43-30)32(40)37-28(18-22-6-4-3-5-7-22)31(39)36-21-25-10-8-24(20-35)9-11-25/h3-17,28-29H,2,18-21,35H2,1H3,(H,36,39)(H,37,40)(H,38,41)/t28-,29+/m0/s1 PUJHQMNZVXXXHE-URLMMPGGSA-N 200125 US9234000, 116 Kallikrein-1 Human 6300 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200125 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200125&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499185 318589953 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356077 CCOc1ccc(C[C@@H](NC(=O)c2scnc2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H37N5O4S/c1-3-42-27-15-13-24(14-16-27)18-29(38-33(41)30-22(2)36-21-43-30)32(40)37-28(17-23-7-5-4-6-8-23)31(39)35-20-26-11-9-25(19-34)10-12-26/h4-16,21,28-29H,3,17-20,34H2,1-2H3,(H,35,39)(H,37,40)(H,38,41)/t28-,29+/m0/s1 NKONHEXDLBKQFF-URLMMPGGSA-N 200126 US9234000, 117 Kallikrein-1 Human 6100 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200126 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200126&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185569 318589954 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356078 CCOc1ccc(C[C@@H](NC(=O)c2ccco2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H36N4O5/c1-2-41-27-16-14-24(15-17-27)20-29(37-33(40)30-9-6-18-42-30)32(39)36-28(19-23-7-4-3-5-8-23)31(38)35-22-26-12-10-25(21-34)11-13-26/h3-18,28-29H,2,19-22,34H2,1H3,(H,35,38)(H,36,39)(H,37,40)/t28-,29+/m0/s1 KXEHMWWWSGDRNZ-URLMMPGGSA-N 200127 US9234000, 118 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200127 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200127&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499200 318589955 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356079 CCOc1ccc(C[C@@H](NC(=O)c2sccc2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H38N4O4S/c1-3-42-28-15-13-25(14-16-28)20-30(38-34(41)31-23(2)17-18-43-31)33(40)37-29(19-24-7-5-4-6-8-24)32(39)36-22-27-11-9-26(21-35)10-12-27/h4-18,29-30H,3,19-22,35H2,1-2H3,(H,36,39)(H,37,40)(H,38,41)/t29-,30+/m0/s1 HBWHYKRQSALKFK-XZWHSSHBSA-N 200128 US9234000, 119 Kallikrein-1 Human 6100 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200128 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200128&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499201 318589956 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356080 CCOc1ccc(C[C@@H](NC(=O)c2cccc(OC)n2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O5/c1-3-45-28-18-16-25(17-19-28)21-31(40-34(42)29-10-7-11-32(38-29)44-2)35(43)39-30(20-24-8-5-4-6-9-24)33(41)37-23-27-14-12-26(22-36)13-15-27/h4-19,30-31H,3,20-23,36H2,1-2H3,(H,37,41)(H,39,43)(H,40,42)/t30-,31+/m0/s1 QJNCCZAUPWBOQN-IOWSJCHKSA-N 200129 US9234000, 120 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200129 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200129&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 122199214 318589957 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356081 CCOc1ccc(C[C@@H](NC(=O)c2cncc(OC)c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O5/c1-3-45-29-15-13-25(14-16-29)18-32(39-33(41)28-19-30(44-2)23-37-22-28)35(43)40-31(17-24-7-5-4-6-8-24)34(42)38-21-27-11-9-26(20-36)10-12-27/h4-16,19,22-23,31-32H,3,17-18,20-21,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 OGBRQNGKSNMMFK-AJQTZOPKSA-N 200130 US9234000, 121 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200130 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200130&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71186187 318589958 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356082 CCOc1ccc(C[C@@H](NC(=O)c2sccc2OC)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H38N4O5S/c1-3-43-27-15-13-24(14-16-27)20-29(38-34(41)31-30(42-2)17-18-44-31)33(40)37-28(19-23-7-5-4-6-8-23)32(39)36-22-26-11-9-25(21-35)10-12-26/h4-18,28-29H,3,19-22,35H2,1-2H3,(H,36,39)(H,37,40)(H,38,41)/t28-,29+/m0/s1 WVUHHNJRARDZRJ-URLMMPGGSA-N 200131 US9234000, 122 Kallikrein-1 Human 4800 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200131 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200131&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 122199215 318589959 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356083 CCOc1ccc(C[C@@H](NC(=O)c2ccnc(OC)c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O5/c1-3-45-29-15-13-25(14-16-29)20-31(39-33(41)28-17-18-37-32(21-28)44-2)35(43)40-30(19-24-7-5-4-6-8-24)34(42)38-23-27-11-9-26(22-36)10-12-27/h4-18,21,30-31H,3,19-20,22-23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t30-,31+/m0/s1 MHNXCQNJTDJPBJ-IOWSJCHKSA-N 200132 US9234000, 123 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200132 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200132&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185938 318589960 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356084 CCOc1ccc(C[C@@H](NC(=O)c2[nH]ccc2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H39N5O4/c1-3-43-28-15-13-25(14-16-28)20-30(39-34(42)31-23(2)17-18-36-31)33(41)38-29(19-24-7-5-4-6-8-24)32(40)37-22-27-11-9-26(21-35)10-12-27/h4-18,29-30,36H,3,19-22,35H2,1-2H3,(H,37,40)(H,38,41)(H,39,42)/t29-,30+/m0/s1 CIHUARIXQZFRDX-XZWHSSHBSA-N 200133 US9234000, 124 Kallikrein-1 Human 8400 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200133 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200133&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499278 318589961 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356085 CCOc1ccc(C[C@@H](NC(=O)c2sccc2N)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H37N5O4S/c1-2-42-26-14-12-23(13-15-26)19-29(38-33(41)30-27(35)16-17-43-30)32(40)37-28(18-22-6-4-3-5-7-22)31(39)36-21-25-10-8-24(20-34)9-11-25/h3-17,28-29H,2,18-21,34-35H2,1H3,(H,36,39)(H,37,40)(H,38,41)/t28-,29+/m0/s1 YNMNVDUWPIIZMN-URLMMPGGSA-N 200134 US9234000, 125 Kallikrein-1 Human 7000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200134 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200134&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499277 318589962 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356086 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](CC2CCCCC2)NC(=O)c2ccccc2)cc1 InChI=1S/C33H40N4O3/c34-22-26-16-18-27(19-17-26)23-35-32(39)29(20-24-10-4-1-5-11-24)37-33(40)30(21-25-12-6-2-7-13-25)36-31(38)28-14-8-3-9-15-28/h1,3-5,8-11,14-19,25,29-30H,2,6-7,12-13,20-23,34H2,(H,35,39)(H,36,38)(H,37,40)/t29-,30+/m0/s1 YIFIDQFIPIUXTH-XZWHSSHBSA-N 200135 US9234000, 126 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200135&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185486 318589963 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356087 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)c2ccccc2)cc1 InChI=1S/C33H33ClN4O3/c34-28-17-15-24(16-18-28)20-30(37-31(39)27-9-5-2-6-10-27)33(41)38-29(19-23-7-3-1-4-8-23)32(40)36-22-26-13-11-25(21-35)12-14-26/h1-18,29-30H,19-22,35H2,(H,36,40)(H,37,39)(H,38,41)/t29-,30+/m0/s1 DFTDXVAGVUMEML-XZWHSSHBSA-N 200136 US9234000, 127 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200136 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200136&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71186001 318589964 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356088 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccc(OCc3ccc(Cl)cc3)cc2)NC(=O)c2ccccc2)cc1 InChI=1S/C40H39ClN4O4/c41-34-19-15-32(16-20-34)27-49-35-21-17-29(18-22-35)24-37(44-38(46)33-9-5-2-6-10-33)40(48)45-36(23-28-7-3-1-4-8-28)39(47)43-26-31-13-11-30(25-42)12-14-31/h1-22,36-37H,23-27,42H2,(H,43,47)(H,44,46)(H,45,48)/t36-,37+/m0/s1 IHLBOTCKEIVMGZ-PQQNNWGCSA-N 200137 US9234000, 128 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200137 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200137&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71186172 318589965 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356089 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)c2ccccc2)cc1 InChI=1S/C33H34N4O4/c34-21-25-11-13-26(14-12-25)22-35-32(40)29(19-23-7-3-1-4-8-23)37-33(41)30(20-24-15-17-28(38)18-16-24)36-31(39)27-9-5-2-6-10-27/h1-18,29-30,38H,19-22,34H2,(H,35,40)(H,36,39)(H,37,41)/t29-,30+/m0/s1 ZDQNDZXAURUSJI-XZWHSSHBSA-N 200138 US9234000, 129 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200138 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200138&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185520 318589966 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356090 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccc(OCc3ccc(F)cc3)cc2)NC(=O)c2ccccc2)cc1 InChI=1S/C40H39FN4O4/c41-34-19-15-32(16-20-34)27-49-35-21-17-29(18-22-35)24-37(44-38(46)33-9-5-2-6-10-33)40(48)45-36(23-28-7-3-1-4-8-28)39(47)43-26-31-13-11-30(25-42)12-14-31/h1-22,36-37H,23-27,42H2,(H,43,47)(H,44,46)(H,45,48)/t36-,37+/m0/s1 WEVQLDNHQXUOLS-PQQNNWGCSA-N 200139 US9234000, 130 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200139 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200139&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71186175 318589967 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356091 CCCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C36H40N4O4/c1-2-21-44-31-19-17-27(18-20-31)23-33(39-34(41)30-11-7-4-8-12-30)36(43)40-32(22-26-9-5-3-6-10-26)35(42)38-25-29-15-13-28(24-37)14-16-29/h3-20,32-33H,2,21-25,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t32-,33+/m0/s1 OTUOSRRHYVCHTB-JHOUSYSJSA-N 200140 US9234000, 131 Kallikrein-1 Human 9500 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200140 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200140&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185674 318589968 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356092 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccc(OCc3ccccc3)cc2)NC(=O)c2ccccc2)cc1 InChI=1S/C40H40N4O4/c41-26-31-16-18-32(19-17-31)27-42-39(46)36(24-29-10-4-1-5-11-29)44-40(47)37(43-38(45)34-14-8-3-9-15-34)25-30-20-22-35(23-21-30)48-28-33-12-6-2-7-13-33/h1-23,36-37H,24-28,41H2,(H,42,46)(H,43,45)(H,44,47)/t36-,37+/m0/s1 QGCXWVPWNLGRGP-PQQNNWGCSA-N 200141 US9234000, 132 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200141 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200141&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185535 318589969 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356093 CC(C)C[C@@H](NC(=O)c1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1 InChI=1S/C30H36N4O3/c1-21(2)17-26(33-28(35)25-11-7-4-8-12-25)30(37)34-27(18-22-9-5-3-6-10-22)29(36)32-20-24-15-13-23(19-31)14-16-24/h3-16,21,26-27H,17-20,31H2,1-2H3,(H,32,36)(H,33,35)(H,34,37)/t26-,27+/m1/s1 SWCPUEOSXZSMHD-SXOMAYOGSA-N 200142 US9234000, 133 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200142 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200142&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185530 318589970 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356094 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccc(OCc3c(Cl)cccc3Cl)cc2)NC(=O)c2ccccc2)cc1 InChI=1S/C40H38Cl2N4O4/c41-34-12-7-13-35(42)33(34)26-50-32-20-18-28(19-21-32)23-37(45-38(47)31-10-5-2-6-11-31)40(49)46-36(22-27-8-3-1-4-9-27)39(48)44-25-30-16-14-29(24-43)15-17-30/h1-21,36-37H,22-26,43H2,(H,44,48)(H,45,47)(H,46,49)/t36-,37+/m0/s1 XCVRNFXSJAMNSP-PQQNNWGCSA-N 200143 US9234000, 134 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200143 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200143&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71186163 318589971 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356095 Cc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H36N4O3/c1-24-12-14-26(15-13-24)21-31(37-32(39)29-10-6-3-7-11-29)34(41)38-30(20-25-8-4-2-5-9-25)33(40)36-23-28-18-16-27(22-35)17-19-28/h2-19,30-31H,20-23,35H2,1H3,(H,36,40)(H,37,39)(H,38,41)/t30-,31+/m0/s1 HXMCBSSHSYKQRK-IOWSJCHKSA-N 200144 US9234000, 135 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200144 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200144&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185534 318589972 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356096 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccc(OCc3cccc(F)c3)cc2)NC(=O)c2ccccc2)cc1 InChI=1S/C40H39FN4O4/c41-34-13-7-10-32(22-34)27-49-35-20-18-29(19-21-35)24-37(44-38(46)33-11-5-2-6-12-33)40(48)45-36(23-28-8-3-1-4-9-28)39(47)43-26-31-16-14-30(25-42)15-17-31/h1-22,36-37H,23-27,42H2,(H,43,47)(H,44,46)(H,45,48)/t36-,37+/m0/s1 QLUQCWBEOZNKTG-PQQNNWGCSA-N 200145 US9234000, 136 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200145 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200145&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185576 318589973 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356097 COc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cn1 InChI=1S/C33H35N5O4/c1-42-30-17-16-26(22-35-30)19-29(37-31(39)27-10-6-3-7-11-27)33(41)38-28(18-23-8-4-2-5-9-23)32(40)36-21-25-14-12-24(20-34)13-15-25/h2-17,22,28-29H,18-21,34H2,1H3,(H,36,40)(H,37,39)(H,38,41)/t28-,29+/m0/s1 WVHMGGCVTKVQNI-URLMMPGGSA-N 200146 US9234000, 137 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200146 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200146&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185782 318589974 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356098 COc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H36N4O4/c1-42-29-18-16-25(17-19-29)21-31(37-32(39)28-10-6-3-7-11-28)34(41)38-30(20-24-8-4-2-5-9-24)33(40)36-23-27-14-12-26(22-35)13-15-27/h2-19,30-31H,20-23,35H2,1H3,(H,36,40)(H,37,39)(H,38,41)/t30-,31+/m0/s1 YOYSQDNQEZYVLQ-IOWSJCHKSA-N 200147 US9234000, 138 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200147 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200147&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185997 318589975 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356099 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)c2ccccc2)cc1 InChI=1S/C33H34N4O3/c34-22-26-16-18-27(19-17-26)23-35-32(39)29(20-24-10-4-1-5-11-24)37-33(40)30(21-25-12-6-2-7-13-25)36-31(38)28-14-8-3-9-15-28/h1-19,29-30H,20-23,34H2,(H,35,39)(H,36,38)(H,37,40)/t29-,30+/m0/s1 NGTNYFZFCLPYMX-XZWHSSHBSA-N 200148 US9234000, 139 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200148 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200148&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185608 318589976 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356100 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccn2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H37N5O4/c1-2-43-29-17-15-24(16-18-29)20-30(38-32(40)27-8-4-3-5-9-27)34(42)39-31(21-28-10-6-7-19-36-28)33(41)37-23-26-13-11-25(22-35)12-14-26/h3-19,30-31H,2,20-23,35H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t30-,31+/m1/s1 BHVUGAWTPFXTSW-JSOSNVBQSA-N 200149 US9234000, 140 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200149&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499250 318589977 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356101 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H36Cl2N4O4/c1-2-45-28-15-12-23(13-16-28)19-32(40-33(42)27-6-4-3-5-7-27)35(44)41-31(20-26-14-17-29(36)30(37)18-26)34(43)39-22-25-10-8-24(21-38)9-11-25/h3-18,31-32H,2,19-22,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t31-,32+/m0/s1 MZNWXAJMLAFTSG-AJQTZOPKSA-N 200150 US9234000, 141 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200150 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200150&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499248 318589978 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356102 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H37ClN4O4/c1-2-44-30-18-14-25(15-19-30)21-32(39-33(41)28-6-4-3-5-7-28)35(43)40-31(20-24-12-16-29(36)17-13-24)34(42)38-23-27-10-8-26(22-37)9-11-27/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 XRXPBLITZSRMPK-AJQTZOPKSA-N 200151 US9234000, 142 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200151 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200151&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499249 318589979 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356103 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccc(F)cc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H37FN4O4/c1-2-44-30-18-14-25(15-19-30)21-32(39-33(41)28-6-4-3-5-7-28)35(43)40-31(20-24-12-16-29(36)17-13-24)34(42)38-23-27-10-8-26(22-37)9-11-27/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 OVUYMWPCQQBURI-AJQTZOPKSA-N 200152 US9234000, 143 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200152&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185963 318589980 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356104 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2cccc(c2)C(F)(F)F)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C36H37F3N4O4/c1-2-47-30-17-15-24(16-18-30)20-32(42-33(44)28-8-4-3-5-9-28)35(46)43-31(21-27-7-6-10-29(19-27)36(37,38)39)34(45)41-23-26-13-11-25(22-40)12-14-26/h3-19,31-32H,2,20-23,40H2,1H3,(H,41,45)(H,42,44)(H,43,46)/t31-,32+/m0/s1 NAYGGTQDFNWPNS-AJQTZOPKSA-N 200153 US9234000, 144 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200153 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200153&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185586 318589981 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356105 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H37N5O4/c1-2-43-29-16-14-24(15-17-29)19-31(38-32(40)28-8-4-3-5-9-28)34(42)39-30(20-27-7-6-18-36-22-27)33(41)37-23-26-12-10-25(21-35)11-13-26/h3-18,22,30-31H,2,19-21,23,35H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t30-,31+/m0/s1 IOKOMILCLYAEGO-IOWSJCHKSA-N 200154 US9234000, 145 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200154 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200154&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185660 318589982 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356106 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccc(OC)cc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C36H40N4O5/c1-3-45-31-19-15-26(16-20-31)22-33(39-34(41)29-7-5-4-6-8-29)36(43)40-32(21-25-13-17-30(44-2)18-14-25)35(42)38-24-28-11-9-27(23-37)10-12-28/h4-20,32-33H,3,21-24,37H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t32-,33+/m0/s1 MNENVOCWAYYIHM-JHOUSYSJSA-N 200155 US9234000, 146 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200155 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200155&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499276 318589983 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356107 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccncc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H37N5O4/c1-2-43-29-14-12-24(13-15-29)20-31(38-32(40)28-6-4-3-5-7-28)34(42)39-30(21-25-16-18-36-19-17-25)33(41)37-23-27-10-8-26(22-35)9-11-27/h3-19,30-31H,2,20-23,35H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t30-,31+/m0/s1 MGPOPQVVNMABOI-IOWSJCHKSA-N 200156 US9234000, 147 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200156 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200156&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499304 318589984 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356108 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccc(cc2)C(F)(F)F)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C36H37F3N4O4/c1-2-47-30-18-14-25(15-19-30)21-32(42-33(44)28-6-4-3-5-7-28)35(46)43-31(20-24-12-16-29(17-13-24)36(37,38)39)34(45)41-23-27-10-8-26(22-40)9-11-27/h3-19,31-32H,2,20-23,40H2,1H3,(H,41,45)(H,42,44)(H,43,46)/t31-,32+/m0/s1 KMFPQSSNRGUHHI-AJQTZOPKSA-N 200157 US9234000, 148 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200157 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200157&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185663 318589985 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356109 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2cccc(F)c2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H37FN4O4/c1-2-44-30-17-15-24(16-18-30)20-32(39-33(41)28-8-4-3-5-9-28)35(43)40-31(21-27-7-6-10-29(36)19-27)34(42)38-23-26-13-11-25(22-37)12-14-26/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 OYMHEDPIXZJWGT-AJQTZOPKSA-N 200158 US9234000, 149 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200158&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71186117 318589986 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356110 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2cccs2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H36N4O4S/c1-2-41-27-16-14-23(15-17-27)19-29(36-31(38)26-7-4-3-5-8-26)33(40)37-30(20-28-9-6-18-42-28)32(39)35-22-25-12-10-24(21-34)11-13-25/h3-18,29-30H,2,19-22,34H2,1H3,(H,35,39)(H,36,38)(H,37,40)/t29-,30+/m1/s1 IBCRPNPROJRPGD-IHLOFXLRSA-N 200159 US9234000, 150 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200159 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200159&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499399 318589987 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356111 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccsc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H36N4O4S/c1-2-41-28-14-12-23(13-15-28)18-30(36-31(38)27-6-4-3-5-7-27)33(40)37-29(19-26-16-17-42-22-26)32(39)35-21-25-10-8-24(20-34)9-11-25/h3-17,22,29-30H,2,18-21,34H2,1H3,(H,35,39)(H,36,38)(H,37,40)/t29-,30+/m0/s1 FEEFLICHCNTQCS-XZWHSSHBSA-N 200160 US9234000, 151 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200160 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200160&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499365 318589988 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356112 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2cscn2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C32H35N5O4S/c1-2-41-27-14-12-22(13-15-27)16-28(36-30(38)25-6-4-3-5-7-25)32(40)37-29(17-26-20-42-21-35-26)31(39)34-19-24-10-8-23(18-33)9-11-24/h3-15,20-21,28-29H,2,16-19,33H2,1H3,(H,34,39)(H,36,38)(H,37,40)/t28-,29+/m1/s1 FHHIRUSMTLKWSO-WDYNHAJCSA-N 200161 US9234000, 152 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200161&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499363 318589989 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356113 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2csc3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C37H38N4O4S/c1-2-45-30-18-16-25(17-19-30)20-32(40-35(42)28-8-4-3-5-9-28)37(44)41-33(21-29-24-46-34-11-7-6-10-31(29)34)36(43)39-23-27-14-12-26(22-38)13-15-27/h3-19,24,32-33H,2,20-23,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t32-,33+/m1/s1 XQQTZKDEZFNLED-SAIUNTKASA-N 200162 US9234000, 153 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200162&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499364 318589990 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356114 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(F)c2)cc1 InChI=1S/C35H37FN4O4/c1-2-44-29-17-14-25(15-18-29)21-32(39-33(41)27-11-7-4-8-12-27)35(43)40-31(20-24-9-5-3-6-10-24)34(42)38-23-26-13-16-28(22-37)30(36)19-26/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 UXHKCWBMPOSFQY-AJQTZOPKSA-N 200163 US9234000, 154 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200163 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200163&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185721 318589991 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356115 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(Cl)c2)cc1 InChI=1S/C35H37ClN4O4/c1-2-44-29-17-14-25(15-18-29)21-32(39-33(41)27-11-7-4-8-12-27)35(43)40-31(20-24-9-5-3-6-10-24)34(42)38-23-26-13-16-28(22-37)30(36)19-26/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 NOORMTUTGSQYIZ-AJQTZOPKSA-N 200164 US9234000, 155 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200164 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200164&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499400 318589992 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356116 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(c2)C(F)(F)F)cc1 InChI=1S/C36H37F3N4O4/c1-2-47-29-17-14-25(15-18-29)21-32(42-33(44)27-11-7-4-8-12-27)35(46)43-31(20-24-9-5-3-6-10-24)34(45)41-23-26-13-16-28(22-40)30(19-26)36(37,38)39/h3-19,31-32H,2,20-23,40H2,1H3,(H,41,45)(H,42,44)(H,43,46)/t31-,32+/m0/s1 KEMDZFGHDRNLTH-AJQTZOPKSA-N 200165 US9234000, 156 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200165 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200165&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185671 318589993 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356117 CCOc1ccc(C[C@@H](NC(=O)c2ccccn2)C(=O)N[C@@H](Cc2cccs2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C32H35N5O4S/c1-2-41-25-14-12-22(13-15-25)18-28(36-31(39)27-7-3-4-16-34-27)32(40)37-29(19-26-6-5-17-42-26)30(38)35-21-24-10-8-23(20-33)9-11-24/h3-17,28-29H,2,18-21,33H2,1H3,(H,35,38)(H,36,39)(H,37,40)/t28-,29+/m1/s1 DOEHDNHECCZREA-WDYNHAJCSA-N 200166 US9234000, 157 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200166&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499431 318589994 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356118 CCOc1ccc(C[C@@H](NC(=O)c2ccc(OC)cc2)C(=O)N[C@@H](Cc2ccccn2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O5/c1-3-45-30-15-11-24(12-16-30)20-31(39-33(41)27-13-17-29(44-2)18-14-27)35(43)40-32(21-28-6-4-5-19-37-28)34(42)38-23-26-9-7-25(22-36)8-10-26/h4-19,31-32H,3,20-23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m1/s1 KGASRYBCGZUNAS-ZWXJPIIXSA-N 200167 US9234000, 158 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200167 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200167&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499401 318589995 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356119 CCOc1ccc(C[C@@H](NC(=O)c2ccccn2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(Cl)c2)cc1 InChI=1S/C34H36ClN5O4/c1-2-44-27-15-12-24(13-16-27)20-31(40-33(42)29-10-6-7-17-37-29)34(43)39-30(19-23-8-4-3-5-9-23)32(41)38-22-25-11-14-26(21-36)28(35)18-25/h3-18,30-31H,2,19-22,36H2,1H3,(H,38,41)(H,39,43)(H,40,42)/t30-,31+/m0/s1 GBUZITZBMSHALN-IOWSJCHKSA-N 200168 US9234000, 159 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200168 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200168&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499432 318589996 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356120 CCOc1ccc(C[C@@H](NC(=O)c2ccc(OC)cc2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O5/c1-3-45-30-14-10-24(11-15-30)19-32(39-33(41)28-12-16-29(44-2)17-13-28)35(43)40-31(20-27-5-4-18-37-22-27)34(42)38-23-26-8-6-25(21-36)7-9-26/h4-18,22,31-32H,3,19-21,23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 AJYZUIMBRBUFPQ-AJQTZOPKSA-N 200169 US9234000, 160 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200169&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185939 318589997 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356121 CCOc1ccc(C[C@@H](NC(=O)c2ccncc2)C(=O)N[C@@H](Cc2ccc(F)c(F)c2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H35F2N5O4/c1-2-45-27-10-7-22(8-11-27)18-31(40-32(42)26-13-15-38-16-14-26)34(44)41-30(19-25-9-12-28(35)29(36)17-25)33(43)39-21-24-5-3-23(20-37)4-6-24/h3-17,30-31H,2,18-21,37H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t30-,31+/m0/s1 UIKVVUURJYWPFD-IOWSJCHKSA-N 200170 US9234000, 161 Kallikrein-1 Human 6900 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200170 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200170&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499433 318589998 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356122 CCOc1ccc(C[C@@H](NC(=O)c2cccs2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C32H35N5O4S/c1-2-41-26-13-11-22(12-14-26)17-28(37-32(40)29-6-4-16-42-29)31(39)36-27(18-25-5-3-15-34-20-25)30(38)35-21-24-9-7-23(19-33)8-10-24/h3-16,20,27-28H,2,17-19,21,33H2,1H3,(H,35,38)(H,36,39)(H,37,40)/t27-,28+/m0/s1 QICJOCRBSRBUHC-WUFINQPMSA-N 200171 US9234000, 162 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200171 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200171&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499451 318589999 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356123 CCOc1ccc(C[C@@H](NC(=O)c2ccc(Cl)cc2)C(=O)N[C@@H](Cc2ccccn2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H36ClN5O4/c1-2-44-29-16-10-23(11-17-29)19-30(39-32(41)26-12-14-27(35)15-13-26)34(43)40-31(20-28-5-3-4-18-37-28)33(42)38-22-25-8-6-24(21-36)7-9-25/h3-18,30-31H,2,19-22,36H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t30-,31+/m1/s1 SJQWETDPGAMVES-JSOSNVBQSA-N 200172 US9234000, 163 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200172 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200172&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185934 318590000 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356124 CCOc1ccc(C[C@@H](NC(=O)c2ccc(C)cc2)C(=O)N[C@@H](Cc2ccccn2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O4/c1-3-44-30-17-13-25(14-18-30)20-31(39-33(41)28-15-7-24(2)8-16-28)35(43)40-32(21-29-6-4-5-19-37-29)34(42)38-23-27-11-9-26(22-36)10-12-27/h4-19,31-32H,3,20-23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m1/s1 XTDUCJDRKRNRPM-ZWXJPIIXSA-N 200173 US9234000, 164 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200173&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185860 318590001 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356125 CCOc1ccc(C[C@@H](NC(=O)c2ccccn2)C(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H35Cl2N5O4/c1-2-45-26-13-10-22(11-14-26)18-31(41-33(43)29-5-3-4-16-38-29)34(44)40-30(19-25-12-15-27(35)28(36)17-25)32(42)39-21-24-8-6-23(20-37)7-9-24/h3-17,30-31H,2,18-21,37H2,1H3,(H,39,42)(H,40,44)(H,41,43)/t30-,31+/m0/s1 ORHWIOJJYJCEEN-IOWSJCHKSA-N 200174 US9234000, 165 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200174&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499452 318590002 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356126 CCOc1ccc(CC(=O)CN(CCC(N)=O)[C@@H](Cc2ccccn2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C30H37N5O4/c1-2-39-27-12-10-22(11-13-27)17-26(36)21-35(16-14-29(32)37)28(18-25-5-3-4-15-33-25)30(38)34-20-24-8-6-23(19-31)7-9-24/h3-13,15,28H,2,14,16-21,31H2,1H3,(H2,32,37)(H,34,38)/t28-/m0/s1 DILSGXCGLKYUGX-NDEPHWFRSA-N 200175 US9234000, 166 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200175&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185872 318590003 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356127 CCOc1ccc(C[C@@H](NC(=O)c2ccncc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(F)c2)cc1 InChI=1S/C34H36FN5O4/c1-2-44-28-12-9-24(10-13-28)20-31(39-32(41)26-14-16-37-17-15-26)34(43)40-30(19-23-6-4-3-5-7-23)33(42)38-22-25-8-11-27(21-36)29(35)18-25/h3-18,30-31H,2,19-22,36H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t30-,31+/m0/s1 LVBXETRZHVPVHL-IOWSJCHKSA-N 200176 US9234000, 167 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200176&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71186140 318590004 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356128 CCOc1ccc(C[C@@H](NC(=O)c2ccccn2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(F)c2)cc1 InChI=1S/C34H36FN5O4/c1-2-44-27-15-12-24(13-16-27)20-31(40-33(42)29-10-6-7-17-37-29)34(43)39-30(19-23-8-4-3-5-9-23)32(41)38-22-25-11-14-26(21-36)28(35)18-25/h3-18,30-31H,2,19-22,36H2,1H3,(H,38,41)(H,39,43)(H,40,42)/t30-,31+/m0/s1 JJQFJIAMVLGSKU-IOWSJCHKSA-N 200177 US9234000, 168 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200177 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200177&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499222 318590005 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356129 CCOc1ccc(C[C@@H](NC(=O)c2cccs2)C(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H34Cl2N4O4S/c1-2-43-25-12-9-21(10-13-25)17-29(39-33(42)30-4-3-15-44-30)32(41)38-28(18-24-11-14-26(34)27(35)16-24)31(40)37-20-23-7-5-22(19-36)6-8-23/h3-16,28-29H,2,17-20,36H2,1H3,(H,37,40)(H,38,41)(H,39,42)/t28-,29+/m0/s1 GBOFJZGDOGSEJK-URLMMPGGSA-N 200178 US9234000, 169 Kallikrein-1 Human 9900 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200178&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499221 318590006 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356130 CCOc1ccc(CC(=O)CN(CCC(N)=O)[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C30H37N5O4/c1-2-39-27-11-9-22(10-12-27)16-26(36)21-35(15-13-29(32)37)28(17-25-4-3-14-33-19-25)30(38)34-20-24-7-5-23(18-31)6-8-24/h3-12,14,19,28H,2,13,15-18,20-21,31H2,1H3,(H2,32,37)(H,34,38)/t28-/m0/s1 VDZMJOARFXFULW-NDEPHWFRSA-N 200179 US9234000, 170 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200179&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 90302182 318590007 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356131 CCOc1ccc(C[C@@H](NC(=O)c2ccncc2)C(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H35Cl2N5O4/c1-2-45-27-10-7-22(8-11-27)18-31(40-32(42)26-13-15-38-16-14-26)34(44)41-30(19-25-9-12-28(35)29(36)17-25)33(43)39-21-24-5-3-23(20-37)4-6-24/h3-17,30-31H,2,18-21,37H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t30-,31+/m0/s1 OKGHJSOTBPWZDZ-IOWSJCHKSA-N 200180 US9234000, 171 Kallikrein-1 Human 9400 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200180&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499303 318590008 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356132 CCOc1ccc(C[C@@H](NC(=O)CC(F)(F)F)C(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C31H33Cl2F3N4O4/c1-2-44-23-10-7-19(8-11-23)14-27(39-28(41)16-31(34,35)36)30(43)40-26(15-22-9-12-24(32)25(33)13-22)29(42)38-18-21-5-3-20(17-37)4-6-21/h3-13,26-27H,2,14-18,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t26-,27+/m0/s1 BAAMDLCQQMJQAZ-RRPNLBNLSA-N 200181 US9234000, 172 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200181 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200181&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499332 318590009 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356133 CCOc1ccc(C[C@@H](NC(=O)c2ccc(Cl)cc2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H36ClN5O4/c1-2-44-29-15-9-23(10-16-29)18-31(39-32(41)27-11-13-28(35)14-12-27)34(43)40-30(19-26-4-3-17-37-21-26)33(42)38-22-25-7-5-24(20-36)6-8-25/h3-17,21,30-31H,2,18-20,22,36H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t30-,31+/m0/s1 COXMDBLAIZHMPI-IOWSJCHKSA-N 200182 US9234000, 173 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200182 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200182&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499330 318590010 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356134 CCOc1ccc(C[C@@H](NC(=O)c2ccno2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C31H34N6O5/c1-2-41-25-11-9-21(10-12-25)16-27(37-31(40)28-13-15-35-42-28)30(39)36-26(17-24-4-3-14-33-19-24)29(38)34-20-23-7-5-22(18-32)6-8-23/h3-15,19,26-27H,2,16-18,20,32H2,1H3,(H,34,38)(H,36,39)(H,37,40)/t26-,27+/m0/s1 GWSFNRAHPBVBJY-RRPNLBNLSA-N 200183 US9234000, 174 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200183&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499331 318590011 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356135 CCOc1ccc(C[C@@H](NC(=O)c2sccc2Cl)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C32H34ClN5O4S/c1-2-42-25-11-9-21(10-12-25)16-28(38-32(41)29-26(33)13-15-43-29)31(40)37-27(17-24-4-3-14-35-19-24)30(39)36-20-23-7-5-22(18-34)6-8-23/h3-15,19,27-28H,2,16-18,20,34H2,1H3,(H,36,39)(H,37,40)(H,38,41)/t27-,28+/m0/s1 YYYMEQVUGUUKPY-WUFINQPMSA-N 200184 US9234000, 175 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200184 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200184&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499477 318590012 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356136 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C37H39N5O4/c1-2-46-30-18-16-25(17-19-30)20-33(41-35(43)28-8-4-3-5-9-28)37(45)42-34(21-29-24-39-32-11-7-6-10-31(29)32)36(44)40-23-27-14-12-26(22-38)13-15-27/h3-19,24,33-34,39H,2,20-23,38H2,1H3,(H,40,44)(H,41,43)(H,42,45)/t33-,34+/m1/s1 GAEPCQZQRDPARJ-NOCHOARKSA-N 200185 US9234000, 176 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200185 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200185&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71187144 318590013 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356137 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C32H36N6O4/c1-2-42-27-14-12-22(13-15-27)16-28(37-30(39)25-6-4-3-5-7-25)32(41)38-29(17-26-20-34-21-36-26)31(40)35-19-24-10-8-23(18-33)9-11-24/h3-15,20-21,28-29H,2,16-19,33H2,1H3,(H,34,36)(H,35,40)(H,37,39)(H,38,41)/t28-,29+/m1/s1 AEYJQJFQRCNAIM-WDYNHAJCSA-N 200186 US9234000, 177 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200186&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71187364 318590014 C00615 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356138 CCOc1ccc(C[C@@H](NC(=O)c2ccncc2)C(=O)N[C@@H](Cc2csc3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C36H37N5O4S/c1-2-45-29-13-11-24(12-14-29)19-31(40-34(42)27-15-17-38-18-16-27)36(44)41-32(20-28-23-46-33-6-4-3-5-30(28)33)35(43)39-22-26-9-7-25(21-37)8-10-26/h3-18,23,31-32H,2,19-22,37H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t31-,32+/m1/s1 ZLHMUZNFVDTJHM-ZWXJPIIXSA-N 200187 US9234000, 178 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200187&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 76901379 318590015 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356139 CCOc1ccc(C[C@@H](NC(=O)c2sccc2NC(C)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O5S/c1-3-45-28-15-13-25(14-16-28)20-31(40-35(44)32-29(17-18-46-32)38-23(2)41)34(43)39-30(19-24-7-5-4-6-8-24)33(42)37-22-27-11-9-26(21-36)10-12-27/h4-18,30-31H,3,19-22,36H2,1-2H3,(H,37,42)(H,38,41)(H,39,43)(H,40,44)/t30-,31+/m0/s1 KDRURSLBLPTKEJ-IOWSJCHKSA-N 200188 US9234000, 179 Kallikrein-1 Human 7200 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200188 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200188&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185867 318590016 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356140 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2F)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H37FN4O4/c1-2-44-29-18-16-24(17-19-29)20-31(39-33(41)27-8-4-3-5-9-27)35(43)40-32(21-28-10-6-7-11-30(28)36)34(42)38-23-26-14-12-25(22-37)13-15-26/h3-19,31-32H,2,20-23,37H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m1/s1 SYUQOCGTPPIJGB-ZWXJPIIXSA-N 200189 US9234000, 180 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200189&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499497 318590017 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356141 CCOc1ccc(C[C@@H](NC(=O)c2sccc2C)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H37N5O4S/c1-3-42-27-12-10-23(11-13-27)17-29(38-33(41)30-22(2)14-16-43-30)32(40)37-28(18-26-5-4-15-35-20-26)31(39)36-21-25-8-6-24(19-34)7-9-25/h4-16,20,28-29H,3,17-19,21,34H2,1-2H3,(H,36,39)(H,37,40)(H,38,41)/t28-,29+/m0/s1 VEGWZKIUWVMXBY-URLMMPGGSA-N 200190 US9234000, 181 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200190 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200190&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499479 318590018 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356142 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(C)c2)cc1 InChI=1S/C36H40N4O4/c1-3-44-31-18-15-27(16-19-31)22-33(39-34(41)29-12-8-5-9-13-29)36(43)40-32(21-26-10-6-4-7-11-26)35(42)38-24-28-14-17-30(23-37)25(2)20-28/h4-20,32-33H,3,21-24,37H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t32-,33+/m0/s1 ZSQXKFNZFSFYRJ-JHOUSYSJSA-N 200191 US9234000, 182 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200191 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200191&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499478 318590019 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356143 CCOc1ccc(C[C@@H](NC(=O)c2sccc2N)C(=O)N[C@@H](Cc2cscn2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C30H34N6O4S2/c1-2-40-23-9-7-19(8-10-23)13-25(36-30(39)27-24(32)11-12-42-27)29(38)35-26(14-22-17-41-18-34-22)28(37)33-16-21-5-3-20(15-31)4-6-21/h3-12,17-18,25-26H,2,13-16,31-32H2,1H3,(H,33,37)(H,35,38)(H,36,39)/t25-,26+/m1/s1 HDDOGAGGUYGJLQ-FTJBHMTQSA-N 200192 US9234000, 183::US9234000, 187 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200192&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 76901757 318590020 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356144 CCOc1ccc(C[C@@H](NC(=O)c2sccc2Cl)C(=O)N[C@@H](Cc2cscn2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C30H32ClN5O4S2/c1-2-40-23-9-7-19(8-10-23)13-25(36-30(39)27-24(31)11-12-42-27)29(38)35-26(14-22-17-41-18-34-22)28(37)33-16-21-5-3-20(15-32)4-6-21/h3-12,17-18,25-26H,2,13-16,32H2,1H3,(H,33,37)(H,35,38)(H,36,39)/t25-,26+/m1/s1 PMTPLZNRQDJDQN-FTJBHMTQSA-N 200193 US9234000, 184 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200193 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200193&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 90302004 318590021 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356145 CCOc1ccc(C[C@@H](NC(=O)c2ccc(C)cc2)C(=O)N[C@@H](Cc2cscn2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H37N5O4S/c1-3-42-28-14-10-23(11-15-28)16-29(37-31(39)26-12-4-22(2)5-13-26)33(41)38-30(17-27-20-43-21-36-27)32(40)35-19-25-8-6-24(18-34)7-9-25/h4-15,20-21,29-30H,3,16-19,34H2,1-2H3,(H,35,40)(H,37,39)(H,38,41)/t29-,30+/m1/s1 XXXMZDCXONCQMR-IHLOFXLRSA-N 200194 US9234000, 185 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200194 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200194&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499498 318590022 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356146 CCOc1ccc(C[C@@H](NC(=O)c2[nH]ccc2C)C(=O)N[C@@H](Cc2csc3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C36H39N5O4S/c1-3-45-28-14-12-24(13-15-28)18-30(41-36(44)33-23(2)16-17-38-33)35(43)40-31(19-27-22-46-32-7-5-4-6-29(27)32)34(42)39-21-26-10-8-25(20-37)9-11-26/h4-17,22,30-31,38H,3,18-21,37H2,1-2H3,(H,39,42)(H,40,43)(H,41,44)/t30-,31+/m1/s1 GCTFSBZKSCJATJ-JSOSNVBQSA-N 200195 US9234000, 186 Kallikrein-1 Human 3800 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200195&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499499 318590023 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356147 CCOc1ccc(C[C@@H](NC(=O)c2sccc2N)C(=O)N[C@@H](Cc2cscn2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C30H34N6O4S2/c1-2-40-23-9-7-19(8-10-23)13-25(36-30(39)27-24(32)11-12-42-27)29(38)35-26(14-22-17-41-18-34-22)28(37)33-16-21-5-3-20(15-31)4-6-21/h3-12,17-18,25-26H,2,13-16,31-32H2,1H3,(H,33,37)(H,35,38)(H,36,39)/t25-,26+/m1/s1 HDDOGAGGUYGJLQ-FTJBHMTQSA-N 200192 US9234000, 183::US9234000, 187 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200192&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 76901757 318590020 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356148 CCOc1ccc(C[C@@H](NC(=O)c2sccc2NC(C)=O)C(=O)N[C@@H](Cc2csc3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C37H39N5O5S2/c1-3-47-28-14-12-24(13-15-28)18-31(42-37(46)34-30(16-17-48-34)40-23(2)43)36(45)41-32(19-27-22-49-33-7-5-4-6-29(27)33)35(44)39-21-26-10-8-25(20-38)9-11-26/h4-17,22,31-32H,3,18-21,38H2,1-2H3,(H,39,44)(H,40,43)(H,41,45)(H,42,46)/t31-,32+/m1/s1 GKOAHNGAVMWGNA-ZWXJPIIXSA-N 200197 US9234000, 188::US9234000, 195 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200197 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200197&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499156 318590024 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356149 CCOc1ccc(C[C@@H](NC(=O)c2cccc(C)c2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O4/c1-3-44-30-15-13-25(14-16-30)19-32(39-33(41)29-8-4-6-24(2)18-29)35(43)40-31(20-28-7-5-17-37-22-28)34(42)38-23-27-11-9-26(21-36)10-12-27/h4-18,22,31-32H,3,19-21,23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 SYHVZEPQLZQVQE-AJQTZOPKSA-N 200198 US9234000, 189 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200198 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200198&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499155 318590025 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356150 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2C)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O4/c1-3-44-29-16-14-25(15-17-29)19-32(39-33(41)30-9-5-4-7-24(30)2)35(43)40-31(20-28-8-6-18-37-22-28)34(42)38-23-27-12-10-26(21-36)11-13-27/h4-18,22,31-32H,3,19-21,23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 YBYIYRFQMSDYKZ-AJQTZOPKSA-N 200199 US9234000, 190 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200199 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200199&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499500 318590026 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356151 CCOc1ccc(C[C@@H](NC(=O)c2[nH]c(C)cc2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H41N5O4/c1-4-44-29-16-14-26(15-17-29)20-31(40-35(43)32-23(2)18-24(3)38-32)34(42)39-30(19-25-8-6-5-7-9-25)33(41)37-22-28-12-10-27(21-36)11-13-28/h5-18,30-31,38H,4,19-22,36H2,1-3H3,(H,37,41)(H,39,42)(H,40,43)/t30-,31+/m0/s1 WJCYGURKBSTJEJ-IOWSJCHKSA-N 200200 US9234000, 191 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200200 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200200&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499157 318590027 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356152 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)c(C)c2)cc1 InChI=1S/C35H39N5O4/c1-3-44-30-15-12-25(13-16-30)19-32(39-33(41)28-9-5-4-6-10-28)35(43)40-31(20-26-8-7-17-37-22-26)34(42)38-23-27-11-14-29(21-36)24(2)18-27/h4-18,22,31-32H,3,19-21,23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 KFOYMQXIDOVWGR-AJQTZOPKSA-N 200201 US9234000, 192 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200201&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499168 318590028 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356153 CCOc1ccc(C[C@@H](NC(=O)c2sccc2NC(C)=O)C(=O)N[C@@H](Cc2ccsc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H37N5O5S2/c1-3-43-26-10-8-22(9-11-26)16-29(38-33(42)30-27(13-15-45-30)36-21(2)39)32(41)37-28(17-25-12-14-44-20-25)31(40)35-19-24-6-4-23(18-34)5-7-24/h4-15,20,28-29H,3,16-19,34H2,1-2H3,(H,35,40)(H,36,39)(H,37,41)(H,38,42)/t28-,29+/m0/s1 FQQAMJLKTANPGO-URLMMPGGSA-N 200202 US9234000, 193 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200202&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499158 318590029 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356154 CCOc1ccc(C[C@@H](NC(=O)c2sccc2N)C(=O)N[C@@H](Cc2csc3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H37N5O4S2/c1-2-44-26-13-11-22(12-14-26)17-29(40-35(43)32-28(37)15-16-45-32)34(42)39-30(18-25-21-46-31-6-4-3-5-27(25)31)33(41)38-20-24-9-7-23(19-36)8-10-24/h3-16,21,29-30H,2,17-20,36-37H2,1H3,(H,38,41)(H,39,42)(H,40,43)/t29-,30+/m1/s1 CYVSDXJVCZURLD-IHLOFXLRSA-N 200203 US9234000, 194 Kallikrein-1 Human 7100 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200203&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 76901380 318590030 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356155 CCOc1ccc(C[C@@H](NC(=O)c2sccc2NC(C)=O)C(=O)N[C@@H](Cc2csc3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C37H39N5O5S2/c1-3-47-28-14-12-24(13-15-28)18-31(42-37(46)34-30(16-17-48-34)40-23(2)43)36(45)41-32(19-27-22-49-33-7-5-4-6-29(27)33)35(44)39-21-26-10-8-25(20-38)9-11-26/h4-17,22,31-32H,3,18-21,38H2,1-2H3,(H,39,44)(H,40,43)(H,41,45)(H,42,46)/t31-,32+/m1/s1 GKOAHNGAVMWGNA-ZWXJPIIXSA-N 200197 US9234000, 188::US9234000, 195 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200197 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200197&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71499156 318590024 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356156 CCOc1ccc(C[C@@H](NC(=O)c2sccc2Cl)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H37ClN4O4S/c1-3-43-27-15-13-24(14-16-27)19-29(38-33(41)31-28(35)17-18-44-31)34(42)39(2)30(20-23-7-5-4-6-8-23)32(40)37-22-26-11-9-25(21-36)10-12-26/h4-18,29-30H,3,19-22,36H2,1-2H3,(H,37,40)(H,38,41)/t29-,30+/m1/s1 OQLWNLNQMCZSSV-IHLOFXLRSA-N 200205 US9234000, 196 Kallikrein-1 Human 9900 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200205&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 76901566 318590031 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356157 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H]([C@H](O)c2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H38N4O5/c1-2-44-29-19-17-24(18-20-29)21-30(38-33(41)28-11-7-4-8-12-28)34(42)39-31(32(40)27-9-5-3-6-10-27)35(43)37-23-26-15-13-25(22-36)14-16-26/h3-20,30-32,40H,2,21-23,36H2,1H3,(H,37,43)(H,38,41)(H,39,42)/t30-,31+,32-/m1/s1 BCBPQVFOASQXEY-YKILCQELSA-N 200206 US9234000, 197 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200206 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200206&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71185740 318590032 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356158 CCOc1ccc(C[C@@H](NC(=O)c2sccc2Cl)C(=O)N[C@@H]([C@H](O)c2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H35ClN4O5S/c1-2-43-25-14-12-21(13-15-25)18-27(37-33(42)30-26(34)16-17-44-30)31(40)38-28(29(39)24-6-4-3-5-7-24)32(41)36-20-23-10-8-22(19-35)9-11-23/h3-17,27-29,39H,2,18-20,35H2,1H3,(H,36,41)(H,37,42)(H,38,40)/t27-,28+,29-/m1/s1 JPIQGCNQXOHJHE-SSBOKUKZSA-N 200207 US9234000, 198 Kallikrein-1 Human 9100 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200207 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200207&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 76901567 318590033 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356159 CCOc1ccc(C[C@@H](NC(=O)c2ccc(C)cc2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O4/c1-3-44-30-16-12-25(13-17-30)19-32(39-33(41)29-14-6-24(2)7-15-29)35(43)40-31(20-28-5-4-18-37-22-28)34(42)38-23-27-10-8-26(21-36)9-11-27/h4-18,22,31-32H,3,19-21,23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 QLQUHMZRFARDGM-AJQTZOPKSA-N 200208 US9234000, 199 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200208 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200208&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71204163 318590034 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356160 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccc(F)c(F)c2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H36F2N4O4/c1-2-45-28-15-12-23(13-16-28)19-32(40-33(42)27-6-4-3-5-7-27)35(44)41-31(20-26-14-17-29(36)30(37)18-26)34(43)39-22-25-10-8-24(21-38)9-11-25/h3-18,31-32H,2,19-22,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t31-,32+/m0/s1 WOXROINLYXJADA-AJQTZOPKSA-N 200209 US9234000, 200 Kallikrein-1 Human 7600 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200209 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200209&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71204124 318590035 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356161 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)C(Cc2ccc(OCC(F)(F)F)cc2)NC(=O)c2ccccc2)cc1 InChI=1S/C35H35F3N4O4/c36-35(37,38)23-46-29-17-15-25(16-18-29)20-31(41-32(43)28-9-5-2-6-10-28)34(45)42-30(19-24-7-3-1-4-8-24)33(44)40-22-27-13-11-26(21-39)12-14-27/h1-18,30-31H,19-23,39H2,(H,40,44)(H,41,43)(H,42,45)/t30-,31?/m0/s1 ZFMHHRGGDRODQQ-FSRLHOSWSA-N 200210 US9234000, 201 Kallikrein-1 Human >10000 US Patent 10.7270/Q2X065W0 aid1802100 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200210&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 71186113 318590036 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 356162 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H38N4O4/c1-2-43-30-19-17-26(18-20-30)22-32(38-33(40)29-11-7-4-8-12-29)35(42)39-31(21-25-9-5-3-6-10-25)34(41)37-24-28-15-13-27(23-36)14-16-28/h3-20,31-32H,2,21-24,36H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t31-,32+/m0/s1 UCIXIQRCAGGOJY-AJQTZOPKSA-N 200012 US9234000, 3::US9512065, N-[(R)-1-[(S)-1-(4-aminomethyl-benzylcarbamoyl)-2-phenyl-ethylcarbamoyl]-2-(4-ethoxy-phenyl)-ethyl]-benzamide Prothrombin Human >40000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200012 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=334&target=Prothrombin&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200012&enzyme=Prothrombin&column=ki&startPg=0&Increment=50&submit=Search 71185716 318589842 1 MAHVRGLQLPGCLALAALCSLVHSQHVFLAPQQARSLLQRVRRANTFLEEVRKGNLERECVEETCSYEEAFEALESSTATDVFWAKYTACETARTPRDKLAACLEGNCAEGLGTNYRGHVNITRSGIECQLWRSRYPHKPEINSTTHPGADLQENFCRNPDSSTTGPWCYTTDPTVRRQECSIPVCGQDQVTVAMTPRSEGSSVNLSPPLEQCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLNYCEEAVEEETGDGLDEDSDRAIEGRTATSEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE 1C1U,1C1V,1C1W,1C4U,1C4V,1C4Y,1C5L,1C5N,1C5O,1CA8,1D3D,1D3P,1D3Q,1D3T,1D4P,1D6W,1D9I,1DE7,1DIT,1DOJ,1DWB,1DWC,1DWD,1DWE,1EB1,1FPC,1FPH,1G30,1G32,1G37,1GHV,1GHW,1GHX,1GHY,1GJ4,1GJ5,1HAG,1HAH,1HAI,1HAO,1HAP,1HBT,1HDT,1HGT,1HLT,1HUT,1HXE,1HXF,1ID5,1IHS,1IHT,1JMO,1JOU,1JWT,1K21,1K22,1KTS,1KTT,1LHC,1LHD,1LHE,1LHF,1LHG,1MU6,1MU8,1MUE,1NM6,1NO9,1NRN,1NRO,1NRP,1NRQ,1NRR,1NRS,1NT1,1NU7,1NU9,1NY2,1NZQ,1O0D,1O2G,1O5G,1OOK,1OYT,1P8V,1PPB,1QBV,1QHR,1QJ1,1QJ6,1QJ7,1QUR,1RIW,1SB1,1SL3,1SR5,1T4U,1T4V,1TA2,1TA6,1TB6,1TBZ,1THR,1THS,1TMB,1TMT,1TMU,1TOM,1UMA,1UVS,1W7G,1WAY,1XM1,1XMN,1YPE,1YPG,1YPJ,1YPK,1YPL,1YPM,1Z71,1ZGI,1ZGV,1ZRB,2A2X,2A45,2AFQ,2ANK,2ANM,2B5T,2BDY,2BVR,2BVS,2BVX,2BXT,2BXU,2C8W,2C8X,2C8Y,2C8Z,2C90,2C93,2CF8,2CF9,2CN0,2FEQ,2FES,2GDE,2H9T,2HGT,2HNT,2HPP,2HPQ,2JH0,2JH5,2JH6,2PGQ,2PKS,2PW8,2R2M,2UUF,2UUJ,2UUK,2V3H,2V3O,2ZC9,2ZDA,2ZDV,2ZF0,2ZFF,2ZFP,2ZFQ,2ZFR,2ZG0,2ZGB,2ZGX,2ZHE,2ZHF,2ZHQ,2ZHW,2ZI2,2ZIQ,2ZNK,2ZO3,3B23,3B9F,3BEF,3BF6,3BIU,3BIV,3C1K,3C27,3D49,3DA9,3DD2,3DHK,3DT0,3DUX,3E6P,3EGK,3EQ0,3F68,3GIS,3HAT,3HTC,3K65,3LDX,3LU9,3P17,3P6Z,3P70,3PMH,3PO1,3QLP,3QTO,3QTV,3QWC,3QX5,3RLW,3RLY,3RM0,3RM2,3RML,3RMM,3RMN,3RMO,3SHA,3SHC,3SI3,3SI4,3SV2,3T5F,3TU7,3U69,3U8O,3U8R,3U8T,3U98,3U9A,3UTU,3UWJ,3VXE,3VXF,4AX9,4AYV,4AYY,4AZ2,4BAH,4BAK,4BAM,4BAN,4BAO,4BAQ,4BOH,4CH2,4CH8,4DIH,4DII,4DY7,4E05,4E06,4E7R,4HTC,4I7Y,4LOY,4LXB,4LZ1,4LZ4,4NZQ,4O03,4THN,4UD9,4UDW,4UE7,4UEH,4UFD,4UFE,4UFF,4UFG,4YES,5A2M,5AF9,5AFY,5AFZ,5AHG,5CMX,5DO4,5E8E,5EW1,5EW2,5GDS,5GIM,5JFD,5JZY,5L6N,5LCE,5LPD,5NHU,5TO3,6CYM,6EO6,6EO7,6EO8,6EO9,6EVV,6GBW,6GN7,6GWE,6HSX,6I51,6PX5,6PXJ,6T3M,6T3Q,6T4A,6T52,6T53,6T54,6T55,6T56,6T57,6T7H,6T89,6T8A,6TDT,6TKG,6TKH,6TKI,6TKJ,6TKL,6V5T,6V64,6Y02,6Y9H,6YB6,6YHG,6YHJ,6YMP,6YN3,6YQV,6YSJ,6YSX,6Z48,6Z8V,6Z8W,6Z8X,6ZGO,6ZUG,6ZUH,6ZUN,6ZUU,6ZUW,6ZUX,6ZV7,6ZV8,7AC9,7KME,7MJ5,7NTU,7PHX,7ZKL,7ZKM,7ZKN,7ZKO,8BW5,8KME Prothrombin THRB_HUMAN P00734 B2R7F7 B4E1A7 Q4QZ40 Q53H04 Q53H06 Q69EZ7 Q7Z7P3 Q9UCA1 356163 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H38N4O4/c1-2-43-30-19-17-26(18-20-30)22-32(38-33(40)29-11-7-4-8-12-29)35(42)39-31(21-25-9-5-3-6-10-25)34(41)37-24-28-15-13-27(23-36)14-16-28/h3-20,31-32H,2,21-24,36H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t31-,32+/m0/s1 UCIXIQRCAGGOJY-AJQTZOPKSA-N 200012 US9234000, 3::US9512065, N-[(R)-1-[(S)-1-(4-aminomethyl-benzylcarbamoyl)-2-phenyl-ethylcarbamoyl]-2-(4-ethoxy-phenyl)-ethyl]-benzamide Serine protease 1 Homo sapiens 10800 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200012 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200012&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search 71185716 318589842 1 MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS 1TRN,2RA3,4WWY,7Z9F,8H3S Serine protease 1 TRY1_HUMAN P07477 A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7 356164 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H38N4O4/c1-2-43-30-19-17-26(18-20-30)22-32(38-33(40)29-11-7-4-8-12-29)35(42)39-31(21-25-9-5-3-6-10-25)34(41)37-24-28-15-13-27(23-36)14-16-28/h3-20,31-32H,2,21-24,36H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t31-,32+/m0/s1 UCIXIQRCAGGOJY-AJQTZOPKSA-N 200012 US9234000, 3::US9512065, N-[(R)-1-[(S)-1-(4-aminomethyl-benzylcarbamoyl)-2-phenyl-ethylcarbamoyl]-2-(4-ethoxy-phenyl)-ethyl]-benzamide Plasminogen Homo sapiens 3500 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200012 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1516&target=Plasminogen&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200012&enzyme=Plasminogen&column=ki&startPg=0&Increment=50&submit=Search 71185716 318589842 1 MEHKEVVLLLLLFLKSGQGEPLDDYVNTQGASLFSVTKKQLGAGSIEECAAKCEEDEEFTCRAFQYHSKEQQCVIMAENRKSSIIIRMRDVVLFEKKVYLSECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILECEEECMHCSGENYDGKISKTMSGLECQAWDSQSPHAHGYIPSKFPNKNLKKNYCRNPDRELRPWCFTTDPNKRWELCDIPRCTTPPPSSGPTYQCLKGTGENYRGNVAVTVSGHTCQHWSAQTPHTHNRTPENFPCKNLDENYCRNPDGKRAPWCHTTNSQVRWEYCKIPSCDSSPVSTEQLAPTAPPELTPVVQDCYHGDGQSYRGTSSTTTTGKKCQSWSSMTPHRHQKTPENYPNAGLTMNYCRNPDADKGPWCFTTDPSVRWEYCNLKKCSGTEASVVAPPPVVLLPDVETPSEEDCMFGNGKGYRGKRATTVTGTPCQDWAAQEPHRHSIFTPETNPRAGLEKNYCRNPDGDVGGPWCYTTNPRKLYDYCDVPQCAAPSFDCGKPQVEPKKCPGRVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVMRNN 1CEA,1CEB,1HPJ,1HPK,1KI0,1KRN,1PK4,1PMK,2KJ4,2PK4,3UIR,4A5T,4CIK,4DUR,4DUU,5UGD,5UGG,6D3X,6D3Y,6D40,6OQJ,6OQK,6Q1U,6UZ4,6UZ5,7E50 Plasminogen PLMN_HUMAN P00747 Q15146 Q5TEH4 Q6PA00 356165 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H38N4O4/c1-2-43-30-19-17-26(18-20-30)22-32(38-33(40)29-11-7-4-8-12-29)35(42)39-31(21-25-9-5-3-6-10-25)34(41)37-24-28-15-13-27(23-36)14-16-28/h3-20,31-32H,2,21-24,36H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t31-,32+/m0/s1 UCIXIQRCAGGOJY-AJQTZOPKSA-N 200012 US9234000, 3::US9512065, N-[(R)-1-[(S)-1-(4-aminomethyl-benzylcarbamoyl)-2-phenyl-ethylcarbamoyl]-2-(4-ethoxy-phenyl)-ethyl]-benzamide Coagulation factor X Homo sapiens >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200012 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1341&target=Coagulation+factor+X&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200012&enzyme=Coagulation+factor+X&column=ki&startPg=0&Increment=50&submit=Search 71185716 318589842 1 MGRPLHLVLLSASLAGLLLLGESLFIRREQANNILARVTRANSFLEEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERRKRSVAQATSSSGEAPDSITWKPYDAADLDPTENPFDLLDFNQTQPERGDNNLTRIVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK 1C5M,1EZQ,1F0R,1F0S,1FAX,1FJS,1G2L,1G2M,1HCG,1IOE,1IQE,1IQF,1IQG,1IQH,1IQI,1IQJ,1IQK,1IQL,1IQM,1IQN,1KSN,1LPG,1LPK,1LPZ,1LQD,1MQ5,1MQ6,1NFU,1NFW,1NFX,1NFY,1P0S,1V3X,1WU1,1XKA,1XKB,1Z6E,2BMG,2BOH,2BOK,2BQ6,2BQ7,2BQW,2CJI,2D1J,2EI6,2EI7,2EI8,2FZZ,2G00,2GD4,2H9E,2J2U,2J34,2J38,2J4I,2J94,2J95,2JKH,2P16,2P3F,2P3T,2P3U,2P93,2P94,2P95,2PHB,2PR3,2Q1J,2RA0,2UWL,2UWO,2UWP,2VH0,2VH6,2VVC,2VVU,2VVV,2VWL,2VWM,2VWN,2VWO,2W26,2W3I,2W3K,2WYG,2WYJ,2XBV,2XBW,2XBX,2XBY,2XC0,2XC4,2XC5,2Y5F,2Y5G,2Y5H,2Y7X,2Y7Z,2Y80,2Y81,2Y82,3CEN,3CS7,3ENS,3FFG,3HPT,3IIT,3K9X,3KL6,3KQB,3KQC,3KQD,3KQE,3LIW,3M36,3M37,3Q3K,3SW2,3TK5,3TK6,4A7I,4BTI,4BTT,4BTU,4Y6D,4Y71,4Y76,4Y79,4Y7A,4Y7B,4ZH8,4ZHA,5K0H,5VOE,5VOF,7AHU,7TPP,7TPQ Coagulation factor X FA10_HUMAN P00742 Q14340 356166 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H38N4O4/c1-2-43-30-19-17-26(18-20-30)22-32(38-33(40)29-11-7-4-8-12-29)35(42)39-31(21-25-9-5-3-6-10-25)34(41)37-24-28-15-13-27(23-36)14-16-28/h3-20,31-32H,2,21-24,36H2,1H3,(H,37,41)(H,38,40)(H,39,42)/t31-,32+/m0/s1 UCIXIQRCAGGOJY-AJQTZOPKSA-N 200012 US9234000, 3::US9512065, N-[(R)-1-[(S)-1-(4-aminomethyl-benzylcarbamoyl)-2-phenyl-ethylcarbamoyl]-2-(4-ethoxy-phenyl)-ethyl]-benzamide Coagulation factor XII Human >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200012 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8446&target=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200012&enzyme=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search 71185716 318589842 1 MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS 4XDE,4XE4,6B74,6B77,6GT6,6L63,6SZW,6X0S,6X0T,7FBP,7PRJ,7PRK Coagulation factor XII FA12_HUMAN P00748 P78339 356167 CCOc1ccc(cc1)[C@H](C(=O)NCCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccc(CN)cc1)c1ccccc1 InChI=1S/C36H40N4O4/c1-2-44-31-19-17-30(18-20-31)34(29-11-7-4-8-12-29)36(43)38-22-21-33(41)40-32(23-26-9-5-3-6-10-26)35(42)39-25-28-15-13-27(24-37)14-16-28/h3-20,32,34H,2,21-25,37H2,1H3,(H,38,43)(H,39,42)(H,40,41)/t32-,34+/m0/s1 SWVKHIKGEAHJDC-UZNNEEJFSA-N 200094 US9234000, 85 Coagulation factor XII Human >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200094 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8446&target=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200094&enzyme=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search 122199210 318589923 1 MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS 4XDE,4XE4,6B74,6B77,6GT6,6L63,6SZW,6X0S,6X0T,7FBP,7PRJ,7PRK Coagulation factor XII FA12_HUMAN P00748 P78339 356168 CCOc1ccc(C[C@@H](NC(=O)C23CC4CC(CC(C4)C2)C3)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C39H48N4O4/c1-2-47-33-14-12-27(13-15-33)20-35(43-38(46)39-21-30-16-31(22-39)18-32(17-30)23-39)37(45)42-34(19-26-6-4-3-5-7-26)36(44)41-25-29-10-8-28(24-40)9-11-29/h3-15,30-32,34-35H,2,16-25,40H2,1H3,(H,41,44)(H,42,45)(H,43,46)/t30?,31?,32?,34-,35+,39?/m0/s1 XNXBICLEPKJLOV-VLRPPYJTSA-N 60914 US9234000, 91 Coagulation factor XII Human >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=60914 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8446&target=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=60914&enzyme=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search 122362656 319494464 ZINC15952940 1 MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS 4XDE,4XE4,6B74,6B77,6GT6,6L63,6SZW,6X0S,6X0T,7FBP,7PRJ,7PRK Coagulation factor XII FA12_HUMAN P00748 P78339 356169 CCOc1ccc(C[C@@H](NC(=O)c2ccc(C)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C36H40N4O4/c1-3-44-31-19-15-27(16-20-31)22-33(39-34(41)30-17-9-25(2)10-18-30)36(43)40-32(21-26-7-5-4-6-8-26)35(42)38-24-29-13-11-28(23-37)12-14-29/h4-20,32-33H,3,21-24,37H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t32-,33+/m0/s1 PQYXYUJVSKCKFL-JHOUSYSJSA-N 200101 US9234000, 92 Coagulation factor XII Human >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200101 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8446&target=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200101&enzyme=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search 71185979 318589929 1 MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS 4XDE,4XE4,6B74,6B77,6GT6,6L63,6SZW,6X0S,6X0T,7FBP,7PRJ,7PRK Coagulation factor XII FA12_HUMAN P00748 P78339 356170 CCOc1ccc(C[C@@H](NC(=O)c2ccc(Cl)c(Cl)c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H36Cl2N4O4/c1-2-45-28-15-12-24(13-16-28)19-32(40-33(42)27-14-17-29(36)30(37)20-27)35(44)41-31(18-23-6-4-3-5-7-23)34(43)39-22-26-10-8-25(21-38)9-11-26/h3-17,20,31-32H,2,18-19,21-22,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t31-,32+/m0/s1 MOIZOCHEDGLANE-AJQTZOPKSA-N 200102 US9234000, 93 Coagulation factor XII Human >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200102 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8446&target=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200102&enzyme=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search 71185695 318589930 1 MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS 4XDE,4XE4,6B74,6B77,6GT6,6L63,6SZW,6X0S,6X0T,7FBP,7PRJ,7PRK Coagulation factor XII FA12_HUMAN P00748 P78339 356171 CCOc1ccc(C[C@@H](NC(=O)c2cc(Cl)cc(Cl)c2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H36Cl2N4O4/c1-2-45-30-14-12-24(13-15-30)17-32(40-33(42)27-18-28(36)20-29(37)19-27)35(44)41-31(16-23-6-4-3-5-7-23)34(43)39-22-26-10-8-25(21-38)9-11-26/h3-15,18-20,31-32H,2,16-17,21-22,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t31-,32+/m0/s1 SLIWSHXFSMCYGU-AJQTZOPKSA-N 200103 US9234000, 94 Coagulation factor XII Human >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200103 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8446&target=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200103&enzyme=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search 90302844 318589931 1 MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS 4XDE,4XE4,6B74,6B77,6GT6,6L63,6SZW,6X0S,6X0T,7FBP,7PRJ,7PRK Coagulation factor XII FA12_HUMAN P00748 P78339 356172 CCOc1ccc(C[C@@H](NC(=O)c2ccc(OC)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C36H40N4O5/c1-3-45-31-17-13-26(14-18-31)22-33(39-34(41)29-15-19-30(44-2)20-16-29)36(43)40-32(21-25-7-5-4-6-8-25)35(42)38-24-28-11-9-27(23-37)10-12-28/h4-20,32-33H,3,21-24,37H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t32-,33+/m0/s1 HODNEEJOSRVWQT-JHOUSYSJSA-N 200104 US9234000, 95 Coagulation factor XII Human >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200104 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8446&target=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200104&enzyme=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search 71185996 318589932 1 MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS 4XDE,4XE4,6B74,6B77,6GT6,6L63,6SZW,6X0S,6X0T,7FBP,7PRJ,7PRK Coagulation factor XII FA12_HUMAN P00748 P78339 356173 CCOc1ccc(C[C@@H](NC(=O)\C=C\c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C37H40N4O4/c1-2-45-32-20-17-29(18-21-32)24-34(40-35(42)22-19-27-9-5-3-6-10-27)37(44)41-33(23-28-11-7-4-8-12-28)36(43)39-26-31-15-13-30(25-38)14-16-31/h3-22,33-34H,2,23-26,38H2,1H3,(H,39,43)(H,40,42)(H,41,44)/b22-19+/t33-,34+/m0/s1 CQESEBINUPDTGP-FCVYXQAUSA-N 200105 US9234000, 96 Coagulation factor XII Human >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200105 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8446&target=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200105&enzyme=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search 89350829 318589933 1 MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS 4XDE,4XE4,6B74,6B77,6GT6,6L63,6SZW,6X0S,6X0T,7FBP,7PRJ,7PRK Coagulation factor XII FA12_HUMAN P00748 P78339 356174 CCOc1ccc(C[C@@H](NC(=O)c2ccccn2)C(=O)N[C@@H](Cc2cccs2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C32H35N5O4S/c1-2-41-25-14-12-22(13-15-25)18-28(36-31(39)27-7-3-4-16-34-27)32(40)37-29(19-26-6-5-17-42-26)30(38)35-21-24-10-8-23(20-33)9-11-24/h3-17,28-29H,2,18-21,33H2,1H3,(H,35,38)(H,36,39)(H,37,40)/t28-,29+/m1/s1 DOEHDNHECCZREA-WDYNHAJCSA-N 200166 US9234000, 157 Coagulation factor XII Human >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8446&target=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200166&enzyme=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search 71499431 318589994 1 MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS 4XDE,4XE4,6B74,6B77,6GT6,6L63,6SZW,6X0S,6X0T,7FBP,7PRJ,7PRK Coagulation factor XII FA12_HUMAN P00748 P78339 356175 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)c(C)c2)cc1 InChI=1S/C36H40N4O4/c1-3-44-31-18-15-27(16-19-31)22-33(39-34(41)29-12-8-5-9-13-29)36(43)40-32(21-26-10-6-4-7-11-26)35(42)38-24-28-14-17-30(23-37)25(2)20-28/h4-20,32-33H,3,21-24,37H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t32-,33+/m0/s1 ZSQXKFNZFSFYRJ-JHOUSYSJSA-N 200191 US9234000, 182 Coagulation factor XII Human >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200191 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8446&target=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200191&enzyme=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search 71499478 318590019 1 MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS 4XDE,4XE4,6B74,6B77,6GT6,6L63,6SZW,6X0S,6X0T,7FBP,7PRJ,7PRK Coagulation factor XII FA12_HUMAN P00748 P78339 356176 CCOc1ccc(C[C@@H](NC(=O)c2sccc2N)C(=O)N[C@@H](Cc2cscn2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C30H34N6O4S2/c1-2-40-23-9-7-19(8-10-23)13-25(36-30(39)27-24(32)11-12-42-27)29(38)35-26(14-22-17-41-18-34-22)28(37)33-16-21-5-3-20(15-31)4-6-21/h3-12,17-18,25-26H,2,13-16,31-32H2,1H3,(H,33,37)(H,35,38)(H,36,39)/t25-,26+/m1/s1 HDDOGAGGUYGJLQ-FTJBHMTQSA-N 200192 US9234000, 183::US9234000, 187 Coagulation factor XII Human >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8446&target=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200192&enzyme=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search 76901757 318590020 1 MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS 4XDE,4XE4,6B74,6B77,6GT6,6L63,6SZW,6X0S,6X0T,7FBP,7PRJ,7PRK Coagulation factor XII FA12_HUMAN P00748 P78339 356177 CCOc1ccc(C[C@@H](NC(=O)c2sccc2Cl)C(=O)N[C@@H](Cc2cscn2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C30H32ClN5O4S2/c1-2-40-23-9-7-19(8-10-23)13-25(36-30(39)27-24(31)11-12-42-27)29(38)35-26(14-22-17-41-18-34-22)28(37)33-16-21-5-3-20(15-32)4-6-21/h3-12,17-18,25-26H,2,13-16,32H2,1H3,(H,33,37)(H,35,38)(H,36,39)/t25-,26+/m1/s1 PMTPLZNRQDJDQN-FTJBHMTQSA-N 200193 US9234000, 184 Coagulation factor XII Human >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200193 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8446&target=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200193&enzyme=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search 90302004 318590021 1 MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS 4XDE,4XE4,6B74,6B77,6GT6,6L63,6SZW,6X0S,6X0T,7FBP,7PRJ,7PRK Coagulation factor XII FA12_HUMAN P00748 P78339 356178 CCOc1ccc(C[C@@H](NC(=O)c2ccc(C)cc2)C(=O)N[C@@H](Cc2cscn2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H37N5O4S/c1-3-42-28-14-10-23(11-15-28)16-29(37-31(39)26-12-4-22(2)5-13-26)33(41)38-30(17-27-20-43-21-36-27)32(40)35-19-25-8-6-24(18-34)7-9-25/h4-15,20-21,29-30H,3,16-19,34H2,1-2H3,(H,35,40)(H,37,39)(H,38,41)/t29-,30+/m1/s1 XXXMZDCXONCQMR-IHLOFXLRSA-N 200194 US9234000, 185 Coagulation factor XII Human >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200194 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8446&target=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200194&enzyme=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search 71499498 318590022 1 MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS 4XDE,4XE4,6B74,6B77,6GT6,6L63,6SZW,6X0S,6X0T,7FBP,7PRJ,7PRK Coagulation factor XII FA12_HUMAN P00748 P78339 356179 CCOc1ccc(C[C@@H](NC(=O)c2[nH]ccc2C)C(=O)N[C@@H](Cc2csc3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C36H39N5O4S/c1-3-45-28-14-12-24(13-15-28)18-30(41-36(44)33-23(2)16-17-38-33)35(43)40-31(19-27-22-46-32-7-5-4-6-29(27)32)34(42)39-21-26-10-8-25(20-37)9-11-26/h4-17,22,30-31,38H,3,18-21,37H2,1-2H3,(H,39,42)(H,40,43)(H,41,44)/t30-,31+/m1/s1 GCTFSBZKSCJATJ-JSOSNVBQSA-N 200195 US9234000, 186 Coagulation factor XII Human >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8446&target=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200195&enzyme=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search 71499499 318590023 1 MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS 4XDE,4XE4,6B74,6B77,6GT6,6L63,6SZW,6X0S,6X0T,7FBP,7PRJ,7PRK Coagulation factor XII FA12_HUMAN P00748 P78339 356180 CCOc1ccc(C[C@@H](NC(=O)c2sccc2N)C(=O)N[C@@H](Cc2cscn2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C30H34N6O4S2/c1-2-40-23-9-7-19(8-10-23)13-25(36-30(39)27-24(32)11-12-42-27)29(38)35-26(14-22-17-41-18-34-22)28(37)33-16-21-5-3-20(15-31)4-6-21/h3-12,17-18,25-26H,2,13-16,31-32H2,1H3,(H,33,37)(H,35,38)(H,36,39)/t25-,26+/m1/s1 HDDOGAGGUYGJLQ-FTJBHMTQSA-N 200192 US9234000, 183::US9234000, 187 Coagulation factor XII Human >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8446&target=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200192&enzyme=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search 76901757 318590020 1 MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS 4XDE,4XE4,6B74,6B77,6GT6,6L63,6SZW,6X0S,6X0T,7FBP,7PRJ,7PRK Coagulation factor XII FA12_HUMAN P00748 P78339 356181 CCOc1ccc(C[C@@H](NC(=O)c2sccc2NC(C)=O)C(=O)N[C@@H](Cc2csc3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C37H39N5O5S2/c1-3-47-28-14-12-24(13-15-28)18-31(42-37(46)34-30(16-17-48-34)40-23(2)43)36(45)41-32(19-27-22-49-33-7-5-4-6-29(27)33)35(44)39-21-26-10-8-25(20-38)9-11-26/h4-17,22,31-32H,3,18-21,38H2,1-2H3,(H,39,44)(H,40,43)(H,41,45)(H,42,46)/t31-,32+/m1/s1 GKOAHNGAVMWGNA-ZWXJPIIXSA-N 200197 US9234000, 188::US9234000, 195 Coagulation factor XII Human >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200197 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8446&target=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200197&enzyme=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search 71499156 318590024 1 MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS 4XDE,4XE4,6B74,6B77,6GT6,6L63,6SZW,6X0S,6X0T,7FBP,7PRJ,7PRK Coagulation factor XII FA12_HUMAN P00748 P78339 356182 CCOc1ccc(C[C@@H](NC(=O)c2cccc(C)c2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O4/c1-3-44-30-15-13-25(14-16-30)19-32(39-33(41)29-8-4-6-24(2)18-29)35(43)40-31(20-28-7-5-17-37-22-28)34(42)38-23-27-11-9-26(21-36)10-12-27/h4-18,22,31-32H,3,19-21,23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 SYHVZEPQLZQVQE-AJQTZOPKSA-N 200198 US9234000, 189 Coagulation factor XII Human >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200198 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8446&target=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200198&enzyme=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search 71499155 318590025 1 MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS 4XDE,4XE4,6B74,6B77,6GT6,6L63,6SZW,6X0S,6X0T,7FBP,7PRJ,7PRK Coagulation factor XII FA12_HUMAN P00748 P78339 356183 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2C)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O4/c1-3-44-29-16-14-25(15-17-29)19-32(39-33(41)30-9-5-4-7-24(30)2)35(43)40-31(20-28-8-6-18-37-22-28)34(42)38-23-27-12-10-26(21-36)11-13-27/h4-18,22,31-32H,3,19-21,23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 YBYIYRFQMSDYKZ-AJQTZOPKSA-N 200199 US9234000, 190 Coagulation factor XII Human >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200199 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8446&target=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200199&enzyme=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search 71499500 318590026 1 MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS 4XDE,4XE4,6B74,6B77,6GT6,6L63,6SZW,6X0S,6X0T,7FBP,7PRJ,7PRK Coagulation factor XII FA12_HUMAN P00748 P78339 356184 CCOc1ccc(C[C@@H](NC(=O)c2[nH]c(C)cc2C)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H41N5O4/c1-4-44-29-16-14-26(15-17-29)20-31(40-35(43)32-23(2)18-24(3)38-32)34(42)39-30(19-25-8-6-5-7-9-25)33(41)37-22-28-12-10-27(21-36)11-13-28/h5-18,30-31,38H,4,19-22,36H2,1-3H3,(H,37,41)(H,39,42)(H,40,43)/t30-,31+/m0/s1 WJCYGURKBSTJEJ-IOWSJCHKSA-N 200200 US9234000, 191 Coagulation factor XII Human >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200200 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8446&target=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200200&enzyme=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search 71499157 318590027 1 MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS 4XDE,4XE4,6B74,6B77,6GT6,6L63,6SZW,6X0S,6X0T,7FBP,7PRJ,7PRK Coagulation factor XII FA12_HUMAN P00748 P78339 356185 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)c(C)c2)cc1 InChI=1S/C35H39N5O4/c1-3-44-30-15-12-25(13-16-30)19-32(39-33(41)28-9-5-4-6-10-28)35(43)40-31(20-26-8-7-17-37-22-26)34(42)38-23-27-11-14-29(21-36)24(2)18-27/h4-18,22,31-32H,3,19-21,23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 KFOYMQXIDOVWGR-AJQTZOPKSA-N 200201 US9234000, 192 Coagulation factor XII Human >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8446&target=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200201&enzyme=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search 71499168 318590028 1 MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS 4XDE,4XE4,6B74,6B77,6GT6,6L63,6SZW,6X0S,6X0T,7FBP,7PRJ,7PRK Coagulation factor XII FA12_HUMAN P00748 P78339 356186 CCOc1ccc(C[C@@H](NC(=O)c2sccc2NC(C)=O)C(=O)N[C@@H](Cc2ccsc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H37N5O5S2/c1-3-43-26-10-8-22(9-11-26)16-29(38-33(42)30-27(13-15-45-30)36-21(2)39)32(41)37-28(17-25-12-14-44-20-25)31(40)35-19-24-6-4-23(18-34)5-7-24/h4-15,20,28-29H,3,16-19,34H2,1-2H3,(H,35,40)(H,36,39)(H,37,41)(H,38,42)/t28-,29+/m0/s1 FQQAMJLKTANPGO-URLMMPGGSA-N 200202 US9234000, 193 Coagulation factor XII Human >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8446&target=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200202&enzyme=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search 71499158 318590029 1 MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS 4XDE,4XE4,6B74,6B77,6GT6,6L63,6SZW,6X0S,6X0T,7FBP,7PRJ,7PRK Coagulation factor XII FA12_HUMAN P00748 P78339 356187 CCOc1ccc(C[C@@H](NC(=O)c2sccc2N)C(=O)N[C@@H](Cc2csc3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H37N5O4S2/c1-2-44-26-13-11-22(12-14-26)17-29(40-35(43)32-28(37)15-16-45-32)34(42)39-30(18-25-21-46-31-6-4-3-5-27(25)31)33(41)38-20-24-9-7-23(19-36)8-10-24/h3-16,21,29-30H,2,17-20,36-37H2,1H3,(H,38,41)(H,39,42)(H,40,43)/t29-,30+/m1/s1 CYVSDXJVCZURLD-IHLOFXLRSA-N 200203 US9234000, 194 Coagulation factor XII Human >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8446&target=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200203&enzyme=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search 76901380 318590030 1 MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS 4XDE,4XE4,6B74,6B77,6GT6,6L63,6SZW,6X0S,6X0T,7FBP,7PRJ,7PRK Coagulation factor XII FA12_HUMAN P00748 P78339 356188 CCOc1ccc(C[C@@H](NC(=O)c2sccc2NC(C)=O)C(=O)N[C@@H](Cc2csc3ccccc23)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C37H39N5O5S2/c1-3-47-28-14-12-24(13-15-28)18-31(42-37(46)34-30(16-17-48-34)40-23(2)43)36(45)41-32(19-27-22-49-33-7-5-4-6-29(27)33)35(44)39-21-26-10-8-25(20-38)9-11-26/h4-17,22,31-32H,3,18-21,38H2,1-2H3,(H,39,44)(H,40,43)(H,41,45)(H,42,46)/t31-,32+/m1/s1 GKOAHNGAVMWGNA-ZWXJPIIXSA-N 200197 US9234000, 188::US9234000, 195 Coagulation factor XII Human >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200197 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8446&target=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200197&enzyme=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search 71499156 318590024 1 MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS 4XDE,4XE4,6B74,6B77,6GT6,6L63,6SZW,6X0S,6X0T,7FBP,7PRJ,7PRK Coagulation factor XII FA12_HUMAN P00748 P78339 356189 CCOc1ccc(C[C@@H](NC(=O)c2sccc2Cl)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C34H37ClN4O4S/c1-3-43-27-15-13-24(14-16-27)19-29(38-33(41)31-28(35)17-18-44-31)34(42)39(2)30(20-23-7-5-4-6-8-23)32(40)37-22-26-11-9-25(21-36)10-12-26/h4-18,29-30H,3,19-22,36H2,1-2H3,(H,37,40)(H,38,41)/t29-,30+/m1/s1 OQLWNLNQMCZSSV-IHLOFXLRSA-N 200205 US9234000, 196 Coagulation factor XII Human >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8446&target=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200205&enzyme=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search 76901566 318590031 1 MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS 4XDE,4XE4,6B74,6B77,6GT6,6L63,6SZW,6X0S,6X0T,7FBP,7PRJ,7PRK Coagulation factor XII FA12_HUMAN P00748 P78339 356190 CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H]([C@H](O)c2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H38N4O5/c1-2-44-29-19-17-24(18-20-29)21-30(38-33(41)28-11-7-4-8-12-28)34(42)39-31(32(40)27-9-5-3-6-10-27)35(43)37-23-26-15-13-25(22-36)14-16-26/h3-20,30-32,40H,2,21-23,36H2,1H3,(H,37,43)(H,38,41)(H,39,42)/t30-,31+,32-/m1/s1 BCBPQVFOASQXEY-YKILCQELSA-N 200206 US9234000, 197 Coagulation factor XII Human >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200206 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8446&target=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200206&enzyme=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search 71185740 318590032 1 MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS 4XDE,4XE4,6B74,6B77,6GT6,6L63,6SZW,6X0S,6X0T,7FBP,7PRJ,7PRK Coagulation factor XII FA12_HUMAN P00748 P78339 356191 CCOc1ccc(C[C@@H](NC(=O)c2sccc2Cl)C(=O)N[C@@H]([C@H](O)c2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C33H35ClN4O5S/c1-2-43-25-14-12-21(13-15-25)18-27(37-33(42)30-26(34)16-17-44-30)31(40)38-28(29(39)24-6-4-3-5-7-24)32(41)36-20-23-10-8-22(19-35)9-11-23/h3-17,27-29,39H,2,18-20,35H2,1H3,(H,36,41)(H,37,42)(H,38,40)/t27-,28+,29-/m1/s1 JPIQGCNQXOHJHE-SSBOKUKZSA-N 200207 US9234000, 198 Coagulation factor XII Human >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200207 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8446&target=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200207&enzyme=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search 76901567 318590033 1 MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS 4XDE,4XE4,6B74,6B77,6GT6,6L63,6SZW,6X0S,6X0T,7FBP,7PRJ,7PRK Coagulation factor XII FA12_HUMAN P00748 P78339 356192 CCOc1ccc(C[C@@H](NC(=O)c2ccc(C)cc2)C(=O)N[C@@H](Cc2cccnc2)C(=O)NCc2ccc(CN)cc2)cc1 InChI=1S/C35H39N5O4/c1-3-44-30-16-12-25(13-17-30)19-32(39-33(41)29-14-6-24(2)7-15-29)35(43)40-31(20-28-5-4-18-37-22-28)34(42)38-23-27-10-8-26(21-36)9-11-27/h4-18,22,31-32H,3,19-21,23,36H2,1-2H3,(H,38,42)(H,39,41)(H,40,43)/t31-,32+/m0/s1 QLQUHMZRFARDGM-AJQTZOPKSA-N 200208 US9234000, 199 Coagulation factor XII Human >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200208 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8446&target=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200208&enzyme=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search 71204163 318590034 1 MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS 4XDE,4XE4,6B74,6B77,6GT6,6L63,6SZW,6X0S,6X0T,7FBP,7PRJ,7PRK Coagulation factor XII FA12_HUMAN P00748 P78339 356193 NCc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)C(Cc2ccc(OCC(F)(F)F)cc2)NC(=O)c2ccccc2)cc1 InChI=1S/C35H35F3N4O4/c36-35(37,38)23-46-29-17-15-25(16-18-29)20-31(41-32(43)28-9-5-2-6-10-28)34(45)42-30(19-24-7-3-1-4-8-24)33(44)40-22-27-13-11-26(21-39)12-14-27/h1-18,30-31H,19-23,39H2,(H,40,44)(H,41,43)(H,42,45)/t30-,31?/m0/s1 ZFMHHRGGDRODQQ-FSRLHOSWSA-N 200210 US9234000, 201 Coagulation factor XII Human >10000 US Patent 10.7270/Q2X065W0 aid1802101 US9234000 Evans, DM; Davie, RL; Edwards, HJ; Rooker, DP 1/12/2016 11/8/2016 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=200210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8446&target=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=200210&enzyme=Coagulation+factor+XII&column=ki&startPg=0&Increment=50&submit=Search 71186113 318590036 1 MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS 4XDE,4XE4,6B74,6B77,6GT6,6L63,6SZW,6X0S,6X0T,7FBP,7PRJ,7PRK Coagulation factor XII FA12_HUMAN P00748 P78339